_id,cohorts.0.id,cohorts.0.label,dataUseConditions.id,dataUseConditions.label,description,externalReferences.0.id,externalReferences.0.label,histologicalDiagnosis.id,histologicalDiagnosis.label,icdoMorphology.id,icdoMorphology.label,icdoTopography.id,icdoTopography.label,id,individualAgeAtCollection,individualId,info.callsetIds.0,info.cnvstatistics.cnvcoverage,info.cnvstatistics.cnvfraction,info.cnvstatistics.delcoverage,info.cnvstatistics.delfraction,info.cnvstatistics.dupcoverage,info.cnvstatistics.dupfraction,info.legacyId.0,pathologicalStage,provenance.geoLocation.geometry.coordinates.0,provenance.geoLocation.geometry.coordinates.1,provenance.geoLocation.geometry.type,provenance.geoLocation.properties.ISO3166alpha3,provenance.geoLocation.properties.city,provenance.geoLocation.properties.country,provenance.geoLocation.properties.label,provenance.geoLocation.properties.latitude,provenance.geoLocation.properties.longitude,provenance.geoLocation.properties.precision,provenance.geoLocation.type,provenance.material.id,provenance.material.label,sampledTissue.id,sampledTissue.label,tumorGrade,updated,info.death,info.followupMonths,info.tnm,pathologicalStage.id,pathologicalStage.label,pathologicalTnmFindings.0.id,pathologicalTnmFindings.0.label,externalReferences.1.id,externalReferences.1.label,pathologicalTnmFindings.1.id,pathologicalTnmFindings.1.label,pathologicalTnmFindings.2.id,pathologicalTnmFindings.2.label,cohorts.1.id,cohorts.1.label,cohorts.2.id,cohorts.2.label,provenance.populations.0.confidence,provenance.populations.0.description,provenance.populations.0.type.id,provenance.populations.0.type.label,provenance.populations.1.confidence,provenance.populations.1.description,provenance.populations.1.type.id,provenance.populations.1.type.label,externalReferences.2.id,externalReferences.2.label,externalReferences.3.id,externalReferences.3.label,cohorts.3.id,cohorts.3.label,externalReferences.0.description,externalReferences.1.description,externalReferences.2.description,info.tumorStage,externalReferences.3.description,info.provenance,externalReferences.4.description,externalReferences.4.id,externalReferences.4.label,cohorts.4.id,cohorts.4.label,info.samplesource,info.seer,info.cellLine,tumorGrade.id,tumorGrade.label,ageAtCollection.age,ageAtCollection.ageClass.id,ageAtCollection.ageClass.label,projectId,sex
5bab56c2727983b2e00abd59,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,refractory cytopenia with multilineage dysplasia and ring sideroblasts,PMID:20645416,"Mackinnon RN, Selan C et al. (2010): The paradox of 20q11.21 amplification in...",NCIT:C27753,Acute Myeloid Leukemia Not Otherwise Specified,icdom-98613,"Acute myeloid leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgmrz,P89Y,pgxind-kftx2doz,pgxcs-kftvndbv,255000987,0.089,188634196,0.066,66366791,0.023,PGX_AM_BS_20645416_AML-mac-SVH01,{},144.96,-37.81,Point,AUS,Melbourne,Australia,"Melbourne, Australia",-37.81,144.96,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:12.694000,0,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abd5b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,acute myeloid leukemia [erythroleukemia],PMID:20645416,"Mackinnon RN, Selan C et al. (2010): The paradox of 20q11.21 amplification in...",NCIT:C27753,Acute Myeloid Leukemia Not Otherwise Specified,icdom-98613,"Acute myeloid leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgms2,P38Y,pgxind-kftx2dp3,pgxcs-kftvndcs,120011665,0.042,118183660,0.041,1828005,0.001,PGX_AM_BS_20645416_AML-mac-SVH05r,{},144.96,-37.81,Point,AUS,Melbourne,Australia,"Melbourne, Australia",-37.81,144.96,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:12.697000,0,11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab69c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,acute panmyelosis with myelofibrosis,PMID:22682625,"Grygalewicz B, Woroniecka R et al. (2012): Acute panmyelosis with myelofibrosis with EVI1...",NCIT:C27753,Acute Myeloid Leukemia Not Otherwise Specified,icdom-98613,"Acute myeloid leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgklf,P66Y,pgxind-kftx2b1z,pgxcs-kftvmq1f,502685337,0.175,479685314,0.167,23000023,0.008,PGX_AM_BS_22682625_APMF-gry-01,{},21.01,52.23,Point,POL,Warsaw,Poland,"Warsaw, Poland",52.23,21.01,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:10.242000,1,2.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab852,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute myeloid leukemia,PMID:21965128,"Gotou M, Hanamura I et al. (2012): Establishment of a novel human myeloid...",NCIT:C27753,Acute Myeloid Leukemia Not Otherwise Specified,icdom-98613,"Acute myeloid leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgl5c,P60Y,pgxind-kftx2bq6,pgxcs-kftvmvyh,50700051,0.018,23400024,0.008,27300027,0.009,PGX_AM_BS_21965128_AML-got-01,{},136.91,35.18,Point,JPN,Nagoya-shi,Japan,"Nagoya-shi, Japan",35.18,136.91,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:10.856000,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5c86623709d374f2dc3e1a2c,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Acute myeloid leukemia,geo:GSE23452,,NCIT:C27753,Acute Myeloid Leukemia Not Otherwise Specified,icdom-98613,"Acute myeloid leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftviwvv,P64Y,pgxind-kftx4oi0,pgxcs-kftwcknb,5131365,0.002,3861340,0.001,1270025,0,PGX_AM_BS_GSM630963,{},-83.74,42.28,Point,USA,Ann Arbor,United States of America,"Ann Arbor, United States",42.28,-83.74,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:45:44.336000,1,14.2,,,,,,geo:GPL6801,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,0.06,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.06,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,PMID:20729466,"Parkin B, Erba H et al. (2010): Acquired genomic copy number aberrations and...",geo:GSM630963,,,,geo:gse,geo:gpl,pubmed,,geo:gsm,arraymap import,,,,,,,,,,,,,,,
5c86623709d374f2dc3e1a30,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Acute myeloid leukemia,geo:GSM630967,,NCIT:C27753,Acute Myeloid Leukemia Not Otherwise Specified,icdom-98613,"Acute myeloid leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftviww1,P70Y,pgxind-kftx4oi8,pgxcs-kftwckp9,149177120,0.052,3634980,0.001,145542140,0.051,PGX_AM_BS_GSM630967,{},-83.74,42.28,Point,USA,Ann Arbor,United States of America,"Ann Arbor, United States",42.28,-83.74,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:45:44.341000,1,5.77,,,,,,geo:GSE23452,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,0.1,SNP2pop 1000 Genomes population,HANCESTRO:0567,Afro-Caribbean,0.96,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,geo:GPL6801,,PMID:20729466,"Parkin B, Erba H et al. (2010): Acquired genomic copy number aberrations and...",pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,geo:gse,geo:gpl,,pubmed,arraymap import,,,,,,,,,,,,,,,
5c86623709d374f2dc3e1a36,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Acute myeloid leukemia,geo:GSM630973,,NCIT:C27753,Acute Myeloid Leukemia Not Otherwise Specified,icdom-98613,"Acute myeloid leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftviwwb,P55Y,pgxind-kftx4oik,pgxcs-kftwcks5,31158602,0.011,30060562,0.01,1098040,0,PGX_AM_BS_GSM630973,{},-83.74,42.28,Point,USA,Ann Arbor,United States of America,"Ann Arbor, United States",42.28,-83.74,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:45:44.350000,1,6.43,,,,,,PMID:20729466,"Parkin B, Erba H et al. (2010): Acquired genomic copy number aberrations and...",,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,0.08,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0014,Hispanic or Latin American,geo:GPL6801,,geo:GSE23452,,,,geo:gsm,pubmed,geo:gpl,,geo:gse,arraymap import,,,,,,,,,,,,,,,
5c86623709d374f2dc3e1a3a,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Acute myeloid leukemia,geo:GSM630977,,NCIT:C27753,Acute Myeloid Leukemia Not Otherwise Specified,icdom-98613,"Acute myeloid leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftviwwi,P62Y,pgxind-kftx4ois,pgxcs-kftwcku3,525369516,0.183,327157708,0.114,198211808,0.069,PGX_AM_BS_GSM630977,{},-83.74,42.28,Point,USA,Ann Arbor,United States of America,"Ann Arbor, United States",42.28,-83.74,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:45:44.356000,1,4.23,,,,,,PMID:20729466,"Parkin B, Erba H et al. (2010): Acquired genomic copy number aberrations and...",,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,0.14,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.08,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,geo:GPL6801,,geo:GSE23452,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,pubmed,geo:gpl,,geo:gse,arraymap import,,,,,,,,,,,,,,,
5c86623809d374f2dc3e1a54,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Acute myeloid leukemia,geo:GSM631003,,NCIT:C27753,Acute Myeloid Leukemia Not Otherwise Specified,icdom-98613,"Acute myeloid leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftviwxp,P28Y,pgxind-kftx4ok8,pgxcs-kftwcl8s,153130916,0.053,3317108,0.001,149813808,0.052,PGX_AM_BS_GSM631003,{},-83.74,42.28,Point,USA,Ann Arbor,United States of America,"Ann Arbor, United States",42.28,-83.74,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:45:44.393000,1,15.83,,,,,,PMID:20729466,"Parkin B, Erba H et al. (2010): Acquired genomic copy number aberrations and...",,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,0.12,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,geo:GSE23452,,geo:GPL6801,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,pubmed,geo:gse,,geo:gpl,arraymap import,,,,,,,,,,,,,,,
5c86623809d374f2dc3e1a5c,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Acute myeloid leukemia,geo:GSM631011,,NCIT:C27753,Acute Myeloid Leukemia Not Otherwise Specified,icdom-98613,"Acute myeloid leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftviwy2,P59Y,pgxind-kftx4oko,pgxcs-kftwclcn,5398448,0.002,3438126,0.001,1960322,0.001,PGX_AM_BS_GSM631011,{},-83.74,42.28,Point,USA,Ann Arbor,United States of America,"Ann Arbor, United States",42.28,-83.74,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:45:44.404000,1,12.1,,,,,,PMID:20729466,"Parkin B, Erba H et al. (2010): Acquired genomic copy number aberrations and...",,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,0.08,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.02,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0014,Hispanic or Latin American,geo:GPL6801,,geo:GSE23452,,,,geo:gsm,pubmed,geo:gpl,,geo:gse,arraymap import,,,,,,,,,,,,,,,
5c86623809d374f2dc3e1a5e,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Acute myeloid leukemia,geo:GSM631013,,NCIT:C27753,Acute Myeloid Leukemia Not Otherwise Specified,icdom-98613,"Acute myeloid leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftviwy5,P75Y,pgxind-kftx4oks,pgxcs-kftwcldl,39533913,0.014,36725214,0.013,2808699,0.001,PGX_AM_BS_GSM631013,{},-83.74,42.28,Point,USA,Ann Arbor,United States of America,"Ann Arbor, United States",42.28,-83.74,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:45:44.407000,1,8.6,,,,,,geo:GPL6801,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,0.06,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,5.55E-17,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0014,Hispanic or Latin American,geo:GSE23452,,PMID:20729466,"Parkin B, Erba H et al. (2010): Acquired genomic copy number aberrations and...",pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,geo:gpl,geo:gse,,pubmed,arraymap import,,,,,,,,,,,,,,,
5c86623909d374f2dc3e1a82,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Acute myeloid leukemia,geo:GSE23452,,NCIT:C27753,Acute Myeloid Leukemia Not Otherwise Specified,icdom-98613,"Acute myeloid leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftviwzs,P78Y,pgxind-kftx4omt,pgxcs-kftwcluz,46554590,0.016,45075214,0.016,1479376,0.001,PGX_AM_BS_GSM631049,{},-83.74,42.28,Point,USA,Ann Arbor,United States of America,"Ann Arbor, United States",42.28,-83.74,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:45:44.457000,1,0.53,,,,,,geo:GPL6801,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,0.02,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.16,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0014,Hispanic or Latin American,PMID:20729466,"Parkin B, Erba H et al. (2010): Acquired genomic copy number aberrations and...",geo:GSM631049,,,,geo:gse,geo:gpl,pubmed,,geo:gsm,arraymap import,,,,,,,,,,,,,,,
5c86623909d374f2dc3e1a84,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Acute myeloid leukemia,geo:GSE23452,,NCIT:C27753,Acute Myeloid Leukemia Not Otherwise Specified,icdom-98613,"Acute myeloid leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftviwzv,P60Y,pgxind-kftx4omx,pgxcs-kftwclvx,10152845,0.004,5210150,0.002,4942695,0.002,PGX_AM_BS_GSM631051,{},-83.74,42.28,Point,USA,Ann Arbor,United States of America,"Ann Arbor, United States",42.28,-83.74,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:45:44.460000,1,26.7,,,,,,geo:GPL6801,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,0.12,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.06,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,PMID:20729466,"Parkin B, Erba H et al. (2010): Acquired genomic copy number aberrations and...",geo:GSM631051,,,,geo:gse,geo:gpl,pubmed,,geo:gsm,arraymap import,,,,,,,,,,,,,,,
5c86623909d374f2dc3e1a9a,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Acute myeloid leukemia,PMID:20729466,"Parkin B, Erba H et al. (2010): Acquired genomic copy number aberrations and...",NCIT:C27753,Acute Myeloid Leukemia Not Otherwise Specified,icdom-98613,"Acute myeloid leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvix0w,P55Y,pgxind-kftx4oo6,pgxcs-kftwcm8k,508987088,0.177,378577337,0.132,130409751,0.045,PGX_AM_BS_GSM631073,{},-83.74,42.28,Point,USA,Ann Arbor,United States of America,"Ann Arbor, United States",42.28,-83.74,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:45:44.491000,1,17.27,,,,,,geo:GSE23452,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,0.04,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.12,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0014,Hispanic or Latin American,geo:GPL6801,,geo:GSM631073,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),pubmed,geo:gse,geo:gpl,,geo:gsm,arraymap import,,,,,,,,,,,,,,,
5c86623a09d374f2dc3e1ab8,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Acute myeloid leukemia,geo:GPL6801,,NCIT:C27753,Acute Myeloid Leukemia Not Otherwise Specified,icdom-98613,"Acute myeloid leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvix29,P67Y,pgxind-kftx4opv,pgxcs-kftwcmn5,468838619,0.163,353543286,0.123,115295333,0.04,PGX_AM_BS_GSM631103,{},-83.74,42.28,Point,USA,Ann Arbor,United States of America,"Ann Arbor, United States",42.28,-83.74,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:45:44.533000,1,3.03,,,,,,geo:GSE23452,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,0.1,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.1,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,PMID:20729466,"Parkin B, Erba H et al. (2010): Acquired genomic copy number aberrations and...",geo:GSM631103,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gpl,geo:gse,pubmed,,geo:gsm,arraymap import,,,,,,,,,,,,,,,
5c86623a09d374f2dc3e1ac0,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Acute myeloid leukemia,geo:GSM631111,,NCIT:C27753,Acute Myeloid Leukemia Not Otherwise Specified,icdom-98613,"Acute myeloid leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvix2n,P52Y,pgxind-kftx4oqb,pgxcs-kftwcmr0,217529567,0.076,183733569,0.064,33795998,0.012,PGX_AM_BS_GSM631111,{},-83.74,42.28,Point,USA,Ann Arbor,United States of America,"Ann Arbor, United States",42.28,-83.74,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:45:44.544000,1,1.37,,,,,,PMID:20729466,"Parkin B, Erba H et al. (2010): Acquired genomic copy number aberrations and...",,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,0.1,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,geo:GSE23452,,geo:GPL6801,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,pubmed,geo:gse,,geo:gpl,arraymap import,,,,,,,,,,,,,,,
5c86623a09d374f2dc3e1ac2,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Acute myeloid leukemia,PMID:20729466,"Parkin B, Erba H et al. (2010): Acquired genomic copy number aberrations and...",NCIT:C27753,Acute Myeloid Leukemia Not Otherwise Specified,icdom-98613,"Acute myeloid leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvix2q,P73Y,pgxind-kftx4oqf,pgxcs-kftwcmrz,426310222,0.148,311386350,0.108,114923872,0.04,PGX_AM_BS_GSM631113,{},-83.74,42.28,Point,USA,Ann Arbor,United States of America,"Ann Arbor, United States",42.28,-83.74,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:45:44.547000,1,9.03,,,,,,geo:GSE23452,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,0.12,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.06,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,geo:GPL6801,,geo:GSM631113,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),pubmed,geo:gse,geo:gpl,,geo:gsm,arraymap import,,,,,,,,,,,,,,,
5c86623b09d374f2dc3e1adc,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Acute myeloid leukemia,geo:GSM631139,,NCIT:C27753,Acute Myeloid Leukemia Not Otherwise Specified,icdom-98613,"Acute myeloid leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvix3x,P80Y,pgxind-kftx4orx,pgxcs-kftwcn4f,70027753,0.024,66149446,0.023,3878307,0.001,PGX_AM_BS_GSM631139,{},-83.74,42.28,Point,USA,Ann Arbor,United States of America,"Ann Arbor, United States",42.28,-83.74,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:45:44.583000,1,18.53,,,,,,geo:GPL6801,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,0.06,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0014,Hispanic or Latin American,geo:GSE23452,,PMID:20729466,"Parkin B, Erba H et al. (2010): Acquired genomic copy number aberrations and...",pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,geo:gpl,geo:gse,,pubmed,arraymap import,,,,,,,,,,,,,,,
5c86623b09d374f2dc3e1ae2,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Acute myeloid leukemia,PMID:20729466,"Parkin B, Erba H et al. (2010): Acquired genomic copy number aberrations and...",NCIT:C27753,Acute Myeloid Leukemia Not Otherwise Specified,icdom-98613,"Acute myeloid leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvix46,P80Y,pgxind-kftx4os9,pgxcs-kftwcn7b,691040378,0.24,500374938,0.174,190665440,0.066,PGX_AM_BS_GSM631145,{},-83.74,42.28,Point,USA,Ann Arbor,United States of America,"Ann Arbor, United States",42.28,-83.74,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:45:44.591000,1,4.63,,,,,,geo:GPL6801,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,0.24,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.18,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,geo:GSE23452,,geo:GSM631145,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),pubmed,geo:gpl,geo:gse,,geo:gsm,arraymap import,,,,,,,,,,,,,,,
5c86623b09d374f2dc3e1afc,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Acute myeloid leukemia,PMID:20729466,"Parkin B, Erba H et al. (2010): Acquired genomic copy number aberrations and...",NCIT:C27753,Acute Myeloid Leukemia Not Otherwise Specified,icdom-98613,"Acute myeloid leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvix5d,P73Y,pgxind-kftx4otq,pgxcs-kftwcnlt,691667962,0.241,526402089,0.183,165265873,0.057,PGX_AM_BS_GSM631171,{},-83.74,42.28,Point,USA,Ann Arbor,United States of America,"Ann Arbor, United States",42.28,-83.74,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:45:44.627000,1,6.57,,,,,,geo:GPL6801,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,0,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,geo:GSE23452,,geo:GSM631171,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),pubmed,geo:gpl,geo:gse,,geo:gsm,arraymap import,,,,,,,,,,,,,,,
5c86623b09d374f2dc3e1aff,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Acute myeloid leukemia,geo:GSM631174,,NCIT:C27753,Acute Myeloid Leukemia Not Otherwise Specified,icdom-98613,"Acute myeloid leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvix5i,P56Y,pgxind-kftx4otw,pgxcs-kftwcnn9,300602633,0.105,121166128,0.042,179436505,0.062,PGX_AM_BS_GSM631174,{},-83.74,42.28,Point,USA,Ann Arbor,United States of America,"Ann Arbor, United States",42.28,-83.74,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:45:44.631000,1,0.27,,,,,,geo:GSE23452,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,0.06,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0014,Hispanic or Latin American,geo:GPL6801,,PMID:20729466,"Parkin B, Erba H et al. (2010): Acquired genomic copy number aberrations and...",pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,geo:gse,geo:gpl,,pubmed,arraymap import,,,,,,,,,,,,,,,
5bab56ca727983b2e00af836,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38-, Rai/Binet stage 0/A]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh5zo,,pgxind-kftx319c,pgxcs-kftvt7cc,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38neg-01,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.968000,0,252,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af839,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38-, Rai/Binet stage II /B]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh5zs,,pgxind-kftx319i,pgxcs-kftvt7dr,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38neg-06,,8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.972000,0,108,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af83a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38-, Rai/Binet stage I /A]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh5zu,,pgxind-kftx319k,pgxcs-kftvt7e8,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38neg-07,,8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.974000,0,96,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af83b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38-, Rai/Binet stage  I]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh5zw,,pgxind-kftx319m,pgxcs-kftvt7ep,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38neg-08,,8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.975000,0,96,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af83c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38-, Rai/Binet stage I /A]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh5zx,,pgxind-kftx319o,pgxcs-kftvt7f6,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38neg-09,,8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.976000,0,84,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af83d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38-, Rai/Binet stage  I]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh5zz,,pgxind-kftx319r,pgxcs-kftvt7fn,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38neg-10,,8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.978000,0,60,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af83e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38-, Rai/Binet stage IV/C]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh601,,pgxind-kftx319t,pgxcs-kftvt7g4,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38neg-11,,8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.979000,0,360,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af83f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38-, Rai/Binet stage I /A]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh602,,pgxind-kftx319v,pgxcs-kftvt7gm,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38neg-13,,8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.981000,0,24,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af840,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38-, Rai/Binet stage I /B]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh604,,pgxind-kftx319x,pgxcs-kftvt7h3,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38neg-14,,8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.982000,0,72,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af841,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38-, Rai/Binet stage II /B]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh605,,pgxind-kftx319z,pgxcs-kftvt7hk,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38neg-16,,8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.983000,0,144,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af842,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38-, Rai/Binet stage II /A]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh607,,pgxind-kftx31a1,pgxcs-kftvt7i2,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38neg-18,,8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.985000,0,84,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af844,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38-, Rai/Binet stage 0/A]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh60a,,pgxind-kftx31a5,pgxcs-kftvt7kx,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38neg-20,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.987000,0,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af845,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38-, Rai/Binet stage  I]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh60c,,pgxind-kftx31a7,pgxcs-kftvt7lg,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38neg-21,,8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.988000,0,24,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af846,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38-, Rai/Binet stage 0/B]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh60d,,pgxind-kftx31a9,pgxcs-kftvt7ly,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38neg-22,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.990000,0,108,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af847,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38-, Rai/Binet stage II /B]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh60f,,pgxind-kftx31ab,pgxcs-kftvt7mg,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38neg-25,,8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.991000,0,48,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af848,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38-, Rai/Binet stage 0/A]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh60h,,pgxind-kftx31ad,pgxcs-kftvt7mx,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38neg-26,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.992000,0,36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af849,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38-, Rai/Binet stage IV /C]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh60i,,pgxind-kftx31af,pgxcs-kftvt7ne,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38neg-27,,8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.994000,0,24,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af84a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38-, Rai/Binet stage 0/A]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh60k,,pgxind-kftx31ah,pgxcs-kftvt7nv,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38neg-29,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.995000,0,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af84b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38-, Rai/Binet stage III/A]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh60m,,pgxind-kftx31aj,pgxcs-kftvt7od,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38neg-30,,8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.997000,0,36,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af84c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38-, Rai/Binet stage 0/A]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh60n,,pgxind-kftx31al,pgxcs-kftvt7ou,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38neg-31,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.998000,0,216,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af84d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38-, Rai/Binet stage 0/A]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh60p,,pgxind-kftx31an,pgxcs-kftvt7pc,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38neg-32,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.999000,0,276,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af84e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38-, Rai/Binet stage I /A]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh60q,,pgxind-kftx31ap,pgxcs-kftvt7pt,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38neg-34,,8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:34.001000,0,156,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af851,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38-, Rai/Binet stage 0/A]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh60v,,pgxind-kftx31av,pgxcs-kftvt7r8,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38neg-37,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:34.005000,0,156,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af852,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38-, Rai/Binet stage II /B]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh60x,,pgxind-kftx31ax,pgxcs-kftvt7rp,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38neg-39,,8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:34.006000,0,12,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af853,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38-, Rai/Binet stage 0/A]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh60z,,pgxind-kftx31az,pgxcs-kftvt7s6,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38neg-40,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:34.007000,0,228,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af854,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38-, Rai/Binet stage IV /C]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh610,,pgxind-kftx31b1,pgxcs-kftvt7sn,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38neg-41,,8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:34.009000,0,192,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af857,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38-, Rai/Binet stage 0/A]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh615,,pgxind-kftx31b7,pgxcs-kftvt7u3,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38neg-46,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:34.013000,0,168,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af858,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38-, Rai/Binet stage 0/A]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh617,,pgxind-kftx31b9,pgxcs-kftvt7uk,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38neg-48,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:34.014000,0,48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af859,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38-, Rai/Binet stage II /B]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh618,,pgxind-kftx31bb,pgxcs-kftvt7v1,99600099,0.035,99600099,0.035,0,0,PGX_AM_BS_BCLLCD38neg-52,,8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:34.016000,0,168,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af85a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38 , Rai/Binet stage II/A]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh61a,,pgxind-kftx31bd,pgxcs-kftvt7vi,191849726,0.067,59500059,0.021,132349667,0.046,PGX_AM_BS_BCLLCD38pos-03,,8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:34.017000,0,84,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af85b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38 , Rai/Binet stage I /A]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh61c,,pgxind-kftx31bf,pgxcs-kftvt7vz,379998593,0.132,88827343,0.031,291171250,0.101,PGX_AM_BS_BCLLCD38pos-05,,8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:34.018000,0,36,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af85c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38 , Rai/Binet stage IV /C]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh61d,,pgxind-kftx31bh,pgxcs-kftvt7wh,134155649,0.047,96606076,0.034,37549573,0.013,PGX_AM_BS_BCLLCD38pos-12,,8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:34.020000,0,48,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af85d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38 , Rai/Binet stage III]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh61f,,pgxind-kftx31bj,pgxcs-kftvt7wy,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38pos-15,,8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:34.021000,0,12,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af85e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38 , Rai/Binet stage I /B]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh61g,,pgxind-kftx31bl,pgxcs-kftvt7xf,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38pos-17,,8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:34.022000,0,96,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af85f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38 , Rai/Binet stage I /A]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh61i,,pgxind-kftx31bn,pgxcs-kftvt7xw,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38pos-23,,8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:34.024000,0,180,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af860,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38 , Rai/Binet stage II /B]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh61k,,pgxind-kftx31bp,pgxcs-kftvt7ye,99306079,0.035,99306079,0.035,0,0,PGX_AM_BS_BCLLCD38pos-24,,8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:34.025000,0,48,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af861,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38 , Rai/Binet stage 0/A]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh61l,,pgxind-kftx31br,pgxcs-kftvt7yu,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38pos-28,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:34.026000,0,84,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af863,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38 , Rai/Binet stage 0-I/B]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh61o,,pgxind-kftx31bv,pgxcs-kftvt7zs,208466897,0.073,0,0,208466897,0.073,PGX_AM_BS_BCLLCD38pos-38,,8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:34.029000,0,60,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af864,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38 , Rai/Binet stage IV /C]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh61q,,pgxind-kftx31bx,pgxcs-kftvt80a,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38pos-42,,8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:34.031000,0,72,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af865,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38 , Rai/Binet stage 0/A]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh61s,,pgxind-kftx31bz,pgxcs-kftvt80r,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38pos-43,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:34.032000,0,96,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af866,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38 , Rai/Binet stage I /A]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh61t,,pgxind-kftx31c1,pgxcs-kftvt818,208466897,0.073,0,0,208466897,0.073,PGX_AM_BS_BCLLCD38pos-47,,8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:34.033000,0,36,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af867,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38 , Rai/Binet stage II /B]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh61v,,pgxind-kftx31c3,pgxcs-kftvt81p,61500060,0.021,61500060,0.021,0,0,PGX_AM_BS_BCLLCD38pos-49,,8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:34.035000,0,6,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af868,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38 , Rai/Binet stage A]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh61w,,pgxind-kftx31c6,pgxcs-kftvt826,208466897,0.073,0,0,208466897,0.073,PGX_AM_BS_BCLLCD38pos-50,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:34.036000,0,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af869,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38 , Rai/Binet stage I/B]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh61y,,pgxind-kftx31c8,pgxcs-kftvt82n,66700066,0.023,66700066,0.023,0,0,PGX_AM_BS_BCLLCD38pos-51,,8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:34.037000,0,3,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afe7f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Binet A],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh807,,pgxind-kftx33s1,pgxcs-kftvttyn,107938745,0.038,0,0,107938745,0.038,PGX_AM_BS_CLL-RS-01a,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.190000,0,56,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe86,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Binet A],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh80i,,pgxind-kftx33sf,pgxcs-kftvtu1z,0,0,0,0,0,0,PGX_AM_BS_CLL-RS-03a,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.200000,0,95,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe8b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Binet A],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh80r,,pgxind-kftx33sp,pgxcs-kftvtu4c,0,0,0,0,0,0,PGX_AM_BS_CLL-RS-05a,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.206000,0,61,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe8f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Binet A],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh80x,,pgxind-kftx33sy,pgxcs-kftvtu69,0,0,0,0,0,0,PGX_AM_BS_CLL-RS-07a,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.212000,0,72,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe93,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Binet A],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh813,,pgxind-kftx33t6,pgxcs-kftvtu86,190418311,0.066,58068644,0.02,132349667,0.046,PGX_AM_BS_CLL-RS-09a,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.217000,0,11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe96,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Binet A],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh818,,pgxind-kftx33tc,pgxcs-kftvtu9l,0,0,0,0,0,0,PGX_AM_BS_CLL-RS-10a,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.221000,0,81,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe9a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Binet A],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh81e,,pgxind-kftx33tk,pgxcs-kftvtubh,0,0,0,0,0,0,PGX_AM_BS_CLL-RS-12a,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.227000,0,98,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe9d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Binet A],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh81j,,pgxind-kftx33tq,pgxcs-kftvtucw,0,0,0,0,0,0,PGX_AM_BS_CLL-RS-13a,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.231000,0,130,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe9f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Binet A],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh81n,,pgxind-kftx33tu,pgxcs-kftvtudu,0,0,0,0,0,0,PGX_AM_BS_CLL-RS-14a,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.234000,0,62,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afea1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Binet A],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh81q,,pgxind-kftx33ty,pgxcs-kftvtues,0,0,0,0,0,0,PGX_AM_BS_CLL-RS-15a,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.236000,0,118,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afea7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Binet A],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh81z,,pgxind-kftx33ub,pgxcs-kftvtuhm,0,0,0,0,0,0,PGX_AM_BS_CLL-RS-18,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.244000,0,96,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afea8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Binet A],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh821,,pgxind-kftx33ud,pgxcs-kftvtui3,0,0,0,0,0,0,PGX_AM_BS_CLL-RS-19,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.246000,0,82,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afea9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Binet A],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh823,,pgxind-kftx33uf,pgxcs-kftvtuil,0,0,0,0,0,0,PGX_AM_BS_CLL-RS-20,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.247000,0,29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afeaa,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Binet B],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh824,,pgxind-kftx33uh,pgxcs-kftvtuj2,0,0,0,0,0,0,PGX_AM_BS_CLL-RS-21,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.248000,0,92,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afeab,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Binet B],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh826,,pgxind-kftx33uj,pgxcs-kftvtujk,0,0,0,0,0,0,PGX_AM_BS_CLL-RS-22,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.250000,0,25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afeac,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Binet B],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh827,,pgxind-kftx33ul,pgxcs-kftvtuk1,0,0,0,0,0,0,PGX_AM_BS_CLL-RS-23,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.251000,0,25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afead,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Binet B],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh829,,pgxind-kftx33un,pgxcs-kftvtuki,0,0,0,0,0,0,PGX_AM_BS_CLL-RS-24,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.252000,0,98,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afeb2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Binet C],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh82h,,pgxind-kftx33ux,pgxcs-kftvtumw,57997481,0.02,57997481,0.02,0,0,PGX_AM_BS_CLL-RS-29,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.259000,0,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afeb3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Binet C],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh82j,,pgxind-kftx33uz,pgxcs-kftvtund,261545348,0.091,237092938,0.082,24452410,0.009,PGX_AM_BS_CLL-RS-30,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.260000,0,55,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afeb4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Richter syndrome],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh82k,,pgxind-kftx33v1,pgxcs-kftvtunu,738831666,0.257,431734066,0.15,307097600,0.107,PGX_AM_BS_CLL-RS-31,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.262000,0,38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afeb7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Richter syndrome],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh82p,,pgxind-kftx33v7,pgxcs-kftvtupa,0,0,0,0,0,0,PGX_AM_BS_CLL-RS-34,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.266000,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afeb8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Richter syndrome],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh82r,,pgxind-kftx33v9,pgxcs-kftvtupr,389502309,0.135,29700029,0.01,359802280,0.125,PGX_AM_BS_CLL-RS-35,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.267000,0,71,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac2d2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia,PMID:20078324,"Jarosova M, Urbankova H et al. (2010): Gain of chromosome 2p in chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvgojo,P44Y,pgxind-kftx2fvy,pgxcs-kftvnwgf,143800143,0.05,48100048,0.017,95700095,0.033,PGX_AM_BS_20078324_CLL-jar-01,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.666000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac2d3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia,PMID:20078324,"Jarosova M, Urbankova H et al. (2010): Gain of chromosome 2p in chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvgojp,P49Y,pgxind-kftx2fw0,pgxcs-kftvnwgv,0,0,0,0,0,0,PGX_AM_BS_20078324_CLL-jar-02,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.667000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac2d4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia,PMID:20078324,"Jarosova M, Urbankova H et al. (2010): Gain of chromosome 2p in chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvgojr,P41Y,pgxind-kftx2fw2,pgxcs-kftvnwhc,105452490,0.037,32852418,0.011,72600072,0.025,PGX_AM_BS_20078324_CLL-jar-03,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.669000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac2d7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia,PMID:20078324,"Jarosova M, Urbankova H et al. (2010): Gain of chromosome 2p in chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvgojw,P57Y,pgxind-kftx2fw8,pgxcs-kftvnwiq,111800111,0.039,16100016,0.006,95700095,0.033,PGX_AM_BS_20078324_CLL-jar-06,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.673000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac2db,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia,PMID:20078324,"Jarosova M, Urbankova H et al. (2010): Gain of chromosome 2p in chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvgok2,P54Y,pgxind-kftx2fwh,pgxcs-kftvnwkl,166210149,0.058,38300038,0.013,127910111,0.044,PGX_AM_BS_20078324_CLL-jar-10,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.678000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac2df,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia,PMID:20078324,"Jarosova M, Urbankova H et al. (2010): Gain of chromosome 2p in chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvgok9,P52Y,pgxind-kftx2fwp,pgxcs-kftvnwmg,298835103,0.104,166096334,0.058,132738769,0.046,PGX_AM_BS_20078324_CLL-jar-14,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.684000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac2e0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia,PMID:20078324,"Jarosova M, Urbankova H et al. (2010): Gain of chromosome 2p in chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvgokb,P53Y,pgxind-kftx2fwr,pgxcs-kftvnwmx,183552568,0.064,99852485,0.035,83700083,0.029,PGX_AM_BS_20078324_CLL-jar-15,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.685000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af838,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38-, Rai/Binet stage II /A]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh5zr,,pgxind-kftx319g,pgxcs-kftvt7da,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38neg-04,,8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.971000,1,180,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af850,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chronic lymphocytic leukemia [CD38-, Rai/Binet stage I /A]",PMID:12857555,"Ottaggio L, Viaggi S et al. (2003): Chromosome aberrations evaluated by comparative genomic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh60u,,pgxind-kftx31at,pgxcs-kftvt7qr,0,0,0,0,0,0,PGX_AM_BS_BCLLCD38neg-36,,8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:34.003000,1,156,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afe84,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Binet A],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh80f,,pgxind-kftx33sb,pgxcs-kftvtu11,0,0,0,0,0,0,PGX_AM_BS_CLL-RS-02a,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.197000,1,39,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe89,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Binet B],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh80n,,pgxind-kftx33sl,pgxcs-kftvtu3e,0,0,0,0,0,0,PGX_AM_BS_CLL-RS-04a,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.204000,1,23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe8d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Binet C],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh80u,,pgxind-kftx33st,pgxcs-kftvtu5b,40400040,0.014,40400040,0.014,0,0,PGX_AM_BS_CLL-RS-06a,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.209000,1,33,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe91,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Binet A],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh810,,pgxind-kftx33t2,pgxcs-kftvtu78,144834620,0.05,15900015,0.006,128934605,0.045,PGX_AM_BS_CLL-RS-08a,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.215000,1,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe99,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Binet C],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh81d,,pgxind-kftx33ti,pgxcs-kftvtub0,154549689,0.054,22200022,0.008,132349667,0.046,PGX_AM_BS_CLL-RS-11b,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.225000,1,25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afea3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Binet C],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh81t,,pgxind-kftx33u2,pgxcs-kftvtufq,0,0,0,0,0,0,PGX_AM_BS_CLL-RS-16a,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.239000,1,57,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afea5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Binet C],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh81w,,pgxind-kftx33u6,pgxcs-kftvtugo,0,0,0,0,0,0,PGX_AM_BS_CLL-RS-17a,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.241000,1,27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afeae,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Binet C],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh82b,,pgxind-kftx33up,pgxcs-kftvtukz,0,0,0,0,0,0,PGX_AM_BS_CLL-RS-25,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.254000,1,25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afeaf,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Binet C],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh82c,,pgxind-kftx33ur,pgxcs-kftvtulg,270394986,0.094,270394986,0.094,0,0,PGX_AM_BS_CLL-RS-26,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.255000,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afeb0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Binet C],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh82e,,pgxind-kftx33ut,pgxcs-kftvtuly,150800149,0.052,57500056,0.02,93300093,0.032,PGX_AM_BS_CLL-RS-27,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.256000,1,31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afeb1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Binet C],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh82f,,pgxind-kftx33uv,pgxcs-kftvtumf,0,0,0,0,0,0,PGX_AM_BS_CLL-RS-28,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.258000,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afeb5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Richter syndrome],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh82m,,pgxind-kftx33v3,pgxcs-kftvtuoc,189849723,0.066,57500056,0.02,132349667,0.046,PGX_AM_BS_CLL-RS-32,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.263000,1,38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afeb6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Richter syndrome],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh82o,,pgxind-kftx33v5,pgxcs-kftvtuot,238711416,0.083,238711416,0.083,0,0,PGX_AM_BS_CLL-RS-33,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.264000,1,23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afeb9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Chronic lymphocytic leukemia [Richter syndrome],PMID:12213724,"Be S, Lpez-Guillermo A et al. (2002): Genetic imbalances in progressed B-cell chronic...",NCIT:C3163,Chronic Lymphocytic Leukemia,icdom-98233,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,icdot-C42.1,Bone marrow,pgxbs-kftvh82s,,pgxind-kftx33vb,pgxcs-kftvtuq9,268392164,0.093,211817365,0.074,56574799,0.02,PGX_AM_BS_CLL-RS-36,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:36.268000,1,64,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac361,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgoq5,P22Y,pgxind-kftx2g42,pgxcs-kftvnyew,79300079,0.028,79300079,0.028,0,0,PGX_AM_BS_20067559_ALL-mat-04,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.861000,0,71,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac362,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgoq6,P40Y,pgxind-kftx2g44,pgxcs-kftvnyfd,84300084,0.029,84300084,0.029,0,0,PGX_AM_BS_20067559_ALL-mat-05,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.862000,0,43,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac366,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgoqd,P28Y,pgxind-kftx2g4c,pgxcs-kftvnyh8,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-09,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.868000,0,75,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac367,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgoqf,P18Y,pgxind-kftx2g4e,pgxcs-kftvnyhp,91400091,0.032,63000063,0.022,28400028,0.01,PGX_AM_BS_20067559_ALL-mat-10,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.869000,0,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac36a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgoqj,P15Y,pgxind-kftx2g4k,pgxcs-kftvnyj3,145677119,0.051,79827334,0.028,65849785,0.023,PGX_AM_BS_20067559_ALL-mat-13,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.873000,0,64,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac36d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgoqp,P24Y,pgxind-kftx2g4q,pgxcs-kftvnykh,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-16,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.877000,0,43,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac372,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgoqx,P32Y,pgxind-kftx2g50,pgxcs-kftvnymt,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-21,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.884000,0,46,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac378,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgor7,P37Y,pgxind-kftx2g5d,pgxcs-kftvnypm,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-27,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.892000,0,41,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac37b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgorc,P24Y,pgxind-kftx2g5j,pgxcs-kftvnyr0,79774822,0.028,23200023,0.008,56574799,0.02,PGX_AM_BS_20067559_ALL-mat-30,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.896000,0,55,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac37c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgord,P19Y,pgxind-kftx2g5l,pgxcs-kftvnyrh,217867554,0.076,36300036,0.013,181567518,0.063,PGX_AM_BS_20067559_ALL-mat-31,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.897000,0,94,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac381,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgorm,P17Y,pgxind-kftx2g5v,pgxcs-kftvnytt,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-36,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.904000,0,61,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac388,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [B-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgorx,P37Y,pgxind-kftx2g69,pgxcs-kftvnyx2,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-43,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.914000,0,49,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac389,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [B-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgorz,P20Y,pgxind-kftx2g6b,pgxcs-kftvnyxi,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-44,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.915000,0,89,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac38d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [B-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgos6,P27Y,pgxind-kftx2g6j,pgxcs-kftvnyzd,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-48,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.921000,0,42,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac38e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [B-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgos7,P27Y,pgxind-kftx2g6l,pgxcs-kftvnyzu,180507586,0.063,0,0,180507586,0.063,PGX_AM_BS_20067559_ALL-mat-49,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.922000,0,49,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac38f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [B-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgos9,P19Y,pgxind-kftx2g6n,pgxcs-kftvnz0b,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-50,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.924000,0,42,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac391,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [B-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgosc,P18Y,pgxind-kftx2g6r,pgxcs-kftvnz19,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-52,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.926000,0,66,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac392,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [B-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgosd,P19Y,pgxind-kftx2g6t,pgxcs-kftvnz1p,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-53,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.928000,0,64,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac393,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [B-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgosf,P36Y,pgxind-kftx2g6v,pgxcs-kftvnz26,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-54,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.929000,0,60,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac396,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [B-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgosk,P17Y,pgxind-kftx2g72,pgxcs-kftvnz3k,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-57,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.933000,0,62,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac397,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [B-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgosm,P16Y,pgxind-kftx2g74,pgxcs-kftvnz41,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-58,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.934000,0,54,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac39a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [B-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgosr,P47Y,pgxind-kftx2g7a,pgxcs-kftvnz5f,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-61,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.938000,0,71,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac39d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [B-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgosw,P26Y,pgxind-kftx2g7g,pgxcs-kftvnz6t,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-64,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.942000,0,58,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac3a0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [B-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgot1,P20Y,pgxind-kftx2g7m,pgxcs-kftvnz8h,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-67,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.946000,0,51,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac3a1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [B-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgot3,P40Y,pgxind-kftx2g7o,pgxcs-kftvnz8z,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-68,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.948000,0,88,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac3a2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [B-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgot4,P19Y,pgxind-kftx2g7q,pgxcs-kftvnz9g,175078744,0.061,22000022,0.008,153078722,0.053,PGX_AM_BS_20067559_ALL-mat-69,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.949000,0,53,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac3a3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [B-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgot6,P19Y,pgxind-kftx2g7s,pgxcs-kftvnz9y,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-70,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.950000,0,79,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af7d4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia/lymphoblastic lymphoma,PMID:12935929,"Jarosov M, Holzerov M et al. (2003): Complex karyotypes in childhood acute lymphoblastic...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvh5v9,P9Y,pgxind-kftx313w,pgxcs-kftvt5za,0,0,0,0,0,0,PGX_AM_BS_12935929_ChALL-jar-02,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.833000,0,61,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af7d5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia/lymphoblastic lymphoma,PMID:12935929,"Jarosov M, Holzerov M et al. (2003): Complex karyotypes in childhood acute lymphoblastic...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvh5vb,P5Y,pgxind-kftx313y,pgxcs-kftvt5zs,0,0,0,0,0,0,PGX_AM_BS_12935929_ChALL-jar-03,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.835000,0,41,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af7d6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia/lymphoblastic lymphoma,PMID:12935929,"Jarosov M, Holzerov M et al. (2003): Complex karyotypes in childhood acute lymphoblastic...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvh5vc,P6Y,pgxind-kftx3140,pgxcs-kftvt608,0,0,0,0,0,0,PGX_AM_BS_12935929_ChALL-jar-06,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.836000,0,17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af7d7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia/lymphoblastic lymphoma,PMID:12935929,"Jarosov M, Holzerov M et al. (2003): Complex karyotypes in childhood acute lymphoblastic...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvh5ve,P7Y,pgxind-kftx3142,pgxcs-kftvt60q,149156885,0.052,61943043,0.022,87213842,0.03,PGX_AM_BS_12935929_ChALL-jar-07,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.837000,0,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af7d8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia/lymphoblastic lymphoma,PMID:12935929,"Jarosov M, Holzerov M et al. (2003): Complex karyotypes in childhood acute lymphoblastic...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvh5vg,P5Y,pgxind-kftx3144,pgxcs-kftvt617,150621577,0.052,31921457,0.011,118700120,0.041,PGX_AM_BS_12935929_ChALL-jar-08,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.839000,0,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af7da,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia/lymphoblastic lymphoma,PMID:12935929,"Jarosov M, Holzerov M et al. (2003): Complex karyotypes in childhood acute lymphoblastic...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvh5vj,P17Y,pgxind-kftx3148,pgxcs-kftvt625,0,0,0,0,0,0,PGX_AM_BS_12935929_ChALL-jar-10,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.842000,0,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af7db,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia/lymphoblastic lymphoma,PMID:12935929,"Jarosov M, Holzerov M et al. (2003): Complex karyotypes in childhood acute lymphoblastic...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvh5vk,P16Y,pgxind-kftx314a,pgxcs-kftvt62n,390939725,0.136,204006183,0.071,186933542,0.065,PGX_AM_BS_12935929_ChALL-jar-11,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.843000,0,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af7dc,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia/lymphoblastic lymphoma,PMID:12935929,"Jarosov M, Holzerov M et al. (2003): Complex karyotypes in childhood acute lymphoblastic...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvh5vm,P9Y,pgxind-kftx314c,pgxcs-kftvt634,1123361166,0.391,0,0,1123361166,0.391,PGX_AM_BS_12935929_ChALL-jar-13,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.845000,0,21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af7de,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia/lymphoblastic lymphoma,PMID:12935929,"Jarosov M, Holzerov M et al. (2003): Complex karyotypes in childhood acute lymphoblastic...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvh5vp,P8Y,pgxind-kftx314g,pgxcs-kftvt643,129679421,0.045,103257970,0.036,26421451,0.009,PGX_AM_BS_12935929_ChALL-jar-17,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.847000,0,22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af7df,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia/lymphoblastic lymphoma,PMID:12935929,"Jarosov M, Holzerov M et al. (2003): Complex karyotypes in childhood acute lymphoblastic...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvh5vr,P5Y,pgxind-kftx314i,pgxcs-kftvt64k,76436041,0.027,76436041,0.027,0,0,PGX_AM_BS_12935929_ChALL-jar-18,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.849000,0,13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af7e0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia/lymphoblastic lymphoma,PMID:12935929,"Jarosov M, Holzerov M et al. (2003): Complex karyotypes in childhood acute lymphoblastic...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvh5vs,P11Y,pgxind-kftx314k,pgxcs-kftvt651,176658041,0.061,131357997,0.046,45300044,0.016,PGX_AM_BS_12935929_ChALL-jar-19,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.850000,0,22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af7e2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia/lymphoblastic lymphoma,PMID:12935929,"Jarosov M, Holzerov M et al. (2003): Complex karyotypes in childhood acute lymphoblastic...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvh5vw,P17Y,pgxind-kftx314o,pgxcs-kftvt660,155938792,0.054,56000055,0.019,99938737,0.035,PGX_AM_BS_12935929_ChALL-jar-21,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.853000,0,34,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac35e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgoq0,P17Y,pgxind-kftx2g3w,pgxcs-kftvnydi,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-01,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.857000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac35f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgoq1,P40Y,pgxind-kftx2g3y,pgxcs-kftvnydz,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-02,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.858000,1,26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac360,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgoq3,P21Y,pgxind-kftx2g40,pgxcs-kftvnyef,147516111,0.051,100806081,0.035,46710030,0.016,PGX_AM_BS_20067559_ALL-mat-03,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.860000,1,19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac363,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgoq8,P50Y,pgxind-kftx2g46,pgxcs-kftvnyfu,80200079,0.028,80200079,0.028,0,0,PGX_AM_BS_20067559_ALL-mat-06,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.864000,1,42,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac364,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgoqa,P32Y,pgxind-kftx2g48,pgxcs-kftvnygb,449196952,0.156,232758099,0.081,216438853,0.075,PGX_AM_BS_20067559_ALL-mat-07,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.865000,1,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac365,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgoqb,P27Y,pgxind-kftx2g4a,pgxcs-kftvnygr,180694900,0.063,180694900,0.063,0,0,PGX_AM_BS_20067559_ALL-mat-08,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.866000,1,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac368,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgoqg,P21Y,pgxind-kftx2g4g,pgxcs-kftvnyi6,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-11,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.870000,1,11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac369,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgoqi,P29Y,pgxind-kftx2g4i,pgxcs-kftvnyin,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-12,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.872000,1,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac36b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgoql,P14Y,pgxind-kftx2g4m,pgxcs-kftvnyjk,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-14,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.874000,1,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac36c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgoqn,P41Y,pgxind-kftx2g4o,pgxcs-kftvnyk1,16400017,0.006,16400017,0.006,0,0,PGX_AM_BS_20067559_ALL-mat-15,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.876000,1,36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac36e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgoqq,P18Y,pgxind-kftx2g4s,pgxcs-kftvnyky,69520054,0.024,30668618,0.011,38851436,0.014,PGX_AM_BS_20067559_ALL-mat-17,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.879000,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac36f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgoqs,P48Y,pgxind-kftx2g4u,pgxcs-kftvnylf,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-18,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.880000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac370,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgoqt,P35Y,pgxind-kftx2g4w,pgxcs-kftvnylv,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-19,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.881000,1,17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac371,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgoqv,P20Y,pgxind-kftx2g4y,pgxcs-kftvnymc,78900078,0.027,78900078,0.027,0,0,PGX_AM_BS_20067559_ALL-mat-20,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.883000,1,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac373,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgoqy,P36Y,pgxind-kftx2g52,pgxcs-kftvnyna,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-22,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.885000,1,14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac374,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgor0,P28Y,pgxind-kftx2g54,pgxcs-kftvnynr,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-23,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.887000,1,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac375,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgor2,P27Y,pgxind-kftx2g56,pgxcs-kftvnyo8,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-24,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.888000,1,33,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac376,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgor4,P51Y,pgxind-kftx2g58,pgxcs-kftvnyoo,182565551,0.064,145496928,0.051,37068623,0.013,PGX_AM_BS_20067559_ALL-mat-25,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.889000,1,27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac377,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgor5,P14Y,pgxind-kftx2g5a,pgxcs-kftvnyp5,178993709,0.062,144793675,0.05,34200034,0.012,PGX_AM_BS_20067559_ALL-mat-26,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.891000,1,23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac379,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgor9,P29Y,pgxind-kftx2g5f,pgxcs-kftvnyq2,365900042,0.127,317385437,0.11,48514605,0.017,PGX_AM_BS_20067559_ALL-mat-28,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.893000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac37a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgora,P37Y,pgxind-kftx2g5h,pgxcs-kftvnyqj,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-29,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.895000,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac37d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgorf,P23Y,pgxind-kftx2g5n,pgxcs-kftvnyrx,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-32,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.899000,1,29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac37e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgorh,P22Y,pgxind-kftx2g5p,pgxcs-kftvnyse,151420687,0.053,40406020,0.014,111014667,0.039,PGX_AM_BS_20067559_ALL-mat-33,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.900000,1,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac37f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgori,P19Y,pgxind-kftx2g5r,pgxcs-kftvnysv,503442231,0.175,158100158,0.055,345342073,0.12,PGX_AM_BS_20067559_ALL-mat-34,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.902000,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac380,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgork,P15Y,pgxind-kftx2g5t,pgxcs-kftvnytc,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-35,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.903000,1,26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac382,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgoro,P47Y,pgxind-kftx2g5x,pgxcs-kftvnyu9,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-37,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.906000,1,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac383,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgorp,P29Y,pgxind-kftx2g5z,pgxcs-kftvnyuq,154136119,0.054,61300062,0.021,92836057,0.032,PGX_AM_BS_20067559_ALL-mat-38,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.907000,1,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac384,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgorr,P31Y,pgxind-kftx2g61,pgxcs-kftvnyv7,116500116,0.041,36000036,0.013,80500080,0.028,PGX_AM_BS_20067559_ALL-mat-39,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.908000,1,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac385,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgort,P26Y,pgxind-kftx2g63,pgxcs-kftvnyvn,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-40,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.910000,1,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac386,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [T-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgoru,P16Y,pgxind-kftx2g65,pgxcs-kftvnyw4,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-41,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.911000,1,27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac387,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [B-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgorw,P23Y,pgxind-kftx2g67,pgxcs-kftvnywl,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-42,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.913000,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac38a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [B-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgos1,P17Y,pgxind-kftx2g6d,pgxcs-kftvnyxz,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-45,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.917000,1,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac38b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [B-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgos2,P18Y,pgxind-kftx2g6f,pgxcs-kftvnyyf,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-46,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.918000,1,23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac38c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [B-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgos4,P23Y,pgxind-kftx2g6h,pgxcs-kftvnyyw,204888702,0.071,0,0,204888702,0.071,PGX_AM_BS_20067559_ALL-mat-47,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.920000,1,46,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac390,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [B-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgosa,P22Y,pgxind-kftx2g6p,pgxcs-kftvnz0s,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-51,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.925000,1,22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac394,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [B-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgosh,P23Y,pgxind-kftx2g6x,pgxcs-kftvnz2n,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-55,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.930000,1,52,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac395,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [B-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgosj,P53Y,pgxind-kftx2g70,pgxcs-kftvnz34,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-56,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.932000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac398,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [B-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgoso,P18Y,pgxind-kftx2g76,pgxcs-kftvnz4i,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-59,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.936000,1,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac399,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [B-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgosp,P16Y,pgxind-kftx2g78,pgxcs-kftvnz4y,268944708,0.094,89900090,0.031,179044618,0.062,PGX_AM_BS_20067559_ALL-mat-60,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.937000,1,25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac39b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [B-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgost,P15Y,pgxind-kftx2g7c,pgxcs-kftvnz5w,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-62,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.939000,1,31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac39c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [B-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgosu,P19Y,pgxind-kftx2g7e,pgxcs-kftvnz6d,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-63,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.941000,1,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac39e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [B-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgosy,P19Y,pgxind-kftx2g7i,pgxcs-kftvnz7a,439482768,0.153,65600065,0.023,373882703,0.13,PGX_AM_BS_20067559_ALL-mat-65,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.943000,1,46,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac39f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [B-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgosz,P18Y,pgxind-kftx2g7k,pgxcs-kftvnz7r,957703134,0.333,0,0,957703134,0.333,PGX_AM_BS_20067559_ALL-mat-66,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.945000,1,18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac3a4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [B-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgot7,P17Y,pgxind-kftx2g7u,pgxcs-kftvnzag,469761849,0.163,0,0,469761849,0.163,PGX_AM_BS_20067559_ALL-mat-71,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.952000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac3a5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia [B-cell],PMID:20067559,"Matteucci C, Barba G et al. (2010): Rescue of genomic information in adult...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvgot9,P35Y,pgxind-kftx2g7w,pgxcs-kftvnzax,0,0,0,0,0,0,PGX_AM_BS_20067559_ALL-mat-72,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:14.953000,1,22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af7d9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia/lymphoblastic lymphoma,PMID:12935929,"Jarosov M, Holzerov M et al. (2003): Complex karyotypes in childhood acute lymphoblastic...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvh5vh,P10Y,pgxind-kftx3146,pgxcs-kftvt61o,94836059,0.033,67736032,0.024,27100027,0.009,PGX_AM_BS_12935929_ChALL-jar-09,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.840000,1,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af7dd,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia/lymphoblastic lymphoma,PMID:12935929,"Jarosov M, Holzerov M et al. (2003): Complex karyotypes in childhood acute lymphoblastic...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvh5vn,P7Y,pgxind-kftx314e,pgxcs-kftvt63l,633690832,0.22,0,0,633690832,0.22,PGX_AM_BS_12935929_ChALL-jar-14,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.846000,1,38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af7e1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute lymphoblastic leukemia/lymphoblastic lymphoma,PMID:12935929,"Jarosov M, Holzerov M et al. (2003): Complex karyotypes in childhood acute lymphoblastic...",NCIT:C3167,Acute Lymphoblastic Leukemia,icdom-98353,"Precursor cell lymphoblastic leukemia, NOS",icdot-C42.1,Bone marrow,pgxbs-kftvh5vu,P13Y,pgxind-kftx314m,pgxcs-kftvt65j,132628443,0.046,98414654,0.034,34213789,0.012,PGX_AM_BS_12935929_ChALL-jar-20,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:33.852000,1,11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab90a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute megakaryoblastic leukemia,PMID:21538823,"Massaro SA, Bajaj R et al. (2011): Bi-allelic deletions within 13q14 and transient...",NCIT:C3170,Acute Megakaryoblastic Leukemia,icdom-99103,Acute megakaryoblastic leukemia,icdot-C42.1,Bone marrow,pgxbs-kftvgldo,P1Y5M,pgxind-kftx2c0g,pgxcs-kftvmyhf,0,0,0,0,0,0,PGX_AM_BS_21538823_AMKL-mas-01,{},-72.93,41.31,Point,USA,New Haven,United States of America,"New Haven, United States",41.31,-72.93,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:11.117000,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00ab0bf,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute promyelocytic leukemia (FAB type M3),PMID:7509627,"Mohamed AN, Macoska JA et al. (1993): Extrachromosomal gene amplification in acute myeloid...",NCIT:C3182,Acute Promyelocytic Leukemia with PML-RARA,icdom-98663,Acute promyelocytic leukemia,icdot-C42.1,Bone marrow,pgxbs-kftvgip8,P59Y,pgxind-kftx28qu,pgxcs-kftvm5dd,0,0,0,0,0,0,PGX_AM_BS_7509627_APL-moh-1,{},-83.05,42.33,Point,USA,Detroit,United States of America,"Detroit, United States",42.33,-83.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:08.096000,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c8727983b2e00ae686,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Follicular lymphoma, NOS",PMID:16213357,"D'Haese JG, Tsukasaki K et al. (2005): Chromosomal aberrations in follicular non-Hodgkin lymphomas...",NCIT:C3209,Follicular Lymphoma,icdom-96903,"Follicular lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh0bl,P48Y,pgxind-kftx2u6i,pgxcs-kftvrg2j,0,0,0,0,0,0,PGX_AM_BS_16213357-FCL-hae-15,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:27.686000,0,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c8727983b2e00ae687,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Follicular lymphoma, NOS",PMID:16213357,"D'Haese JG, Tsukasaki K et al. (2005): Chromosomal aberrations in follicular non-Hodgkin lymphomas...",NCIT:C3209,Follicular Lymphoma,icdom-96903,"Follicular lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh0bn,P58Y,pgxind-kftx2u6j,pgxcs-kftvrg30,349960410,0.122,120000118,0.042,229960292,0.08,PGX_AM_BS_16213357-FCL-hae-16,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:27.688000,0,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c8727983b2e00ae689,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Follicular lymphoma, NOS",PMID:16213357,"D'Haese JG, Tsukasaki K et al. (2005): Chromosomal aberrations in follicular non-Hodgkin lymphomas...",NCIT:C3209,Follicular Lymphoma,icdom-96903,"Follicular lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh0bq,P48Y,pgxind-kftx2u6n,pgxcs-kftvrg3z,0,0,0,0,0,0,PGX_AM_BS_16213357-FCL-hae-18,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:27.691000,0,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c8727983b2e00ae68b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Follicular lymphoma, NOS",PMID:16213357,"D'Haese JG, Tsukasaki K et al. (2005): Chromosomal aberrations in follicular non-Hodgkin lymphomas...",NCIT:C3209,Follicular Lymphoma,icdom-96903,"Follicular lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh0bt,P54Y,pgxind-kftx2u6s,pgxcs-kftvrg4x,112217266,0.039,36100036,0.013,76117230,0.026,PGX_AM_BS_16213357-FCL-hae-20,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:27.693000,0,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c8727983b2e00ae68d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Follicular lymphoma, NOS",PMID:16213357,"D'Haese JG, Tsukasaki K et al. (2005): Chromosomal aberrations in follicular non-Hodgkin lymphomas...",NCIT:C3209,Follicular Lymphoma,icdom-96903,"Follicular lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh0bw,P79Y,pgxind-kftx2u6v,pgxcs-kftvrg5v,0,0,0,0,0,0,PGX_AM_BS_16213357-FCL-hae-22,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:27.696000,0,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c8727983b2e00ae691,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Follicular lymphoma, NOS",PMID:16213357,"D'Haese JG, Tsukasaki K et al. (2005): Chromosomal aberrations in follicular non-Hodgkin lymphomas...",NCIT:C3209,Follicular Lymphoma,icdom-96903,"Follicular lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh0c3,P48Y,pgxind-kftx2u73,pgxcs-kftvrg7s,167533563,0.058,110306090,0.038,57227473,0.02,PGX_AM_BS_16213357-FCL-hae-3,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:27.702000,0,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c8727983b2e00ae692,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Follicular lymphoma, NOS",PMID:16213357,"D'Haese JG, Tsukasaki K et al. (2005): Chromosomal aberrations in follicular non-Hodgkin lymphomas...",NCIT:C3209,Follicular Lymphoma,icdom-96903,"Follicular lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh0c5,P65Y,pgxind-kftx2u75,pgxcs-kftvrg8a,41113796,0.014,24000024,0.008,17113772,0.006,PGX_AM_BS_16213357-FCL-hae-4,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:27.703000,0,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c8727983b2e00ae696,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Follicular lymphoma, NOS",PMID:16213357,"D'Haese JG, Tsukasaki K et al. (2005): Chromosomal aberrations in follicular non-Hodgkin lymphomas...",NCIT:C3209,Follicular Lymphoma,icdom-96903,"Follicular lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh0cb,P32Y,pgxind-kftx2u7d,pgxcs-kftvrga7,0,0,0,0,0,0,PGX_AM_BS_16213357-FCL-hae-6,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:27.708000,0,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c8727983b2e00ae697,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Follicular lymphoma, NOS",PMID:16213357,"D'Haese JG, Tsukasaki K et al. (2005): Chromosomal aberrations in follicular non-Hodgkin lymphomas...",NCIT:C3209,Follicular Lymphoma,icdom-96903,"Follicular lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh0cd,P50Y,pgxind-kftx2u7f,pgxcs-kftvrgao,266541436,0.093,0,0,266541436,0.093,PGX_AM_BS_16213357-FCL-hae-7d,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:27.710000,0,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c8727983b2e00ae69a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Follicular lymphoma, NOS",PMID:16213357,"D'Haese JG, Tsukasaki K et al. (2005): Chromosomal aberrations in follicular non-Hodgkin lymphomas...",NCIT:C3209,Follicular Lymphoma,icdom-96903,"Follicular lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh0ci,P34Y,pgxind-kftx2u7l,pgxcs-kftvrgc7,196713950,0.068,0,0,196713950,0.068,PGX_AM_BS_16213357-FCL-hae-9d,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:27.714000,0,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ade2d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Follicular lymphoma, NOS",PMID:17170743,"Berglund M, Enblad G et al. (2007): Genomic imbalances during transformation from follicular...",NCIT:C3209,Follicular Lymphoma,icdom-96903,"Follicular lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxbu,P37Y,pgxind-kftx2qus,pgxcs-kftvqm5w,0,0,0,0,0,0,PGX_AM_BS_TF-FCL-ber-16,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.345000,1,26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad9f7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Mycosis fungoides [CD30-,  Skin sample]",PMID:17584911,"Prochazkova M, Chevret E et al. (2007): Common chromosomal abnormalities in mycosis fungoides...",NCIT:C3246,Mycosis Fungoides,icdom-97003,Mycosis Fungoides,icdot-C44.9,"Skin, NOS",pgxbs-kftvgvyy,P78Y,pgxind-kftx2p63,pgxcs-kftvq73c,1661636782,0.578,926379487,0.322,735257295,0.256,PGX_AM_BS_MF-pro-06-IV,,-0.58,44.84,Point,FRA,Bordeaux,France,"Bordeaux, France",44.84,-0.58,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:22.854000,0,24,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad9f9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Mycosis fungoides [CD30 ,  Skin sample]",PMID:17584911,"Prochazkova M, Chevret E et al. (2007): Common chromosomal abnormalities in mycosis fungoides...",NCIT:C3246,Mycosis Fungoides,icdom-97003,Mycosis Fungoides,icdot-C44.9,"Skin, NOS",pgxbs-kftvgvz1,P34Y,pgxind-kftx2p67,pgxcs-kftvq74b,174167325,0.061,0,0,174167325,0.061,PGX_AM_BS_MF-pro-08-V,{},-0.58,44.84,Point,FRA,Bordeaux,France,"Bordeaux, France",44.84,-0.58,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:22.856000,0,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad9ff,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Mycosis fungoides [CD30 ,  Skin sample]",PMID:17584911,"Prochazkova M, Chevret E et al. (2007): Common chromosomal abnormalities in mycosis fungoides...",NCIT:C3246,Mycosis Fungoides,icdom-97003,Mycosis Fungoides,icdot-C44.9,"Skin, NOS",pgxbs-kftvgvzb,P54Y,pgxind-kftx2p6j,pgxcs-kftvq77a,975891437,0.339,472800473,0.164,503090964,0.175,PGX_AM_BS_MF-pro-14-IX,,-0.58,44.84,Point,FRA,Bordeaux,France,"Bordeaux, France",44.84,-0.58,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:22.865000,0,36,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ada00,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Mycosis fungoides [CD30 ,  Skin sample]",PMID:17584911,"Prochazkova M, Chevret E et al. (2007): Common chromosomal abnormalities in mycosis fungoides...",NCIT:C3246,Mycosis Fungoides,icdom-97003,Mycosis Fungoides,icdot-C44.9,"Skin, NOS",pgxbs-kftvgvzc,P62Y,pgxind-kftx2p6l,pgxcs-kftvq77r,135327263,0.047,56552442,0.02,78774821,0.027,PGX_AM_BS_MF-pro-15-X,,-0.58,44.84,Point,FRA,Bordeaux,France,"Bordeaux, France",44.84,-0.58,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:22.866000,0,6,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af249,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mycosis fungoides [stage Ib],PMID:15086538,"Fischer TC, Gellrich S et al. (2004): Genomic aberrations and survival in cutaneous...",NCIT:C3246,Mycosis Fungoides,icdom-97003,Mycosis Fungoides,icdot-C44.9,"Skin, NOS",pgxbs-kftvh43d,P75Y,pgxind-kftx2ywc,pgxcs-kftvsm56,0,0,0,0,0,0,PGX_AM_BS_CTNHL-Fi-01,,13.37,52.52,Point,DEU,Berlin,Germany,"Berlin, Germany",52.52,13.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.867000,0,108,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af24a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mycosis fungoides [stage Ia],PMID:15086538,"Fischer TC, Gellrich S et al. (2004): Genomic aberrations and survival in cutaneous...",NCIT:C3246,Mycosis Fungoides,icdom-97003,Mycosis Fungoides,icdot-C44.9,"Skin, NOS",pgxbs-kftvh43f,P52Y,pgxind-kftx2ywe,pgxcs-kftvsm5n,0,0,0,0,0,0,PGX_AM_BS_CTNHL-Fi-02,,13.37,52.52,Point,DEU,Berlin,Germany,"Berlin, Germany",52.52,13.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.868000,0,13,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af24b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mycosis fungoides [stage Ib],PMID:15086538,"Fischer TC, Gellrich S et al. (2004): Genomic aberrations and survival in cutaneous...",NCIT:C3246,Mycosis Fungoides,icdom-97003,Mycosis Fungoides,icdot-C44.9,"Skin, NOS",pgxbs-kftvh43h,P70Y,pgxind-kftx2ywg,pgxcs-kftvsm64,0,0,0,0,0,0,PGX_AM_BS_CTNHL-Fi-03,,13.37,52.52,Point,DEU,Berlin,Germany,"Berlin, Germany",52.52,13.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.870000,0,72,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af24c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mycosis fungoides [stage IIa],PMID:15086538,"Fischer TC, Gellrich S et al. (2004): Genomic aberrations and survival in cutaneous...",NCIT:C3246,Mycosis Fungoides,icdom-97003,Mycosis Fungoides,icdot-C44.9,"Skin, NOS",pgxbs-kftvh43i,P60Y,pgxind-kftx2ywi,pgxcs-kftvsm6l,0,0,0,0,0,0,PGX_AM_BS_CTNHL-Fi-04,,13.37,52.52,Point,DEU,Berlin,Germany,"Berlin, Germany",52.52,13.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.871000,0,10,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af24d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mycosis fungoides [stage Ib],PMID:15086538,"Fischer TC, Gellrich S et al. (2004): Genomic aberrations and survival in cutaneous...",NCIT:C3246,Mycosis Fungoides,icdom-97003,Mycosis Fungoides,icdot-C44.9,"Skin, NOS",pgxbs-kftvh43k,P61Y,pgxind-kftx2ywk,pgxcs-kftvsm73,0,0,0,0,0,0,PGX_AM_BS_CTNHL-Fi-05,,13.37,52.52,Point,DEU,Berlin,Germany,"Berlin, Germany",52.52,13.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.872000,0,51,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af24e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mycosis fungoides [stage Ia],PMID:15086538,"Fischer TC, Gellrich S et al. (2004): Genomic aberrations and survival in cutaneous...",NCIT:C3246,Mycosis Fungoides,icdom-97003,Mycosis Fungoides,icdot-C44.9,"Skin, NOS",pgxbs-kftvh43m,P61Y,pgxind-kftx2ywn,pgxcs-kftvsm7j,0,0,0,0,0,0,PGX_AM_BS_CTNHL-Fi-06,,13.37,52.52,Point,DEU,Berlin,Germany,"Berlin, Germany",52.52,13.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.874000,0,11,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af250,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mycosis fungoides [stage Ib],PMID:15086538,"Fischer TC, Gellrich S et al. (2004): Genomic aberrations and survival in cutaneous...",NCIT:C3246,Mycosis Fungoides,icdom-97003,Mycosis Fungoides,icdot-C44.9,"Skin, NOS",pgxbs-kftvh43p,P83Y,pgxind-kftx2ywr,pgxcs-kftvsm8h,0,0,0,0,0,0,PGX_AM_BS_CTNHL-Fi-08,,13.37,52.52,Point,DEU,Berlin,Germany,"Berlin, Germany",52.52,13.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.877000,0,91,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af251,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mycosis fungoides [stage Ib],PMID:15086538,"Fischer TC, Gellrich S et al. (2004): Genomic aberrations and survival in cutaneous...",NCIT:C3246,Mycosis Fungoides,icdom-97003,Mycosis Fungoides,icdot-C44.9,"Skin, NOS",pgxbs-kftvh43q,P79Y,pgxind-kftx2ywt,pgxcs-kftvsm8y,0,0,0,0,0,0,PGX_AM_BS_CTNHL-Fi-09,,13.37,52.52,Point,DEU,Berlin,Germany,"Berlin, Germany",52.52,13.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.878000,0,16,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af252,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mycosis fungoides [stage Ib],PMID:15086538,"Fischer TC, Gellrich S et al. (2004): Genomic aberrations and survival in cutaneous...",NCIT:C3246,Mycosis Fungoides,icdom-97003,Mycosis Fungoides,icdot-C44.9,"Skin, NOS",pgxbs-kftvh43s,P80Y,pgxind-kftx2ywv,pgxcs-kftvsm9f,0,0,0,0,0,0,PGX_AM_BS_CTNHL-Fi-10,,13.37,52.52,Point,DEU,Berlin,Germany,"Berlin, Germany",52.52,13.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.879000,0,8,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af253,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mycosis fungoides [stage Ib],PMID:15086538,"Fischer TC, Gellrich S et al. (2004): Genomic aberrations and survival in cutaneous...",NCIT:C3246,Mycosis Fungoides,icdom-97003,Mycosis Fungoides,icdot-C44.9,"Skin, NOS",pgxbs-kftvh43u,P61Y,pgxind-kftx2ywx,pgxcs-kftvsm9w,0,0,0,0,0,0,PGX_AM_BS_CTNHL-Fi-11,,13.37,52.52,Point,DEU,Berlin,Germany,"Berlin, Germany",52.52,13.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.881000,0,5,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af254,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mycosis fungoides [stage IIb],PMID:15086538,"Fischer TC, Gellrich S et al. (2004): Genomic aberrations and survival in cutaneous...",NCIT:C3246,Mycosis Fungoides,icdom-97003,Mycosis Fungoides,icdot-C44.9,"Skin, NOS",pgxbs-kftvh43v,P62Y,pgxind-kftx2ywz,pgxcs-kftvsmad,0,0,0,0,0,0,PGX_AM_BS_CTNHL-Fi-12,,13.37,52.52,Point,DEU,Berlin,Germany,"Berlin, Germany",52.52,13.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.882000,0,5,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af255,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mycosis fungoides [stage IIa],PMID:15086538,"Fischer TC, Gellrich S et al. (2004): Genomic aberrations and survival in cutaneous...",NCIT:C3246,Mycosis Fungoides,icdom-97003,Mycosis Fungoides,icdot-C44.9,"Skin, NOS",pgxbs-kftvh43x,P54Y,pgxind-kftx2yx1,pgxcs-kftvsmau,0,0,0,0,0,0,PGX_AM_BS_CTNHL-Fi-13,,13.37,52.52,Point,DEU,Berlin,Germany,"Berlin, Germany",52.52,13.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.884000,0,40,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af256,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mycosis fungoides [stage Ib],PMID:15086538,"Fischer TC, Gellrich S et al. (2004): Genomic aberrations and survival in cutaneous...",NCIT:C3246,Mycosis Fungoides,icdom-97003,Mycosis Fungoides,icdot-C44.9,"Skin, NOS",pgxbs-kftvh43z,P90Y,pgxind-kftx2yx3,pgxcs-kftvsmbb,87474830,0.03,87474830,0.03,0,0,PGX_AM_BS_CTNHL-Fi-14,,13.37,52.52,Point,DEU,Berlin,Germany,"Berlin, Germany",52.52,13.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.885000,0,186,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af257,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mycosis fungoides [stage IIb],PMID:15086538,"Fischer TC, Gellrich S et al. (2004): Genomic aberrations and survival in cutaneous...",NCIT:C3246,Mycosis Fungoides,icdom-97003,Mycosis Fungoides,icdot-C44.9,"Skin, NOS",pgxbs-kftvh440,P51Y,pgxind-kftx2yx5,pgxcs-kftvsmbs,202891225,0.071,0,0,202891225,0.071,PGX_AM_BS_CTNHL-Fi-15,,13.37,52.52,Point,DEU,Berlin,Germany,"Berlin, Germany",52.52,13.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.887000,0,15,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af258,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mycosis fungoides [stage IIa],PMID:15086538,"Fischer TC, Gellrich S et al. (2004): Genomic aberrations and survival in cutaneous...",NCIT:C3246,Mycosis Fungoides,icdom-97003,Mycosis Fungoides,icdot-C44.9,"Skin, NOS",pgxbs-kftvh442,P78Y,pgxind-kftx2yx7,pgxcs-kftvsmca,103674845,0.036,103674845,0.036,0,0,PGX_AM_BS_CTNHL-Fi-16,,13.37,52.52,Point,DEU,Berlin,Germany,"Berlin, Germany",52.52,13.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.888000,0,126,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af259,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mycosis fungoides [stage Ib],PMID:15086538,"Fischer TC, Gellrich S et al. (2004): Genomic aberrations and survival in cutaneous...",NCIT:C3246,Mycosis Fungoides,icdom-97003,Mycosis Fungoides,icdot-C44.9,"Skin, NOS",pgxbs-kftvh444,P69Y,pgxind-kftx2yx9,pgxcs-kftvsmcr,216049056,0.075,57227473,0.02,158821583,0.055,PGX_AM_BS_CTNHL-Fi-17,,13.37,52.52,Point,DEU,Berlin,Germany,"Berlin, Germany",52.52,13.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.889000,0,14,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af25e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mycosis fungoides [stage IIb],PMID:15086538,"Fischer TC, Gellrich S et al. (2004): Genomic aberrations and survival in cutaneous...",NCIT:C3246,Mycosis Fungoides,icdom-97003,Mycosis Fungoides,icdot-C44.9,"Skin, NOS",pgxbs-kftvh44c,P37Y,pgxind-kftx2yxj,pgxcs-kftvsmf5,593936744,0.207,278601625,0.097,315335119,0.11,PGX_AM_BS_CTNHL-Fi-22,,13.37,52.52,Point,DEU,Berlin,Germany,"Berlin, Germany",52.52,13.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.896000,0,12,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad9f2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Mycosis fungoides [CD30-, Skin sample]",PMID:17584911,"Prochazkova M, Chevret E et al. (2007): Common chromosomal abnormalities in mycosis fungoides...",NCIT:C3246,Mycosis Fungoides,icdom-97003,Mycosis Fungoides,icdot-C44.9,"Skin, NOS",pgxbs-kftvgvyp,P63Y,pgxind-kftx2p5t,pgxcs-kftvq70w,639949941,0.223,104593635,0.036,535356306,0.186,PGX_AM_BS_MF-pro-01-I,,-0.58,44.84,Point,FRA,Bordeaux,France,"Bordeaux, France",44.84,-0.58,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:22.846000,1,12,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad9f4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Mycosis fungoides [CD30-,  Skin sample]",PMID:17584911,"Prochazkova M, Chevret E et al. (2007): Common chromosomal abnormalities in mycosis fungoides...",NCIT:C3246,Mycosis Fungoides,icdom-97003,Mycosis Fungoides,icdot-C44.9,"Skin, NOS",pgxbs-kftvgvys,P80Y,pgxind-kftx2p5x,pgxcs-kftvq71v,160688408,0.056,64693595,0.023,95994813,0.033,PGX_AM_BS_MF-pro-03-II,,-0.58,44.84,Point,FRA,Bordeaux,France,"Bordeaux, France",44.84,-0.58,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:22.849000,1,24,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ad9f5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Mycosis fungoides [CD30-,  Node sample]",PMID:17584911,"Prochazkova M, Chevret E et al. (2007): Common chromosomal abnormalities in mycosis fungoides...",NCIT:C3246,Mycosis Fungoides,icdom-97003,Mycosis Fungoides,icdot-C44.9,"Skin, NOS",pgxbs-kftvgvyu,P62Y,pgxind-kftx2p5z,pgxcs-kftvq72c,2401893288,0.835,1029845960,0.358,1372047328,0.477,PGX_AM_BS_MF-pro-04-III,,-0.58,44.84,Point,FRA,Bordeaux,France,"Bordeaux, France",44.84,-0.58,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:22.851000,1,12,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad9fa,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Mycosis fungoides [CD30 ,  Skin sample]",PMID:17584911,"Prochazkova M, Chevret E et al. (2007): Common chromosomal abnormalities in mycosis fungoides...",NCIT:C3246,Mycosis Fungoides,icdom-97003,Mycosis Fungoides,icdot-C44.9,"Skin, NOS",pgxbs-kftvgvz2,P71Y,pgxind-kftx2p69,pgxcs-kftvq74t,720690801,0.251,94400095,0.033,626290706,0.218,PGX_AM_BS_MF-pro-09-VI,,-0.58,44.84,Point,FRA,Bordeaux,France,"Bordeaux, France",44.84,-0.58,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:22.858000,1,36,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ad9fb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Mycosis fungoides [CD30 ,  Skin sample]",PMID:17584911,"Prochazkova M, Chevret E et al. (2007): Common chromosomal abnormalities in mycosis fungoides...",NCIT:C3246,Mycosis Fungoides,icdom-97003,Mycosis Fungoides,icdot-C44.9,"Skin, NOS",pgxbs-kftvgvz4,P70Y,pgxind-kftx2p6b,pgxcs-kftvq75a,1184735832,0.412,517336497,0.18,667399335,0.232,PGX_AM_BS_MF-pro-10-VII,,-0.58,44.84,Point,FRA,Bordeaux,France,"Bordeaux, France",44.84,-0.58,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:22.859000,1,38,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad9fd,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Mycosis fungoides [CD30 ,  Skin sample]",PMID:17584911,"Prochazkova M, Chevret E et al. (2007): Common chromosomal abnormalities in mycosis fungoides...",NCIT:C3246,Mycosis Fungoides,icdom-97003,Mycosis Fungoides,icdot-C44.9,"Skin, NOS",pgxbs-kftvgvz7,P66Y,pgxind-kftx2p6f,pgxcs-kftvq769,703702296,0.245,200058065,0.07,503644231,0.175,PGX_AM_BS_MF-pro-12-VIII,,-0.58,44.84,Point,FRA,Bordeaux,France,"Bordeaux, France",44.84,-0.58,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:22.862000,1,12,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ada01,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Mycosis fungoides [CD30 ,  Skin sample]",PMID:17584911,"Prochazkova M, Chevret E et al. (2007): Common chromosomal abnormalities in mycosis fungoides...",NCIT:C3246,Mycosis Fungoides,icdom-97003,Mycosis Fungoides,icdot-C44.9,"Skin, NOS",pgxbs-kftvgvze,P67Y,pgxind-kftx2p6n,pgxcs-kftvq788,0,0,0,0,0,0,PGX_AM_BS_MF-pro-16-XI,,-0.58,44.84,Point,FRA,Bordeaux,France,"Bordeaux, France",44.84,-0.58,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:22.868000,1,12,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af25b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mycosis fungoides [stage IVa],PMID:15086538,"Fischer TC, Gellrich S et al. (2004): Genomic aberrations and survival in cutaneous...",NCIT:C3246,Mycosis Fungoides,icdom-97003,Mycosis Fungoides,icdot-C44.9,"Skin, NOS",pgxbs-kftvh447,P70Y,pgxind-kftx2yxd,pgxcs-kftvsmdp,120831832,0.042,60814618,0.021,60017214,0.021,PGX_AM_BS_CTNHL-Fi-19,,13.37,52.52,Point,DEU,Berlin,Germany,"Berlin, Germany",52.52,13.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.892000,1,69,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af25f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mycosis fungoides [stage IVb],PMID:15086538,"Fischer TC, Gellrich S et al. (2004): Genomic aberrations and survival in cutaneous...",NCIT:C3246,Mycosis Fungoides,icdom-97003,Mycosis Fungoides,icdot-C44.9,"Skin, NOS",pgxbs-kftvh44d,P75Y,pgxind-kftx2yxl,pgxcs-kftvsmfm,421081197,0.146,132033519,0.046,289047678,0.101,PGX_AM_BS_CTNHL-Fi-23,,13.37,52.52,Point,DEU,Berlin,Germany,"Berlin, Germany",52.52,13.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.898000,1,54,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adcf9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute myeloblastic leukemia without maturation [FAB type M1],PMID:17268525,"Tyybkinoja A, Elonen E et al. (2007): Oligonucleotide array-CGH reveals cryptic gene copy...",NCIT:C3249,Acute Myeloid Leukemia without Maturation,icdom-98733,Acute myeloid leukemia without maturation,icdot-C42.1,Bone marrow,pgxbs-kftvgwxs,P74Y,pgxind-kftx2qdm,pgxcs-kftvqhtz,0,0,0,0,0,0,PGX_AM_BS_AMLkarnorm-tyy-18,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:23.920000,0,17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adce8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute myeloblastic leukemia without maturation [FAB type M1],PMID:17268525,"Tyybkinoja A, Elonen E et al. (2007): Oligonucleotide array-CGH reveals cryptic gene copy...",NCIT:C3249,Acute Myeloid Leukemia without Maturation,icdom-98733,Acute myeloid leukemia without maturation,icdot-C42.1,Bone marrow,pgxbs-kftvgwx1,P75Y,pgxind-kftx2qco,pgxcs-kftvqhlw,0,0,0,0,0,0,PGX_AM_BS_AMLkarnorm-tyy-01,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:23.897000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adcf0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute myeloblastic leukemia without maturation [FAB type M1],PMID:17268525,"Tyybkinoja A, Elonen E et al. (2007): Oligonucleotide array-CGH reveals cryptic gene copy...",NCIT:C3249,Acute Myeloid Leukemia without Maturation,icdom-98733,Acute myeloid leukemia without maturation,icdot-C42.1,Bone marrow,pgxbs-kftvgwxe,P35Y,pgxind-kftx2qd3,pgxcs-kftvqhpp,0,0,0,0,0,0,PGX_AM_BS_AMLkarnorm-tyy-09,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:23.908000,1,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adcf1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute myeloblastic leukemia without maturation [FAB type M1],PMID:17268525,"Tyybkinoja A, Elonen E et al. (2007): Oligonucleotide array-CGH reveals cryptic gene copy...",NCIT:C3249,Acute Myeloid Leukemia without Maturation,icdom-98733,Acute myeloid leukemia without maturation,icdot-C42.1,Bone marrow,pgxbs-kftvgwxf,P45Y,pgxind-kftx2qd5,pgxcs-kftvqhq6,0,0,0,0,0,0,PGX_AM_BS_AMLkarnorm-tyy-10,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:23.909000,1,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adcf8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute myeloblastic leukemia without maturation [FAB type M1],PMID:17268525,"Tyybkinoja A, Elonen E et al. (2007): Oligonucleotide array-CGH reveals cryptic gene copy...",NCIT:C3249,Acute Myeloid Leukemia without Maturation,icdom-98733,Acute myeloid leukemia without maturation,icdot-C42.1,Bone marrow,pgxbs-kftvgwxq,P49Y,pgxind-kftx2qdk,pgxcs-kftvqhtj,0,0,0,0,0,0,PGX_AM_BS_AMLkarnorm-tyy-17,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:23.919000,1,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00add00,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute myeloblastic leukemia without maturation [FAB type M1],PMID:17268525,"Tyybkinoja A, Elonen E et al. (2007): Oligonucleotide array-CGH reveals cryptic gene copy...",NCIT:C3249,Acute Myeloid Leukemia without Maturation,icdom-98733,Acute myeloid leukemia without maturation,icdot-C42.1,Bone marrow,pgxbs-kftvgwy3,P70Y,pgxind-kftx2qe0,pgxcs-kftvqhxc,0,0,0,0,0,0,PGX_AM_BS_AMLkarnorm-tyy-25,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:23.930000,1,45,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afb7e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute myeloblastic leukemia without maturation (FAB type M1),PMID:12550752,"Matteucci C, La Starza R et al. (2003): Different mechanisms lead to a karyotypically...",NCIT:C3249,Acute Myeloid Leukemia without Maturation,icdom-98733,Acute myeloid leukemia without maturation,icdot-C42.1,Bone marrow,pgxbs-kftvh71h,P52Y,pgxind-kftx32ko,pgxcs-kftvtj57,180474782,0.063,35336000,0.012,145138782,0.05,PGX_AM_BS_12550752_AMLM1-mat-1,{},12.39,43.11,Point,ITA,Perugia,Italy,"Perugia, Italy",43.11,12.39,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:35.128000,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adce9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute myeloblastic leukemia with maturation [FAB M2],PMID:17268525,"Tyybkinoja A, Elonen E et al. (2007): Oligonucleotide array-CGH reveals cryptic gene copy...",NCIT:C3250,Acute Myeloid Leukemia with Maturation,icdom-98743,Acute myeloid leukemia with maturation,icdot-C42.1,Bone marrow,pgxbs-kftvgwx3,P69Y,pgxind-kftx2qcq,pgxcs-kftvqhmd,0,0,0,0,0,0,PGX_AM_BS_AMLkarnorm-tyy-02,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:23.899000,0,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adcf4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute myeloblastic leukemia with maturation [FAB M2],PMID:17268525,"Tyybkinoja A, Elonen E et al. (2007): Oligonucleotide array-CGH reveals cryptic gene copy...",NCIT:C3250,Acute Myeloid Leukemia with Maturation,icdom-98743,Acute myeloid leukemia with maturation,icdot-C42.1,Bone marrow,pgxbs-kftvgwxk,P21Y,pgxind-kftx2qdb,pgxcs-kftvqhrl,0,0,0,0,0,0,PGX_AM_BS_AMLkarnorm-tyy-13,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:23.914000,0,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adcfb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute myeloblastic leukemia with maturation [FAB M2],PMID:17268525,"Tyybkinoja A, Elonen E et al. (2007): Oligonucleotide array-CGH reveals cryptic gene copy...",NCIT:C3250,Acute Myeloid Leukemia with Maturation,icdom-98743,Acute myeloid leukemia with maturation,icdot-C42.1,Bone marrow,pgxbs-kftvgwxv,P47Y,pgxind-kftx2qdq,pgxcs-kftvqhux,0,0,0,0,0,0,PGX_AM_BS_AMLkarnorm-tyy-20,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:23.923000,0,21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adcfd,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute myeloblastic leukemia with maturation [FAB M2],PMID:17268525,"Tyybkinoja A, Elonen E et al. (2007): Oligonucleotide array-CGH reveals cryptic gene copy...",NCIT:C3250,Acute Myeloid Leukemia with Maturation,icdom-98743,Acute myeloid leukemia with maturation,icdot-C42.1,Bone marrow,pgxbs-kftvgwxz,P29Y,pgxind-kftx2qdu,pgxcs-kftvqhvw,0,0,0,0,0,0,PGX_AM_BS_AMLkarnorm-tyy-22,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:23.926000,0,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adcea,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute myeloblastic leukemia with maturation [FAB M2],PMID:17268525,"Tyybkinoja A, Elonen E et al. (2007): Oligonucleotide array-CGH reveals cryptic gene copy...",NCIT:C3250,Acute Myeloid Leukemia with Maturation,icdom-98743,Acute myeloid leukemia with maturation,icdot-C42.1,Bone marrow,pgxbs-kftvgwx4,P43Y,pgxind-kftx2qcs,pgxcs-kftvqhmu,0,0,0,0,0,0,PGX_AM_BS_AMLkarnorm-tyy-03,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:23.900000,1,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adceb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute myeloblastic leukemia with maturation [FAB M2],PMID:17268525,"Tyybkinoja A, Elonen E et al. (2007): Oligonucleotide array-CGH reveals cryptic gene copy...",NCIT:C3250,Acute Myeloid Leukemia with Maturation,icdom-98743,Acute myeloid leukemia with maturation,icdot-C42.1,Bone marrow,pgxbs-kftvgwx6,P70Y,pgxind-kftx2qcu,pgxcs-kftvqhnb,0,0,0,0,0,0,PGX_AM_BS_AMLkarnorm-tyy-04,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:23.901000,1,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adcec,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute myeloblastic leukemia with maturation [FAB M2],PMID:17268525,"Tyybkinoja A, Elonen E et al. (2007): Oligonucleotide array-CGH reveals cryptic gene copy...",NCIT:C3250,Acute Myeloid Leukemia with Maturation,icdom-98743,Acute myeloid leukemia with maturation,icdot-C42.1,Bone marrow,pgxbs-kftvgwx7,P56Y,pgxind-kftx2qcw,pgxcs-kftvqhns,0,0,0,0,0,0,PGX_AM_BS_AMLkarnorm-tyy-05,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:23.903000,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adcf3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute myeloblastic leukemia with maturation [FAB M2],PMID:17268525,"Tyybkinoja A, Elonen E et al. (2007): Oligonucleotide array-CGH reveals cryptic gene copy...",NCIT:C3250,Acute Myeloid Leukemia with Maturation,icdom-98743,Acute myeloid leukemia with maturation,icdot-C42.1,Bone marrow,pgxbs-kftvgwxi,P47Y,pgxind-kftx2qd9,pgxcs-kftvqhr4,0,0,0,0,0,0,PGX_AM_BS_AMLkarnorm-tyy-12,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:23.912000,1,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adcf7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute myeloblastic leukemia with maturation [FAB M2],PMID:17268525,"Tyybkinoja A, Elonen E et al. (2007): Oligonucleotide array-CGH reveals cryptic gene copy...",NCIT:C3250,Acute Myeloid Leukemia with Maturation,icdom-98743,Acute myeloid leukemia with maturation,icdot-C42.1,Bone marrow,pgxbs-kftvgwxp,P70Y,pgxind-kftx2qdi,pgxcs-kftvqht1,29500030,0.01,12700013,0.004,16800017,0.006,PGX_AM_BS_AMLkarnorm-tyy-16,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:23.918000,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adcfe,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute myeloblastic leukemia with maturation [FAB M2],PMID:17268525,"Tyybkinoja A, Elonen E et al. (2007): Oligonucleotide array-CGH reveals cryptic gene copy...",NCIT:C3250,Acute Myeloid Leukemia with Maturation,icdom-98743,Acute myeloid leukemia with maturation,icdot-C42.1,Bone marrow,pgxbs-kftvgwy0,P76Y,pgxind-kftx2qdw,pgxcs-kftvqhwd,0,0,0,0,0,0,PGX_AM_BS_AMLkarnorm-tyy-23,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:23.927000,1,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adcff,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute myeloblastic leukemia with maturation [FAB M2],PMID:17268525,"Tyybkinoja A, Elonen E et al. (2007): Oligonucleotide array-CGH reveals cryptic gene copy...",NCIT:C3250,Acute Myeloid Leukemia with Maturation,icdom-98743,Acute myeloid leukemia with maturation,icdot-C42.1,Bone marrow,pgxbs-kftvgwy2,P62Y,pgxind-kftx2qdy,pgxcs-kftvqhwu,0,0,0,0,0,0,PGX_AM_BS_AMLkarnorm-tyy-24,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:23.929000,1,21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af264,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Sezary syndrome [stage IVa],PMID:15086538,"Fischer TC, Gellrich S et al. (2004): Genomic aberrations and survival in cutaneous...",NCIT:C3366,Sezary Syndrome,icdom-97013,Sezary syndrome,icdot-C44.9,"Skin, NOS",pgxbs-kftvh44m,P82Y,pgxind-kftx2yxv,pgxcs-kftvsmi0,367174966,0.128,171336135,0.06,195838831,0.068,PGX_AM_BS_CTNHL-Fi-29,,13.37,52.52,Point,DEU,Berlin,Germany,"Berlin, Germany",52.52,13.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.905000,0,7,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af262,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Sezary syndrome [stage IIIb],PMID:15086538,"Fischer TC, Gellrich S et al. (2004): Genomic aberrations and survival in cutaneous...",NCIT:C3366,Sezary Syndrome,icdom-97013,Sezary syndrome,icdot-C44.9,"Skin, NOS",pgxbs-kftvh44i,P86Y,pgxind-kftx2yxr,pgxcs-kftvsmh2,0,0,0,0,0,0,PGX_AM_BS_CTNHL-Fi-26,,13.37,52.52,Point,DEU,Berlin,Germany,"Berlin, Germany",52.52,13.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.902000,1,48,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af265,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Sezary syndrome [stage IVb],PMID:15086538,"Fischer TC, Gellrich S et al. (2004): Genomic aberrations and survival in cutaneous...",NCIT:C3366,Sezary Syndrome,icdom-97013,Sezary syndrome,icdot-C44.9,"Skin, NOS",pgxbs-kftvh44n,P60Y,pgxind-kftx2yxx,pgxcs-kftvsmih,843087640,0.293,327076542,0.114,516011098,0.179,PGX_AM_BS_CTNHL-Fi-30,,13.37,52.52,Point,DEU,Berlin,Germany,"Berlin, Germany",52.52,13.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.907000,1,24,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af266,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Sezary syndrome [stage IVb],PMID:15086538,"Fischer TC, Gellrich S et al. (2004): Genomic aberrations and survival in cutaneous...",NCIT:C3366,Sezary Syndrome,icdom-97013,Sezary syndrome,icdot-C44.9,"Skin, NOS",pgxbs-kftvh44p,P87Y,pgxind-kftx2yxz,pgxcs-kftvsmiz,760979882,0.265,492540977,0.171,268438905,0.093,PGX_AM_BS_CTNHL-Fi-31,,13.37,52.52,Point,DEU,Berlin,Germany,"Berlin, Germany",52.52,13.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.908000,1,27,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac5de,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [cutaneous],PMID:19710685,"van Kester MS, Tensen CP et al. (2010): Cutaneous anaplastic large cell lymphoma and...",NCIT:C3467,Cutaneous T-Cell Non-Hodgkin Lymphoma,icdom-97093,"Cutaneous T-cell lymphoma, NOS",icdot-C44.9,"Skin, NOS",pgxbs-kftvgpix,P33Y,pgxind-kftx2h45,pgxcs-kftvo730,477081648,0.166,142398581,0.05,334683067,0.116,PGX_AM_BS_PMID19710685-kes-ctnhl12,{},4.5,52.16,Point,NLD,Leiden,Netherlands,"Leiden, The Netherlands",52.16,4.5,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:15.734000,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac5df,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [cutaneous],PMID:19710685,"van Kester MS, Tensen CP et al. (2010): Cutaneous anaplastic large cell lymphoma and...",NCIT:C3467,Cutaneous T-Cell Non-Hodgkin Lymphoma,icdom-97093,"Cutaneous T-cell lymphoma, NOS",icdot-C44.9,"Skin, NOS",pgxbs-kftvgpiz,P65Y,pgxind-kftx2h47,pgxcs-kftvo73h,201008814,0.07,201008814,0.07,0,0,PGX_AM_BS_PMID19710685-kes-ctnhl13,{},4.5,52.16,Point,NLD,Leiden,Netherlands,"Leiden, The Netherlands",52.16,4.5,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:15.735000,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac5e0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [cutaneous],PMID:19710685,"van Kester MS, Tensen CP et al. (2010): Cutaneous anaplastic large cell lymphoma and...",NCIT:C3467,Cutaneous T-Cell Non-Hodgkin Lymphoma,icdom-97093,"Cutaneous T-cell lymphoma, NOS",icdot-C44.9,"Skin, NOS",pgxbs-kftvgpj0,P80Y,pgxind-kftx2h49,pgxcs-kftvo73y,298989562,0.104,99281291,0.035,199708271,0.069,PGX_AM_BS_PMID19710685-kes-ctnhl14,{},4.5,52.16,Point,NLD,Leiden,Netherlands,"Leiden, The Netherlands",52.16,4.5,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:15.736000,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac5e1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [cutaneous],PMID:19710685,"van Kester MS, Tensen CP et al. (2010): Cutaneous anaplastic large cell lymphoma and...",NCIT:C3467,Cutaneous T-Cell Non-Hodgkin Lymphoma,icdom-97093,"Cutaneous T-cell lymphoma, NOS",icdot-C44.9,"Skin, NOS",pgxbs-kftvgpj2,P70Y,pgxind-kftx2h4b,pgxcs-kftvo74e,380543998,0.132,168897710,0.059,211646288,0.074,PGX_AM_BS_PMID19710685-kes-ctnhl15,{},4.5,52.16,Point,NLD,Leiden,Netherlands,"Leiden, The Netherlands",52.16,4.5,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:15.738000,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac5e2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [cutaneous],PMID:19710685,"van Kester MS, Tensen CP et al. (2010): Cutaneous anaplastic large cell lymphoma and...",NCIT:C3467,Cutaneous T-Cell Non-Hodgkin Lymphoma,icdom-97093,"Cutaneous T-cell lymphoma, NOS",icdot-C44.9,"Skin, NOS",pgxbs-kftvgpj3,P75Y,pgxind-kftx2h4d,pgxcs-kftvo74v,340589972,0.118,145022613,0.05,195567359,0.068,PGX_AM_BS_PMID19710685-kes-ctnhl16,{},4.5,52.16,Point,NLD,Leiden,Netherlands,"Leiden, The Netherlands",52.16,4.5,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:15.739000,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac5e3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [cutaneous],PMID:19710685,"van Kester MS, Tensen CP et al. (2010): Cutaneous anaplastic large cell lymphoma and...",NCIT:C3467,Cutaneous T-Cell Non-Hodgkin Lymphoma,icdom-97093,"Cutaneous T-cell lymphoma, NOS",icdot-C44.9,"Skin, NOS",pgxbs-kftvgpj5,P73Y,pgxind-kftx2h4f,pgxcs-kftvo75c,490516226,0.171,301994199,0.105,188522027,0.066,PGX_AM_BS_PMID19710685-kes-ctnhl17,{},4.5,52.16,Point,NLD,Leiden,Netherlands,"Leiden, The Netherlands",52.16,4.5,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:15.741000,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac5e4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [cutaneous],PMID:19710685,"van Kester MS, Tensen CP et al. (2010): Cutaneous anaplastic large cell lymphoma and...",NCIT:C3467,Cutaneous T-Cell Non-Hodgkin Lymphoma,icdom-97093,"Cutaneous T-cell lymphoma, NOS",icdot-C44.9,"Skin, NOS",pgxbs-kftvgpj7,P58Y,pgxind-kftx2h4h,pgxcs-kftvo75t,182574542,0.064,158794198,0.055,23780344,0.008,PGX_AM_BS_PMID19710685-kes-ctnhl18,{},4.5,52.16,Point,NLD,Leiden,Netherlands,"Leiden, The Netherlands",52.16,4.5,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:15.742000,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac5e5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [cutaneous],PMID:19710685,"van Kester MS, Tensen CP et al. (2010): Cutaneous anaplastic large cell lymphoma and...",NCIT:C3467,Cutaneous T-Cell Non-Hodgkin Lymphoma,icdom-97093,"Cutaneous T-cell lymphoma, NOS",icdot-C44.9,"Skin, NOS",pgxbs-kftvgpj8,P65Y,pgxind-kftx2h4j,pgxcs-kftvo76a,550064815,0.191,190310437,0.066,359754378,0.125,PGX_AM_BS_PMID19710685-kes-ctnhl19,{},4.5,52.16,Point,NLD,Leiden,Netherlands,"Leiden, The Netherlands",52.16,4.5,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:15.743000,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac5e6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [cutaneous],PMID:19710685,"van Kester MS, Tensen CP et al. (2010): Cutaneous anaplastic large cell lymphoma and...",NCIT:C3467,Cutaneous T-Cell Non-Hodgkin Lymphoma,icdom-97093,"Cutaneous T-cell lymphoma, NOS",icdot-C44.9,"Skin, NOS",pgxbs-kftvgpja,P33Y,pgxind-kftx2h4l,pgxcs-kftvo76r,179333611,0.062,155553267,0.054,23780344,0.008,PGX_AM_BS_PMID19710685-kes-ctnhl20,{},4.5,52.16,Point,NLD,Leiden,Netherlands,"Leiden, The Netherlands",52.16,4.5,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:15.745000,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac5e7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [cutaneous],PMID:19710685,"van Kester MS, Tensen CP et al. (2010): Cutaneous anaplastic large cell lymphoma and...",NCIT:C3467,Cutaneous T-Cell Non-Hodgkin Lymphoma,icdom-97093,"Cutaneous T-cell lymphoma, NOS",icdot-C44.9,"Skin, NOS",pgxbs-kftvgpjb,P59Y,pgxind-kftx2h4n,pgxcs-kftvo777,215652071,0.075,187194897,0.065,28457174,0.01,PGX_AM_BS_PMID19710685-kes-ctnhl21,{},4.5,52.16,Point,NLD,Leiden,Netherlands,"Leiden, The Netherlands",52.16,4.5,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:15.746000,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af20c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [Cutaneous],PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C3467,Cutaneous T-Cell Non-Hodgkin Lymphoma,icdom-97093,"Cutaneous T-cell lymphoma, NOS",icdot-C44.9,"Skin, NOS",pgxbs-kftvh40l,P67Y,pgxind-kftx2ysy,pgxcs-kftvsla9,0,0,0,0,0,0,PGX_AM_BS_PTCL-ALCL-42R,{},9.95,49.79,Point,DEU,Wurzburg,Germany,"Wurzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.783000,1,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af20d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, systemic type [ALK pos.]",PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C3720,Anaplastic Large Cell Lymphoma,icdom-97143,"Anaplastic large cell lymphoma, T cell and Null cell type",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh40n,P13Y,pgxind-kftx2yt0,pgxcs-kftvslaq,0,0,0,0,0,0,PGX_AM_BS_PTCL-ALCL-43,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.784000,0,62,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af20f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, systemic type [ALK pos.]",PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C3720,Anaplastic Large Cell Lymphoma,icdom-97143,"Anaplastic large cell lymphoma, T cell and Null cell type",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh40q,P73Y,pgxind-kftx2yt4,pgxcs-kftvslbo,378166082,0.132,220069758,0.077,158096324,0.055,PGX_AM_BS_PTCL-ALCL-45,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.787000,0,48,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af211,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, systemic type [ALK pos.]",PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C3720,Anaplastic Large Cell Lymphoma,icdom-97143,"Anaplastic large cell lymphoma, T cell and Null cell type",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh40u,P28Y,pgxind-kftx2yt8,pgxcs-kftvslcm,0,0,0,0,0,0,PGX_AM_BS_PTCL-ALCL-47,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.789000,0,9,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af212,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, systemic type [ALK pos.]",PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C3720,Anaplastic Large Cell Lymphoma,icdom-97143,"Anaplastic large cell lymphoma, T cell and Null cell type",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh40v,P11Y,pgxind-kftx2yta,pgxcs-kftvsld4,61500060,0.021,29700029,0.01,31800031,0.011,PGX_AM_BS_PTCL-ALCL-48,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.791000,0,13,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af213,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, systemic type [ALK pos.]",PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C3720,Anaplastic Large Cell Lymphoma,icdom-97143,"Anaplastic large cell lymphoma, T cell and Null cell type",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh40x,P50Y,pgxind-kftx2ytc,pgxcs-kftvslfh,0,0,0,0,0,0,PGX_AM_BS_PTCL-ALCL-49,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.792000,0,2,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af214,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, systemic type [ALK pos.]",PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C3720,Anaplastic Large Cell Lymphoma,icdom-97143,"Anaplastic large cell lymphoma, T cell and Null cell type",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh40z,P51Y,pgxind-kftx2yte,pgxcs-kftvslfy,234916896,0.082,111967053,0.039,122949843,0.043,PGX_AM_BS_PTCL-ALCL-50,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.794000,0,6,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af215,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, systemic type [ALK pos.]",PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C3720,Anaplastic Large Cell Lymphoma,icdom-97143,"Anaplastic large cell lymphoma, T cell and Null cell type",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh411,P15Y,pgxind-kftx2ytg,pgxcs-kftvslgh,309356008,0.108,110306090,0.038,199049918,0.069,PGX_AM_BS_PTCL-ALCL-51R,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.795000,0,32,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af218,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, systemic type [ALK neg.]",PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C3720,Anaplastic Large Cell Lymphoma,icdom-97143,"Anaplastic large cell lymphoma, T cell and Null cell type",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh416,P71Y,pgxind-kftx2ytm,pgxcs-kftvslhw,0,0,0,0,0,0,PGX_AM_BS_PTCL-ALCL-54,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.799000,0,74,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af219,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, systemic type [ALK neg.]",PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C3720,Anaplastic Large Cell Lymphoma,icdom-97143,"Anaplastic large cell lymphoma, T cell and Null cell type",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh418,P7Y,pgxind-kftx2yto,pgxcs-kftvslid,0,0,0,0,0,0,PGX_AM_BS_PTCL-ALCL-55,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.800000,0,72,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af224,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, systemic type [ALK neg.]",PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C3720,Anaplastic Large Cell Lymphoma,icdom-97143,"Anaplastic large cell lymphoma, T cell and Null cell type",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh41q,P34Y,pgxind-kftx2yua,pgxcs-kftvslnl,380670767,0.132,280949243,0.098,99721524,0.035,PGX_AM_BS_PTCL-ALCL-66R,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.816000,0,46,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af216,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, systemic type [ALK neg.]",PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C3720,Anaplastic Large Cell Lymphoma,icdom-97143,"Anaplastic large cell lymphoma, T cell and Null cell type",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh412,P29Y,pgxind-kftx2yti,pgxcs-kftvslgy,0,0,0,0,0,0,PGX_AM_BS_PTCL-ALCL-52,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.796000,1,86,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af21b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, systemic type [ALK neg.]",PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C3720,Anaplastic Large Cell Lymphoma,icdom-97143,"Anaplastic large cell lymphoma, T cell and Null cell type",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh41b,P69Y,pgxind-kftx2yts,pgxcs-kftvsljb,536228854,0.187,354837243,0.123,181391611,0.063,PGX_AM_BS_PTCL-ALCL-57,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.803000,1,10,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af21c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, systemic type [ALK neg.]",PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C3720,Anaplastic Large Cell Lymphoma,icdom-97143,"Anaplastic large cell lymphoma, T cell and Null cell type",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh41d,P88Y,pgxind-kftx2ytu,pgxcs-kftvsljt,248855948,0.087,43700044,0.015,205155904,0.071,PGX_AM_BS_PTCL-ALCL-58,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.804000,1,1,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af21d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, systemic type [ALK neg.]",PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C3720,Anaplastic Large Cell Lymphoma,icdom-97143,"Anaplastic large cell lymphoma, T cell and Null cell type",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh41e,P45Y,pgxind-kftx2ytw,pgxcs-kftvslka,477479938,0.166,279533515,0.097,197946423,0.069,PGX_AM_BS_PTCL-ALCL-59,{},9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.806000,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af21e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, systemic type [ALK neg.]",PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C3720,Anaplastic Large Cell Lymphoma,icdom-97143,"Anaplastic large cell lymphoma, T cell and Null cell type",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh41g,P92Y,pgxind-kftx2yty,pgxcs-kftvslkr,237247379,0.083,202097624,0.07,35149755,0.012,PGX_AM_BS_PTCL-ALCL-60,{},9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.807000,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af221,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, systemic type [ALK neg.]",PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C3720,Anaplastic Large Cell Lymphoma,icdom-97143,"Anaplastic large cell lymphoma, T cell and Null cell type",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh41l,P79Y,pgxind-kftx2yu4,pgxcs-kftvslm6,0,0,0,0,0,0,PGX_AM_BS_PTCL-ALCL-63,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.811000,1,10,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af222,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, systemic type [ALK neg.]",PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C3720,Anaplastic Large Cell Lymphoma,icdom-97143,"Anaplastic large cell lymphoma, T cell and Null cell type",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh41m,P63Y,pgxind-kftx2yu6,pgxcs-kftvslmn,263499772,0.092,263499772,0.092,0,0,PGX_AM_BS_PTCL-ALCL-64,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.813000,1,3,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af226,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, systemic type [ALK neg.]",PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C3720,Anaplastic Large Cell Lymphoma,icdom-97143,"Anaplastic large cell lymphoma, T cell and Null cell type",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh41t,P73Y,pgxind-kftx2yue,pgxcs-kftvsloj,309014063,0.107,187913943,0.065,121100120,0.042,PGX_AM_BS_PTCL-ALCL-68R,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.818000,1,24,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aab8a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:9559341,"Monni O, Oinonen R et al. (1998): Gain of 3q and deletion of...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftva6f5,P62Y,pgxind-kftx26p1,pgxcs-kftvln8k,0,0,0,0,0,0,PGX_AM_BS_MC02,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:06.233000,0,82,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aab8b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:9559341,"Monni O, Oinonen R et al. (1998): Gain of 3q and deletion of...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftva6f7,P60Y,pgxind-kftx26p3,pgxcs-kftvln91,493140670,0.172,320206300,0.111,172934370,0.06,PGX_AM_BS_MC03,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:06.234000,0,12,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aab8c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:9559341,"Monni O, Oinonen R et al. (1998): Gain of 3q and deletion of...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftva6f9,P45Y,pgxind-kftx26p5,pgxcs-kftvln9i,431833680,0.15,15900015,0.006,415933665,0.145,PGX_AM_BS_MC04,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:06.236000,0,53,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aab8d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:9559341,"Monni O, Oinonen R et al. (1998): Gain of 3q and deletion of...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftva6fa,P53Y,pgxind-kftx26p7,pgxcs-kftvln9y,100395661,0.035,22200022,0.008,78195639,0.027,PGX_AM_BS_MC05,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:06.237000,0,56,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aab92,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:9559341,"Monni O, Oinonen R et al. (1998): Gain of 3q and deletion of...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftva6fi,P58Y,pgxind-kftx26ph,pgxcs-kftvlncc,255333514,0.089,114143095,0.04,141190419,0.049,PGX_AM_BS_MC08,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:06.244000,0,104,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aab9b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:9559341,"Monni O, Oinonen R et al. (1998): Gain of 3q and deletion of...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftva6fx,P61Y,pgxind-kftx26pz,pgxcs-kftvlngn,289338831,0.101,74643056,0.026,214695775,0.075,PGX_AM_BS_MC14,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:06.257000,0,5,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aab9e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:9559341,"Monni O, Oinonen R et al. (1998): Gain of 3q and deletion of...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftva6g2,P46Y,pgxind-kftx26q5,pgxcs-kftvlni1,105800105,0.037,28400028,0.01,77400077,0.027,PGX_AM_BS_MC16,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:06.261000,0,53,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aab9f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:9559341,"Monni O, Oinonen R et al. (1998): Gain of 3q and deletion of...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftva6g4,P45Y,pgxind-kftx26q7,pgxcs-kftvlnii,198014753,0.069,162900162,0.057,35114591,0.012,PGX_AM_BS_MC17a,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:06.262000,0,105,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aaba0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:9559341,"Monni O, Oinonen R et al. (1998): Gain of 3q and deletion of...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftva6g6,P45Y,pgxind-kftx26q9,pgxcs-kftvlniz,318496493,0.111,240243221,0.084,78253272,0.027,PGX_AM_BS_MC17b,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:06.263000,0,105,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aaba6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:9559341,"Monni O, Oinonen R et al. (1998): Gain of 3q and deletion of...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftva6gg,P68Y,pgxind-kftx26ql,pgxcs-kftvlnls,386553580,0.134,80900081,0.028,305653499,0.106,PGX_AM_BS_MC23,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:06.271000,0,6,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aaba8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:9559341,"Monni O, Oinonen R et al. (1998): Gain of 3q and deletion of...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftva6gj,P63Y,pgxind-kftx26qp,pgxcs-kftvlnoo,177743159,0.062,177743159,0.062,0,0,PGX_AM_BS_MC25,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:06.274000,0,33,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aabaa,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:9559341,"Monni O, Oinonen R et al. (1998): Gain of 3q and deletion of...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftva6gm,P68Y,pgxind-kftx26qt,pgxcs-kftvlnpo,1119778130,0.389,229556965,0.08,890221165,0.31,PGX_AM_BS_MC27,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:06.277000,0,31,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ade42,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:17161458,Flordal Thelander E et al. (2007): Detailed assessment of copy number alterations...,NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxcs,,pgxind-kftx2qvy,pgxcs-kftvqmfx,0,0,0,0,0,0,PGX_AM_BS_MCL-fle-03,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.374000,0,78,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ade56,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:17161458,Flordal Thelander E et al. (2007): Detailed assessment of copy number alterations...,NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxdp,,pgxind-kftx2qx3,pgxcs-kftvqmph,75991509,0.026,75991509,0.026,0,0,PGX_AM_BS_MCL-fle-23,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.401000,0,73,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ade57,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma [blastoid],PMID:17161458,Flordal Thelander E et al. (2007): Detailed assessment of copy number alterations...,NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxdq,,pgxind-kftx2qx5,pgxcs-kftvqmpy,343404218,0.119,296129428,0.103,47274790,0.016,PGX_AM_BS_MCL-fle-24,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.402000,0,101,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ade58,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:17161458,Flordal Thelander E et al. (2007): Detailed assessment of copy number alterations...,NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxds,,pgxind-kftx2qx7,pgxcs-kftvqmqf,128943110,0.045,0,0,128943110,0.045,PGX_AM_BS_MCL-fle-25,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.404000,0,71,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ade5a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:17161458,Flordal Thelander E et al. (2007): Detailed assessment of copy number alterations...,NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxdv,,pgxind-kftx2qxb,pgxcs-kftvqmrd,372851937,0.13,250534662,0.087,122317275,0.043,PGX_AM_BS_MCL-fle-27,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.406000,0,45,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c9727983b2e00aefd8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3b7,P79Y,pgxind-kftx2xx1,pgxcs-kftvsdgc,457274346,0.159,271343251,0.094,185931095,0.065,PGX_AM_BS_15257315-MCL-the-106,,18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},10.09.20 17:44,0,29,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00aefe0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3bk,P75Y,pgxind-kftx2xxh,pgxcs-kftvsdk4,123583655,0.043,84544979,0.029,39038676,0.014,PGX_AM_BS_15257315-MCL-the-1709,,18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.011000,0,29,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00aefe4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma [blastoid],PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3br,P51Y,pgxind-kftx2xxp,pgxcs-kftvsdm1,112334526,0.039,94134508,0.033,18200018,0.006,PGX_AM_BS_15257315-MCL-the-1933,,18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.017000,0,86,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00aefee,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3c7,P62Y,pgxind-kftx2xya,pgxcs-kftvsdqs,172413927,0.06,42400042,0.015,130013885,0.045,PGX_AM_BS_15257315-MCL-the-62,,18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.030000,0,57,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00aeff1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma [blastoid],PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3cc,P62Y,pgxind-kftx2xyg,pgxcs-kftvsds7,300649264,0.105,264306246,0.092,36343018,0.013,PGX_AM_BS_15257315-MCL-the-66_93,,18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.034000,0,73,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00aeff2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3ce,P65Y,pgxind-kftx2xyi,pgxcs-kftvsdso,96601636,0.034,21706001,0.008,74895635,0.026,PGX_AM_BS_15257315-MCL-the-68_95,,18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.036000,0,51,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00aeff8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3cn,P51Y,pgxind-kftx2xyv,pgxcs-kftvsdvj,0,0,0,0,0,0,PGX_AM_BS_15257315-MCL-the-92_87,,18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.044000,0,63,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00aeff9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3cp,P59Y,pgxind-kftx2xyx,pgxcs-kftvsdvz,134243115,0.047,0,0,134243115,0.047,PGX_AM_BS_15257315-MCL-the-94,,18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.045000,0,55,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aab89,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:9559341,"Monni O, Oinonen R et al. (1998): Gain of 3q and deletion of...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftva6f3,P75Y,pgxind-kftx26oz,pgxcs-kftvln83,102334300,0.036,0,0,102334300,0.036,PGX_AM_BS_MC01,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:06.231000,1,5,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aab8e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:9559341,"Monni O, Oinonen R et al. (1998): Gain of 3q and deletion of...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftva6fc,P61Y,pgxind-kftx26p9,pgxcs-kftvlnaf,173338715,0.06,20343002,0.007,152995713,0.053,PGX_AM_BS_MC06,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:06.238000,1,44,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aab8f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:9559341,"Monni O, Oinonen R et al. (1998): Gain of 3q and deletion of...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftva6fd,P61Y,pgxind-kftx26pb,pgxcs-kftvlnax,0,0,0,0,0,0,PGX_AM_BS_MC07a,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:06.240000,1,76,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aab90,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:9559341,"Monni O, Oinonen R et al. (1998): Gain of 3q and deletion of...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftva6ff,P61Y,pgxind-kftx26pd,pgxcs-kftvlnbd,172234649,0.06,56700057,0.02,115534592,0.04,PGX_AM_BS_MC07b,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:06.241000,1,76,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aab91,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:9559341,"Monni O, Oinonen R et al. (1998): Gain of 3q and deletion of...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftva6fh,P61Y,pgxind-kftx26pf,pgxcs-kftvlnbv,461755520,0.161,382716525,0.133,79038995,0.027,PGX_AM_BS_MC07c,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:06.242000,1,76,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aab93,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:9559341,"Monni O, Oinonen R et al. (1998): Gain of 3q and deletion of...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftva6fk,P71Y,pgxind-kftx26pj,pgxcs-kftvlnct,282301821,0.098,122706102,0.043,159595719,0.056,PGX_AM_BS_MC09,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:06.245000,1,41,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aab94,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:9559341,"Monni O, Oinonen R et al. (1998): Gain of 3q and deletion of...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftva6fm,P64Y,pgxind-kftx26pl,pgxcs-kftvlndc,596212883,0.207,73293603,0.025,522919280,0.182,PGX_AM_BS_MC10,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:06.247000,1,5,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aab95,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:9559341,"Monni O, Oinonen R et al. (1998): Gain of 3q and deletion of...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftva6fn,P73Y,pgxind-kftx26pn,pgxcs-kftvlndt,265995824,0.093,159400157,0.055,106595667,0.037,PGX_AM_BS_MC11,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:06.248000,1,2,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aab96,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:9559341,"Monni O, Oinonen R et al. (1998): Gain of 3q and deletion of...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftva6fp,P58Y,pgxind-kftx26pp,pgxcs-kftvlnea,88200088,0.031,22200022,0.008,66000066,0.023,PGX_AM_BS_MC12,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:06.250000,1,7,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aab97,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:9559341,"Monni O, Oinonen R et al. (1998): Gain of 3q and deletion of...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftva6fr,P51Y,pgxind-kftx26pr,pgxcs-kftvlner,0,0,0,0,0,0,PGX_AM_BS_MC13a,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:06.251000,1,20,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aab98,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:9559341,"Monni O, Oinonen R et al. (1998): Gain of 3q and deletion of...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftva6ft,P51Y,pgxind-kftx26pt,pgxcs-kftvlnf8,119195679,0.041,29700029,0.01,89495650,0.031,PGX_AM_BS_MC13b,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:06.253000,1,20,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aab99,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:9559341,"Monni O, Oinonen R et al. (1998): Gain of 3q and deletion of...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftva6fu,P51Y,pgxind-kftx26pv,pgxcs-kftvlnfp,151395712,0.053,45200045,0.016,106195667,0.037,PGX_AM_BS_MC13c,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:06.254000,1,20,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aab9a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:9559341,"Monni O, Oinonen R et al. (1998): Gain of 3q and deletion of...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftva6fw,P51Y,pgxind-kftx26px,pgxcs-kftvlng6,698551705,0.243,490417300,0.171,208134405,0.072,PGX_AM_BS_MC13d,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:06.255000,1,20,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aab9c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:9559341,"Monni O, Oinonen R et al. (1998): Gain of 3q and deletion of...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftva6fz,P68Y,pgxind-kftx26q1,pgxcs-kftvlnh4,197200198,0.069,69700070,0.024,127500128,0.044,PGX_AM_BS_MC15a,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:06.258000,1,74,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aab9d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:9559341,"Monni O, Oinonen R et al. (1998): Gain of 3q and deletion of...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftva6g1,P68Y,pgxind-kftx26q3,pgxcs-kftvlnhl,290600291,0.101,168800169,0.059,121800122,0.042,PGX_AM_BS_MC15b,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:06.259000,1,74,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aaba1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:9559341,"Monni O, Oinonen R et al. (1998): Gain of 3q and deletion of...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftva6g7,P63Y,pgxind-kftx26qb,pgxcs-kftvlnjg,398306378,0.139,398306378,0.139,0,0,PGX_AM_BS_MC18,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:06.265000,1,46,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aaba2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:9559341,"Monni O, Oinonen R et al. (1998): Gain of 3q and deletion of...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftva6g9,P79Y,pgxind-kftx26qd,pgxcs-kftvlnjx,109606089,0.038,64406044,0.022,45200045,0.016,PGX_AM_BS_MC19,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:06.266000,1,7,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aaba3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:9559341,"Monni O, Oinonen R et al. (1998): Gain of 3q and deletion of...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftva6gb,P60Y,pgxind-kftx26qf,pgxcs-kftvlnke,125806105,0.044,125806105,0.044,0,0,PGX_AM_BS_MC20,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:06.267000,1,45,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aaba4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:9559341,"Monni O, Oinonen R et al. (1998): Gain of 3q and deletion of...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftva6gc,P54Y,pgxind-kftx26qh,pgxcs-kftvlnkv,255437954,0.089,188543169,0.066,66894785,0.023,PGX_AM_BS_MC21,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:06.269000,1,67,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aaba5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:9559341,"Monni O, Oinonen R et al. (1998): Gain of 3q and deletion of...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftva6ge,P64Y,pgxind-kftx26qj,pgxcs-kftvlnlb,105939022,0.037,48300048,0.017,57638974,0.02,PGX_AM_BS_MC22,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:06.270000,1,11,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aaba7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:9559341,"Monni O, Oinonen R et al. (1998): Gain of 3q and deletion of...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftva6gh,P80Y,pgxind-kftx26qn,pgxcs-kftvlno6,0,0,0,0,0,0,PGX_AM_BS_MC24,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:06.273000,1,19,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aaba9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:9559341,"Monni O, Oinonen R et al. (1998): Gain of 3q and deletion of...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftva6gk,P65Y,pgxind-kftx26qr,pgxcs-kftvlnp6,402258773,0.14,234706214,0.082,167552559,0.058,PGX_AM_BS_MC26,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:06.275000,1,22,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ade3e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:17161458,Flordal Thelander E et al. (2007): Detailed assessment of copy number alterations...,NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxcm,,pgxind-kftx2qvq,pgxcs-kftvqme1,607468375,0.211,469138167,0.163,138330208,0.048,PGX_AM_BS_MCL-fle-22,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.368000,1,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ade40,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:17161458,Flordal Thelander E et al. (2007): Detailed assessment of copy number alterations...,NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxcp,,pgxind-kftx2qvu,pgxcs-kftvqmez,0,0,0,0,0,0,PGX_AM_BS_MCL-fle-01,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.371000,1,65,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ade41,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma [blastoid],PMID:17161458,Flordal Thelander E et al. (2007): Detailed assessment of copy number alterations...,NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxcr,,pgxind-kftx2qvw,pgxcs-kftvqmfg,132900131,0.046,132900131,0.046,0,0,PGX_AM_BS_MCL-fle-02,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.372000,1,36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ade43,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:17161458,Flordal Thelander E et al. (2007): Detailed assessment of copy number alterations...,NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxcu,,pgxind-kftx2qw0,pgxcs-kftvqmge,233821657,0.081,45100044,0.016,188721613,0.066,PGX_AM_BS_MCL-fle-04,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.375000,1,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ade44,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma [blastoid],PMID:17161458,Flordal Thelander E et al. (2007): Detailed assessment of copy number alterations...,NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxcw,,pgxind-kftx2qw2,pgxcs-kftvqmgv,182134595,0.063,182134595,0.063,0,0,PGX_AM_BS_MCL-fle-05,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.377000,1,62,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ade45,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:17161458,Flordal Thelander E et al. (2007): Detailed assessment of copy number alterations...,NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxcx,,pgxind-kftx2qw4,pgxcs-kftvqmhc,134101674,0.047,15205995,0.005,118895679,0.041,PGX_AM_BS_MCL-fle-06,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.378000,1,51,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ade46,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:17161458,Flordal Thelander E et al. (2007): Detailed assessment of copy number alterations...,NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxcz,,pgxind-kftx2qw6,pgxcs-kftvqmhu,104517720,0.036,58500058,0.02,46017662,0.016,PGX_AM_BS_MCL-fle-07,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.379000,1,43,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ade47,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:17161458,Flordal Thelander E et al. (2007): Detailed assessment of copy number alterations...,NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxd1,,pgxind-kftx2qw8,pgxcs-kftvqmib,86423221,0.03,62306042,0.022,24117179,0.008,PGX_AM_BS_MCL-fle-08,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.381000,1,42,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ade48,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:17161458,Flordal Thelander E et al. (2007): Detailed assessment of copy number alterations...,NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxd2,,pgxind-kftx2qwa,pgxcs-kftvqmis,440366235,0.153,362170597,0.126,78195638,0.027,PGX_AM_BS_MCL-fle-09,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.382000,1,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ade49,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma [blastoid],PMID:17161458,Flordal Thelander E et al. (2007): Detailed assessment of copy number alterations...,NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxd4,,pgxind-kftx2qwc,pgxcs-kftvqmj9,185843167,0.065,93743075,0.033,92100092,0.032,PGX_AM_BS_MCL-fle-10,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.383000,1,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ade4a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma [blastoid],PMID:17161458,Flordal Thelander E et al. (2007): Detailed assessment of copy number alterations...,NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxd6,,pgxind-kftx2qwe,pgxcs-kftvqmjq,143891577,0.05,143891577,0.05,0,0,PGX_AM_BS_MCL-fle-11,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.385000,1,37,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ade4b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma [blastoid],PMID:17161458,Flordal Thelander E et al. (2007): Detailed assessment of copy number alterations...,NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxd7,,pgxind-kftx2qwg,pgxcs-kftvqmk7,169153134,0.059,122443104,0.043,46710030,0.016,PGX_AM_BS_MCL-fle-12,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.386000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ade4c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma [blastoid],PMID:17161458,Flordal Thelander E et al. (2007): Detailed assessment of copy number alterations...,NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxd9,,pgxind-kftx2qwj,pgxcs-kftvqmkp,274213556,0.095,193443172,0.067,80770384,0.028,PGX_AM_BS_MCL-fle-13,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.388000,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ade4d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma [blastoid],PMID:17161458,Flordal Thelander E et al. (2007): Detailed assessment of copy number alterations...,NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxda,,pgxind-kftx2qwl,pgxcs-kftvqml6,279449240,0.097,192506171,0.067,86943069,0.03,PGX_AM_BS_MCL-fle-14,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.389000,1,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ade4e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma [blastoid],PMID:17161458,Flordal Thelander E et al. (2007): Detailed assessment of copy number alterations...,NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxdc,,pgxind-kftx2qwn,pgxcs-kftvqmln,0,0,0,0,0,0,PGX_AM_BS_MCL-fle-15,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.390000,1,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ade4f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:17161458,Flordal Thelander E et al. (2007): Detailed assessment of copy number alterations...,NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxde,,pgxind-kftx2qwp,pgxcs-kftvqmm4,95200095,0.033,95200095,0.033,0,0,PGX_AM_BS_MCL-fle-16,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.392000,1,26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ade50,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:17161458,Flordal Thelander E et al. (2007): Detailed assessment of copy number alterations...,NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxdf,,pgxind-kftx2qwr,pgxcs-kftvqmml,200900202,0.07,200900202,0.07,0,0,PGX_AM_BS_MCL-fle-17,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.393000,1,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ade51,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:17161458,Flordal Thelander E et al. (2007): Detailed assessment of copy number alterations...,NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxdh,,pgxind-kftx2qwt,pgxcs-kftvqmn3,349427527,0.122,166392868,0.058,183034659,0.064,PGX_AM_BS_MCL-fle-18,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.394000,1,23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ade52,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:17161458,Flordal Thelander E et al. (2007): Detailed assessment of copy number alterations...,NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxdi,,pgxind-kftx2qwv,pgxcs-kftvqmnk,240860838,0.084,216343197,0.075,24517641,0.009,PGX_AM_BS_MCL-fle-19,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.396000,1,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ade53,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:17161458,Flordal Thelander E et al. (2007): Detailed assessment of copy number alterations...,NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxdk,,pgxind-kftx2qwx,pgxcs-kftvqmo1,206317360,0.072,0,0,206317360,0.072,PGX_AM_BS_MCL-fle-20,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.397000,1,27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ade54,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:17161458,Flordal Thelander E et al. (2007): Detailed assessment of copy number alterations...,NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxdm,,pgxind-kftx2qwz,pgxcs-kftvqmoi,341744863,0.119,266849228,0.093,74895635,0.026,PGX_AM_BS_MCL-fle-21,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.398000,1,47,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ade59,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:17161458,Flordal Thelander E et al. (2007): Detailed assessment of copy number alterations...,NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxdu,,pgxind-kftx2qx9,pgxcs-kftvqmqw,580558479,0.202,196049157,0.068,384509322,0.134,PGX_AM_BS_MCL-fle-26,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.405000,1,28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ade5b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:17161458,Flordal Thelander E et al. (2007): Detailed assessment of copy number alterations...,NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxdx,,pgxind-kftx2qxd,pgxcs-kftvqmru,376933635,0.131,302038000,0.105,74895635,0.026,PGX_AM_BS_MCL-fle-28,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.408000,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ade5c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:17161458,Flordal Thelander E et al. (2007): Detailed assessment of copy number alterations...,NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxdz,,pgxind-kftx2qxf,pgxcs-kftvqmsc,60643042,0.021,41143023,0.014,19500019,0.007,PGX_AM_BS_MCL-fle-29,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.409000,1,13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ade5d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:17161458,Flordal Thelander E et al. (2007): Detailed assessment of copy number alterations...,NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxe0,,pgxind-kftx2qxh,pgxcs-kftvqmst,172460769,0.06,102017718,0.035,70443051,0.025,PGX_AM_BS_MCL-fle-30,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.410000,1,29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ade5e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma [blastoid],PMID:17161458,Flordal Thelander E et al. (2007): Detailed assessment of copy number alterations...,NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxe2,,pgxind-kftx2qxk,pgxcs-kftvqmta,496901212,0.173,357992485,0.125,138908727,0.048,PGX_AM_BS_MCL-fle-31,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.412000,1,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ade5f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:17161458,Flordal Thelander E et al. (2007): Detailed assessment of copy number alterations...,NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxe4,,pgxind-kftx2qxm,pgxcs-kftvqmts,352538043,0.123,189682088,0.066,162855955,0.057,PGX_AM_BS_MCL-fle-32,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.413000,1,27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ade60,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:17161458,Flordal Thelander E et al. (2007): Detailed assessment of copy number alterations...,NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxe6,,pgxind-kftx2qxo,pgxcs-kftvqmu9,412159924,0.143,176543158,0.061,235616766,0.082,PGX_AM_BS_MCL-fle-33,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.415000,1,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ade61,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:17161458,Flordal Thelander E et al. (2007): Detailed assessment of copy number alterations...,NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxe7,,pgxind-kftx2qxq,pgxcs-kftvqmuq,629190051,0.219,344540735,0.12,284649316,0.099,PGX_AM_BS_MCL-fle-34,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.416000,1,22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ade62,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:17161458,Flordal Thelander E et al. (2007): Detailed assessment of copy number alterations...,NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxe9,,pgxind-kftx2qxr,pgxcs-kftvqmv8,423240979,0.147,203931821,0.071,219309158,0.076,PGX_AM_BS_MCL-fle-35,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.417000,1,21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c9727983b2e00aefd7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma [blastoid],PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3b6,P78Y,pgxind-kftx2xwz,pgxcs-kftvsdfv,0,0,0,0,0,0,PGX_AM_BS_15257315-MCL-the-104,,18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:30.998000,1,15,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00aefd9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma [blastoid],PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3b9,P78Y,pgxind-kftx2xx3,pgxcs-kftvsdgt,315618166,0.11,255600952,0.089,60017214,0.021,PGX_AM_BS_15257315-MCL-the-118,,18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.001000,1,16,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00aefda,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3ba,P72Y,pgxind-kftx2xx5,pgxcs-kftvsdha,293420828,0.102,157082054,0.055,136338774,0.047,PGX_AM_BS_15257315-MCL-the-124,,18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.003000,1,27,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00aefdb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3bc,P73Y,pgxind-kftx2xx7,pgxcs-kftvsdhr,207200207,0.072,207200207,0.072,0,0,PGX_AM_BS_15257315-MCL-the-130,,18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.004000,1,16,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00aefdc,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3be,P68Y,pgxind-kftx2xx9,pgxcs-kftvsdi8,33643015,0.012,33643015,0.012,0,0,PGX_AM_BS_15257315-MCL-the-131,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.005000,1,13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00aefdd,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3bf,P81Y,pgxind-kftx2xxb,pgxcs-kftvsdip,350244871,0.122,350244871,0.122,0,0,PGX_AM_BS_15257315-MCL-the-132,,18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.007000,1,85,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00aefde,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3bh,P84Y,pgxind-kftx2xxd,pgxcs-kftvsdj6,144043124,0.05,114143095,0.04,29900029,0.01,PGX_AM_BS_15257315-MCL-the-133,,18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.008000,1,10,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00aefdf,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3bj,P71Y,pgxind-kftx2xxf,pgxcs-kftvsdjn,396333367,0.138,165549125,0.058,230784242,0.08,PGX_AM_BS_15257315-MCL-the-1706,,18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.010000,1,12,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00aefe1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3bm,P80Y,pgxind-kftx2xxj,pgxcs-kftvsdkl,395027573,0.137,203392905,0.071,191634668,0.067,PGX_AM_BS_15257315-MCL-the-183_91,,18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.013000,1,23,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00aefe2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3bn,P67Y,pgxind-kftx2xxl,pgxcs-kftvsdl2,345159858,0.12,129843111,0.045,215316747,0.075,PGX_AM_BS_15257315-MCL-the-1927,,18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.014000,1,10,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00aefe3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3bp,P76Y,pgxind-kftx2xxn,pgxcs-kftvsdlk,367294700,0.128,114143095,0.04,253151605,0.088,PGX_AM_BS_15257315-MCL-the-1929,,18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.016000,1,28,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00aefe5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3bs,P78Y,pgxind-kftx2xxs,pgxcs-kftvsdmi,619503799,0.215,149440542,0.052,470063257,0.164,PGX_AM_BS_15257315-MCL-the-1935,,18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.018000,1,22,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00aefe6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3bu,P56Y,pgxind-kftx2xxu,pgxcs-kftvsdmz,0,0,0,0,0,0,PGX_AM_BS_15257315-MCL-the-1940,,18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.020000,1,26,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00aefe7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3bw,P85Y,pgxind-kftx2xxw,pgxcs-kftvsdng,120495680,0.042,53700053,0.019,66795627,0.023,PGX_AM_BS_15257315-MCL-the-32_2,,18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.021000,1,5,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00aefe8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3bx,P49Y,pgxind-kftx2xxy,pgxcs-kftvsdnx,78800078,0.027,43400043,0.015,35400035,0.012,PGX_AM_BS_15257315-MCL-the-33_11,,18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.022000,1,43,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00aefe9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma [blastoid],PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3bz,P48Y,pgxind-kftx2xy0,pgxcs-kftvsdoe,320311487,0.111,320311487,0.111,0,0,PGX_AM_BS_15257315-MCL-the-34_12,,18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.024000,1,37,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00aefea,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3c0,P79Y,pgxind-kftx2xy2,pgxcs-kftvsdov,0,0,0,0,0,0,PGX_AM_BS_15257315-MCL-the-54_59,,18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.025000,1,65,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00aefeb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3c2,P74Y,pgxind-kftx2xy4,pgxcs-kftvsdpc,441150048,0.153,107931725,0.038,333218323,0.116,PGX_AM_BS_15257315-MCL-the-56,,18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.026000,1,21,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00aefec,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3c4,P58Y,pgxind-kftx2xy6,pgxcs-kftvsdpt,221437920,0.077,221437920,0.077,0,0,PGX_AM_BS_15257315-MCL-the-57,,18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.028000,1,8,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00aefed,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma [blastoid],PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3c5,P70Y,pgxind-kftx2xy8,pgxcs-kftvsdqa,303850508,0.106,212843193,0.074,91007315,0.032,PGX_AM_BS_15257315-MCL-the-58_65,,18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.029000,1,24,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00aefef,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3c9,P65Y,pgxind-kftx2xyc,pgxcs-kftvsdr9,149517303,0.052,0,0,149517303,0.052,PGX_AM_BS_15257315-MCL-the-63,,18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.032000,1,27,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00aeff0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3ca,P65Y,pgxind-kftx2xye,pgxcs-kftvsdrq,103643084,0.036,22200022,0.008,81443062,0.028,PGX_AM_BS_15257315-MCL-the-64,,18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.033000,1,29,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00aeff3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma [blastoid],PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3cf,P70Y,pgxind-kftx2xyk,pgxcs-kftvsdt5,285233544,0.099,188643169,0.066,96590375,0.034,PGX_AM_BS_15257315-MCL-the-72_99,,18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.037000,1,8,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00aeff4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma [blastoid],PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3ch,P49Y,pgxind-kftx2xym,pgxcs-kftvsdtm,0,0,0,0,0,0,PGX_AM_BS_15257315-MCL-the-74_102,,18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.039000,1,62,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00aeff5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma [blastoid],PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3ci,P79Y,pgxind-kftx2xyo,pgxcs-kftvsdu3,317567036,0.11,283157018,0.098,34410018,0.012,PGX_AM_BS_15257315-MCL-the-86_112,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.040000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00aeff6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3ck,P66Y,pgxind-kftx2xyq,pgxcs-kftvsduk,0,0,0,0,0,0,PGX_AM_BS_15257315-MCL-the-91_22,,18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.041000,1,32,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00aeff7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3cm,P69Y,pgxind-kftx2xys,pgxcs-kftvsdv2,499768268,0.174,390738088,0.136,109030180,0.038,PGX_AM_BS_15257315-MCL-the-92,,18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.043000,1,10,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00aeffa,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3cr,P68Y,pgxind-kftx2xyz,pgxcs-kftvsdwg,80023214,0.028,40406020,0.014,39617194,0.014,PGX_AM_BS_15257315-MCL-the-97_23,,18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.047000,1,42,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00aeffb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma [blastoid],PMID:15257315,"Thelander EF, Walsh SH et al. (2005): Mantle cell lymphomas with clonal immunoglobulin...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3ct,P58Y,pgxind-kftx2xz1,pgxcs-kftvsdwx,0,0,0,0,0,0,PGX_AM_BS_15257315-MCL-the-98_111,,18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.048000,1,36,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00aeffd,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15223644,"Jarosov M, Papajk T et al. (2004): High incidence of unbalanced chromosomal changes...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3cw,P77Y,pgxind-kftx2xz5,pgxcs-kftvsdxv,168992675,0.059,112796115,0.039,56196560,0.02,PGX_AM_BS_15223644-MCL-jar-10,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.051000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00aeffe,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15223644,"Jarosov M, Papajk T et al. (2004): High incidence of unbalanced chromosomal changes...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3cy,P66Y,pgxind-kftx2xz7,pgxcs-kftvsdyc,0,0,0,0,0,0,PGX_AM_BS_15223644-MCL-jar-11,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.052000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af001,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15223644,"Jarosov M, Papajk T et al. (2004): High incidence of unbalanced chromosomal changes...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3d3,P77Y,pgxind-kftx2xzd,pgxcs-kftvsdzs,0,0,0,0,0,0,PGX_AM_BS_15223644-MCL-jar-14,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.056000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af002,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15223644,"Jarosov M, Papajk T et al. (2004): High incidence of unbalanced chromosomal changes...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3d4,P52Y,pgxind-kftx2xzg,pgxcs-kftvse09,154097575,0.054,154097575,0.054,0,0,PGX_AM_BS_15223644-MCL-jar-15,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.057000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af004,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15223644,"Jarosov M, Papajk T et al. (2004): High incidence of unbalanced chromosomal changes...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3d8,P71Y,pgxind-kftx2xzk,pgxcs-kftvse17,63938701,0.022,12300012,0.004,51638689,0.018,PGX_AM_BS_15223644-MCL-jar-17,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.060000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af005,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15223644,"Jarosov M, Papajk T et al. (2004): High incidence of unbalanced chromosomal changes...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3d9,P72Y,pgxind-kftx2xzm,pgxcs-kftvse1o,612121895,0.213,250997663,0.087,361124232,0.126,PGX_AM_BS_15223644-MCL-jar-18,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.061000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af006,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15223644,"Jarosov M, Papajk T et al. (2004): High incidence of unbalanced chromosomal changes...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3db,P62Y,pgxind-kftx2xzo,pgxcs-kftvse41,474620731,0.165,234986015,0.082,239634716,0.083,PGX_AM_BS_15223644-MCL-jar-19,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.063000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af009,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15223644,"Jarosov M, Papajk T et al. (2004): High incidence of unbalanced chromosomal changes...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3dg,P72Y,pgxind-kftx2xzu,pgxcs-kftvse5i,404551542,0.141,41000041,0.014,363551501,0.126,PGX_AM_BS_15223644-MCL-jar-21,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.067000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af00a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15223644,"Jarosov M, Papajk T et al. (2004): High incidence of unbalanced chromosomal changes...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3dh,P55Y,pgxind-kftx2xzw,pgxcs-kftvse5z,107643089,0.037,107643089,0.037,0,0,PGX_AM_BS_15223644-MCL-jar-22,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.068000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af00b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15223644,"Jarosov M, Papajk T et al. (2004): High incidence of unbalanced chromosomal changes...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3dj,P65Y,pgxind-kftx2xzy,pgxcs-kftvse6g,806346012,0.28,404466907,0.141,401879105,0.14,PGX_AM_BS_15223644-MCL-jar-23,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.070000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af00d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15223644,"Jarosov M, Papajk T et al. (2004): High incidence of unbalanced chromosomal changes...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3dm,P51Y,pgxind-kftx2y02,pgxcs-kftvse7f,464252758,0.161,271200268,0.094,193052490,0.067,PGX_AM_BS_15223644-MCL-jar-25,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.073000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af00e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15223644,"Jarosov M, Papajk T et al. (2004): High incidence of unbalanced chromosomal changes...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3do,P69Y,pgxind-kftx2y04,pgxcs-kftvse7w,447109481,0.156,308670705,0.107,138438776,0.048,PGX_AM_BS_15223644-MCL-jar-26,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.074000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af00f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15223644,"Jarosov M, Papajk T et al. (2004): High incidence of unbalanced chromosomal changes...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3dp,P63Y,pgxind-kftx2y06,pgxcs-kftvse8d,526851693,0.183,388602020,0.135,138249673,0.048,PGX_AM_BS_15223644-MCL-jar-27,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.076000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af011,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15223644,"Jarosov M, Papajk T et al. (2004): High incidence of unbalanced chromosomal changes...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3dt,P79Y,pgxind-kftx2y0b,pgxcs-kftvse9b,406513119,0.141,186017339,0.065,220495780,0.077,PGX_AM_BS_15223644-MCL-jar-29,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.079000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af012,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15223644,"Jarosov M, Papajk T et al. (2004): High incidence of unbalanced chromosomal changes...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3du,P70Y,pgxind-kftx2y0d,pgxcs-kftvse9t,525373403,0.183,366551820,0.127,158821583,0.055,PGX_AM_BS_15223644-MCL-jar-3,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.080000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af013,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15223644,"Jarosov M, Papajk T et al. (2004): High incidence of unbalanced chromosomal changes...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3dw,P46Y,pgxind-kftx2y0f,pgxcs-kftvseaa,272194990,0.095,0,0,272194990,0.095,PGX_AM_BS_15223644-MCL-jar-30,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.081000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af016,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15223644,"Jarosov M, Papajk T et al. (2004): High incidence of unbalanced chromosomal changes...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3e1,P46Y,pgxind-kftx2y0l,pgxcs-kftvsebq,179910163,0.063,133200133,0.046,46710030,0.016,PGX_AM_BS_15223644-MCL-jar-6,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.086000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af019,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Mantle cell lymphoma,PMID:15223644,"Jarosov M, Papajk T et al. (2004): High incidence of unbalanced chromosomal changes...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3e6,P73Y,pgxind-kftx2y0r,pgxcs-kftvsed6,543164670,0.189,306755119,0.107,236409551,0.082,PGX_AM_BS_15223644-MCL-jar-9,{},17.25,49.6,Point,CZE,Olomouc,Czech Republic,"Olomouc, Czech Republic",49.6,17.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.090000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00afb7f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Mantle cell lymphoma [blastoid, diagnostic biopsy]",PMID:12547156,"Flordal E, Berglund M et al. (2002): Clonal development of a blastoid mantle...",NCIT:C4337,Mantle Cell Lymphoma,icdom-96733,Mantle cell lymphoma,icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh71j,P45Y,pgxind-kftx32kq,pgxcs-kftvtj5p,322813733,0.112,116806095,0.041,206007638,0.072,PGX_AM_BS_MCL-blast-dia,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:35.129000,1,47,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af1eb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [Nodal],PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C4340,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",icdom-97023,"Mature T-cell lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3z2,P63Y,pgxind-kftx2yr3,pgxcs-kftvskuj,943845060,0.328,495229349,0.172,448615711,0.156,PGX_AM_BS_PTCL-ALCL-11,{},9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.737000,0,48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af1f1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [Nodal],PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C4340,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",icdom-97023,"Mature T-cell lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3zc,P66Y,pgxind-kftx2yrf,pgxcs-kftvskxd,324921303,0.113,171200171,0.06,153721132,0.053,PGX_AM_BS_PTCL-ALCL-17,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.745000,0,36,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af1f9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [Nodal],PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C4340,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",icdom-97023,"Mature T-cell lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3zp,P77Y,pgxind-kftx2yrw,pgxcs-kftvsl17,217700218,0.076,189500190,0.066,28200028,0.01,PGX_AM_BS_PTCL-ALCL-25,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.756000,0,17,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af1fa,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [Nodal],PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C4340,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",icdom-97023,"Mature T-cell lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3zr,P72Y,pgxind-kftx2yry,pgxcs-kftvsl1p,865006751,0.301,687332765,0.239,177673986,0.062,PGX_AM_BS_PTCL-ALCL-26,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.757000,0,5,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af1fc,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [Nodal],PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C4340,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",icdom-97023,"Mature T-cell lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3zu,P58Y,pgxind-kftx2ys2,pgxcs-kftvsl2n,688253277,0.239,457070029,0.159,231183248,0.08,PGX_AM_BS_PTCL-ALCL-28,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.760000,0,8,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af1fd,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [Nodal],PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C4340,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",icdom-97023,"Mature T-cell lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3zw,P59Y,pgxind-kftx2ys4,pgxcs-kftvsl34,721686963,0.251,630686873,0.219,91000090,0.032,PGX_AM_BS_PTCL-ALCL-29,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.762000,0,12,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af1fe,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [Nodal],PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C4340,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",icdom-97023,"Mature T-cell lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3zy,P64Y,pgxind-kftx2ys6,pgxcs-kftvsl3m,468477645,0.163,382482000,0.133,85995645,0.03,PGX_AM_BS_PTCL-ALCL-30,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.763000,0,8,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af206,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [Nodal],PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C4340,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",icdom-97023,"Mature T-cell lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh40b,P61Y,pgxind-kftx2ysm,pgxcs-kftvsl7f,341412717,0.119,241691193,0.084,99721524,0.035,PGX_AM_BS_PTCL-ALCL-37R,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.774000,0,80,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af1e3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [Nodal],PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C4340,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",icdom-97023,"Mature T-cell lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3yo,P45Y,pgxind-kftx2yqn,pgxcs-kftvskqp,655633062,0.228,533638222,0.186,121994840,0.042,PGX_AM_BS_PTCL-ALCL-03,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.726000,1,20,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af1e4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [Nodal],PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C4340,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",icdom-97023,"Mature T-cell lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3yq,P45Y,pgxind-kftx2yqp,pgxcs-kftvskr7,196074938,0.068,100000100,0.035,96074838,0.033,PGX_AM_BS_PTCL-ALCL-04,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.727000,1,7,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af1e6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [Nodal],PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C4340,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",icdom-97023,"Mature T-cell lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3yt,P59Y,pgxind-kftx2yqt,pgxcs-kftvsks5,617469357,0.215,535589983,0.186,81879374,0.028,PGX_AM_BS_PTCL-ALCL-06,{},9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.730000,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af1e7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [Nodal],PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C4340,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",icdom-97023,"Mature T-cell lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3yv,P66Y,pgxind-kftx2yqv,pgxcs-kftvsksm,564350369,0.196,278097699,0.097,286252670,0.1,PGX_AM_BS_PTCL-ALCL-07,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.731000,1,32,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af1e8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [Nodal],PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C4340,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",icdom-97023,"Mature T-cell lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3yx,P59Y,pgxind-kftx2yqx,pgxcs-kftvskt3,720305094,0.251,503266299,0.175,217038795,0.075,PGX_AM_BS_PTCL-ALCL-08,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.733000,1,25,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af1e9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [Nodal],PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C4340,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",icdom-97023,"Mature T-cell lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3yy,P59Y,pgxind-kftx2yqz,pgxcs-kftvsktk,78200078,0.027,78200078,0.027,0,0,PGX_AM_BS_PTCL-ALCL-09,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.734000,1,31,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af1ea,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [Nodal],PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C4340,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",icdom-97023,"Mature T-cell lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3z0,P51Y,pgxind-kftx2yr1,pgxcs-kftvsku2,0,0,0,0,0,0,PGX_AM_BS_PTCL-ALCL-10,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.735000,1,5,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af1ec,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [Nodal],PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C4340,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",icdom-97023,"Mature T-cell lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3z4,P72Y,pgxind-kftx2yr5,pgxcs-kftvskv0,0,0,0,0,0,0,PGX_AM_BS_PTCL-ALCL-12,{},9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.738000,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af1ee,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [Nodal],PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C4340,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",icdom-97023,"Mature T-cell lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3z7,P77Y,pgxind-kftx2yr9,pgxcs-kftvskvy,472987080,0.165,328437216,0.114,144549864,0.05,PGX_AM_BS_PTCL-ALCL-14,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.741000,1,1,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af1ef,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [Nodal],PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C4340,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",icdom-97023,"Mature T-cell lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3z8,P80Y,pgxind-kftx2yrb,pgxcs-kftvskwf,334822022,0.116,143106122,0.05,191715900,0.067,PGX_AM_BS_PTCL-ALCL-15,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.742000,1,3,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af1f0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [Nodal],PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C4340,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",icdom-97023,"Mature T-cell lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3za,P83Y,pgxind-kftx2yrd,pgxcs-kftvskww,0,0,0,0,0,0,PGX_AM_BS_PTCL-ALCL-16,{},9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.744000,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af1f2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [Nodal],PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C4340,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",icdom-97023,"Mature T-cell lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3zd,P66Y,pgxind-kftx2yrh,pgxcs-kftvskxv,472899241,0.164,472899241,0.164,0,0,PGX_AM_BS_PTCL-ALCL-18,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.747000,1,10,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af1f3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [Nodal],PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C4340,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",icdom-97023,"Mature T-cell lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3zf,P74Y,pgxind-kftx2yrj,pgxcs-kftvskyc,418890114,0.146,158293687,0.055,260596427,0.091,PGX_AM_BS_PTCL-ALCL-19,{},9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.748000,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af1f5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [Nodal],PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C4340,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",icdom-97023,"Mature T-cell lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3zj,P84Y,pgxind-kftx2yrn,pgxcs-kftvskza,385039532,0.134,176943158,0.062,208096374,0.072,PGX_AM_BS_PTCL-ALCL-21,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.751000,1,13,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af1f6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [Nodal],PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C4340,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",icdom-97023,"Mature T-cell lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3zk,P46Y,pgxind-kftx2yrp,pgxcs-kftvskzs,485671629,0.169,211200210,0.073,274471419,0.095,PGX_AM_BS_PTCL-ALCL-22,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.752000,1,15,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af1f7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [Nodal],PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C4340,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",icdom-97023,"Mature T-cell lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3zm,P78Y,pgxind-kftx2yrr,pgxcs-kftvsl09,397740800,0.138,272440676,0.095,125300124,0.044,PGX_AM_BS_PTCL-ALCL-23,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.753000,1,25,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af1f8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [Adrenal],PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C4340,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",icdom-97023,"Mature T-cell lymphoma, NOS",icdot-C74.9,adrenal glands,pgxbs-kftvh3zo,P70Y,pgxind-kftx2yrt,pgxcs-kftvsl0q,664790157,0.231,81152466,0.028,583637691,0.203,PGX_AM_BS_PTCL-ALCL-24,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002369,adrenal gland,{},2020-09-10 17:44:31.755000,1,10,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af1fb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [Nodal],PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C4340,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",icdom-97023,"Mature T-cell lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh3zt,P72Y,pgxind-kftx2ys0,pgxcs-kftvsl26,189060251,0.066,50300051,0.017,138760200,0.048,PGX_AM_BS_PTCL-ALCL-27,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.759000,1,1,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af200,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [Nodal],PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C4340,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",icdom-97023,"Mature T-cell lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh401,P90Y,pgxind-kftx2ysa,pgxcs-kftvsl4k,307729223,0.107,243495803,0.085,64233420,0.022,PGX_AM_BS_PTCL-ALCL-32,{},9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.766000,1,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af201,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [Nodal],PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C4340,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",icdom-97023,"Mature T-cell lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh403,P63Y,pgxind-kftx2ysc,pgxcs-kftvsl51,630045790,0.219,400745562,0.139,229300228,0.08,PGX_AM_BS_PTCL-ALCL-33,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.767000,1,4,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af202,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [Nodal],PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C4340,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",icdom-97023,"Mature T-cell lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh404,P81Y,pgxind-kftx2yse,pgxcs-kftvsl5i,118613873,0.041,13300013,0.005,105313860,0.037,PGX_AM_BS_PTCL-ALCL-34,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.769000,1,2,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af203,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [Nodal],PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C4340,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",icdom-97023,"Mature T-cell lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh406,P82Y,pgxind-kftx2ysg,pgxcs-kftvsl60,627356797,0.218,134700135,0.047,492656662,0.171,PGX_AM_BS_PTCL-ALCL-35,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.770000,1,5,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af204,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [Soft tissue],PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C4340,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",icdom-97023,"Mature T-cell lymphoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh408,P80Y,pgxind-kftx2ysi,pgxcs-kftvsl6h,0,0,0,0,0,0,PGX_AM_BS_PTCL-ALCL-36,{},9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:31.771000,1,13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af207,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [Nodal],PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C4340,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",icdom-97023,"Mature T-cell lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh40d,P54Y,pgxind-kftx2yso,pgxcs-kftvsl7w,72638710,0.025,0,0,72638710,0.025,PGX_AM_BS_PTCL-ALCL-38R,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.775000,1,4,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af208,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [Nodal],PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C4340,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",icdom-97023,"Mature T-cell lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh40e,P35Y,pgxind-kftx2ysq,pgxcs-kftvsl8d,281749122,0.098,65700066,0.023,216049056,0.075,PGX_AM_BS_PTCL-ALCL-39R,{},9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.777000,1,11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af20b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Peripheral T-cell lymphoma [Nodal],PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C4340,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",icdom-97023,"Mature T-cell lymphoma, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh40j,P56Y,pgxind-kftx2ysw,pgxcs-kftvsl9s,40152425,0.014,26400026,0.009,13752399,0.005,PGX_AM_BS_PTCL-ALCL-41R,,9.95,49.79,Point,DEU,Wuerzburg,Germany,"Wuerzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:31.781000,1,6,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af435,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Splenic Marginal Zone Lymphoma [Spleen, Bm, PB]",PMID:14681321,"Boonstra R, Bosga-Bouwer A et al. (2003): Splenic marginal zone lymphomas presenting with...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvh4ph,P50Y,pgxind-kftx2zo6,pgxcs-kftvst17,0,0,0,0,0,0,PGX_AM_BS_14681321-SMZL-boo-1,,6.57,53.22,Point,NLD,Groningen,Netherlands,"Groningen, The Netherlands",53.22,6.57,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:32.546000,0,54,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af436,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Splenic Marginal Zone Lymphoma [Spleen, Bm, PB]",PMID:14681321,"Boonstra R, Bosga-Bouwer A et al. (2003): Splenic marginal zone lymphomas presenting with...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvh4pi,P54Y,pgxind-kftx2zo8,pgxcs-kftvst1r,228795788,0.08,0,0,228795788,0.08,PGX_AM_BS_14681321-SMZL-boo-10,,6.57,53.22,Point,NLD,Groningen,Netherlands,"Groningen, The Netherlands",53.22,6.57,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:32.548000,0,112,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af437,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Splenic Marginal Zone Lymphoma [Spleen],PMID:14681321,"Boonstra R, Bosga-Bouwer A et al. (2003): Splenic marginal zone lymphomas presenting with...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvh4pk,P78Y,pgxind-kftx2zob,pgxcs-kftvst29,0,0,0,0,0,0,PGX_AM_BS_14681321-SMZL-boo-11,,6.57,53.22,Point,NLD,Groningen,Netherlands,"Groningen, The Netherlands",53.22,6.57,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:32.549000,0,43,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af438,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Splenic Marginal Zone Lymphoma [Spleen, Bm, PB]",PMID:14681321,"Boonstra R, Bosga-Bouwer A et al. (2003): Splenic marginal zone lymphomas presenting with...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvh4pl,P65Y,pgxind-kftx2zod,pgxcs-kftvst2q,126117280,0.044,25000025,0.009,101117255,0.035,PGX_AM_BS_14681321-SMZL-boo-12,,6.57,53.22,Point,NLD,Groningen,Netherlands,"Groningen, The Netherlands",53.22,6.57,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:32.550000,0,17,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af439,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Splenic Marginal Zone Lymphoma [Spleen, BM]",PMID:14681321,"Boonstra R, Bosga-Bouwer A et al. (2003): Splenic marginal zone lymphomas presenting with...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvh4pn,P48Y,pgxind-kftx2zof,pgxcs-kftvst39,271517425,0.094,19500020,0.007,252017405,0.088,PGX_AM_BS_14681321-SMZL-boo-13,,6.57,53.22,Point,NLD,Groningen,Netherlands,"Groningen, The Netherlands",53.22,6.57,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:32.552000,0,21,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af43a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Splenic Marginal Zone Lymphoma [Spleen],PMID:14681321,"Boonstra R, Bosga-Bouwer A et al. (2003): Splenic marginal zone lymphomas presenting with...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvh4pp,P71Y,pgxind-kftx2zoh,pgxcs-kftvst3q,51900051,0.018,51900051,0.018,0,0,PGX_AM_BS_14681321-SMZL-boo-2,,6.57,53.22,Point,NLD,Groningen,Netherlands,"Groningen, The Netherlands",53.22,6.57,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:32.553000,0,52,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af43b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Splenic Marginal Zone Lymphoma [Spleen, Bm, PB]",PMID:14681321,"Boonstra R, Bosga-Bouwer A et al. (2003): Splenic marginal zone lymphomas presenting with...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvh4pq,P74Y,pgxind-kftx2zoj,pgxcs-kftvst47,138400139,0.048,39400039,0.014,99000100,0.034,PGX_AM_BS_14681321-SMZL-boo-3,,6.57,53.22,Point,NLD,Groningen,Netherlands,"Groningen, The Netherlands",53.22,6.57,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:32.555000,0,29,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af43c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Splenic Marginal Zone Lymphoma [Spleen, PB]",PMID:14681321,"Boonstra R, Bosga-Bouwer A et al. (2003): Splenic marginal zone lymphomas presenting with...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvh4ps,P74Y,pgxind-kftx2zol,pgxcs-kftvst4o,0,0,0,0,0,0,PGX_AM_BS_14681321-SMZL-boo-4,{},6.57,53.22,Point,NLD,Groningen,Netherlands,"Groningen, The Netherlands",53.22,6.57,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:32.556000,0,66,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af43d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Splenic Marginal Zone Lymphoma [Spleen, Bm, PB]",PMID:14681321,"Boonstra R, Bosga-Bouwer A et al. (2003): Splenic marginal zone lymphomas presenting with...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvh4pt,P57Y,pgxind-kftx2zon,pgxcs-kftvst55,792100043,0.276,275999526,0.096,516100517,0.18,PGX_AM_BS_14681321-SMZL-boo-5,,6.57,53.22,Point,NLD,Groningen,Netherlands,"Groningen, The Netherlands",53.22,6.57,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:32.557000,0,180,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af43e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Splenic Marginal Zone Lymphoma [Spleen, Bm, PB]",PMID:14681321,"Boonstra R, Bosga-Bouwer A et al. (2003): Splenic marginal zone lymphomas presenting with...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvh4pv,P54Y,pgxind-kftx2zop,pgxcs-kftvst5n,76633432,0.027,40100040,0.014,36533392,0.013,PGX_AM_BS_14681321-SMZL-boo-6,,6.57,53.22,Point,NLD,Groningen,Netherlands,"Groningen, The Netherlands",53.22,6.57,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:32.559000,0,98,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af43f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Splenic Marginal Zone Lymphoma [Spleen, Bm, PB]",PMID:14681321,"Boonstra R, Bosga-Bouwer A et al. (2003): Splenic marginal zone lymphomas presenting with...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvh4px,P47Y,pgxind-kftx2zor,pgxcs-kftvst64,274412988,0.095,0,0,274412988,0.095,PGX_AM_BS_14681321-SMZL-boo-7,,6.57,53.22,Point,NLD,Groningen,Netherlands,"Groningen, The Netherlands",53.22,6.57,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:32.560000,0,54,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af440,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Splenic Marginal Zone Lymphoma [Spleen, Bm, PB]",PMID:14681321,"Boonstra R, Bosga-Bouwer A et al. (2003): Splenic marginal zone lymphomas presenting with...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvh4py,P46Y,pgxind-kftx2zot,pgxcs-kftvst6l,0,0,0,0,0,0,PGX_AM_BS_14681321-SMZL-boo-8,,6.57,53.22,Point,NLD,Groningen,Netherlands,"Groningen, The Netherlands",53.22,6.57,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:32.561000,0,92,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af441,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Splenic Marginal Zone Lymphoma [Spleen, Bm, PB]",PMID:14681321,"Boonstra R, Bosga-Bouwer A et al. (2003): Splenic marginal zone lymphomas presenting with...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvh4q0,P56Y,pgxind-kftx2zov,pgxcs-kftvst73,0,0,0,0,0,0,PGX_AM_BS_14681321-SMZL-boo-9,,6.57,53.22,Point,NLD,Groningen,Netherlands,"Groningen, The Netherlands",53.22,6.57,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:32.563000,0,65,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cd727983b2e00b0bde,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Splenic Marginal Zone Lymphoma,PMID:11337382,"Hernndez JM, Garca JL et al. (2001): Novel genomic imbalances in B-cell splenic...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvhcao,P67Y,pgxind-kftx394x,pgxcs-kftvv618,627553575,0.218,51621476,0.018,575932099,0.2,PGX_AM_BS_SMZL01,{},-3.68,40.43,Point,ESP,Salamanca,Spain,"Salamanca, Spain",40.43,-3.68,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:40.911000,0,53,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cd727983b2e00b0bdf,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Splenic Marginal Zone Lymphoma,PMID:11337382,"Hernndez JM, Garca JL et al. (2001): Novel genomic imbalances in B-cell splenic...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvhcap,P62Y,pgxind-kftx3950,pgxcs-kftvv61q,0,0,0,0,0,0,PGX_AM_BS_SMZL02,{},-3.68,40.43,Point,ESP,Salamanca,Spain,"Salamanca, Spain",40.43,-3.68,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:40.912000,0,59,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0be2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Splenic Marginal Zone Lymphoma,PMID:11337382,"Hernndez JM, Garca JL et al. (2001): Novel genomic imbalances in B-cell splenic...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvhcau,P65Y,pgxind-kftx3956,pgxcs-kftvv636,438917423,0.153,0,0,438917423,0.153,PGX_AM_BS_SMZL05,{},-3.68,40.43,Point,ESP,Salamanca,Spain,"Salamanca, Spain",40.43,-3.68,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:40.916000,0,53,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cd727983b2e00b0be4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Splenic Marginal Zone Lymphoma,PMID:11337382,"Hernndez JM, Garca JL et al. (2001): Novel genomic imbalances in B-cell splenic...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvhcax,P61Y,pgxind-kftx395a,pgxcs-kftvv644,158853740,0.055,0,0,158853740,0.055,PGX_AM_BS_SMZL07,{},-3.68,40.43,Point,ESP,Salamanca,Spain,"Salamanca, Spain",40.43,-3.68,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:40.919000,0,42,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0be7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Splenic Marginal Zone Lymphoma,PMID:11337382,"Hernndez JM, Garca JL et al. (2001): Novel genomic imbalances in B-cell splenic...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvhcb2,P53Y,pgxind-kftx395g,pgxcs-kftvv65k,202485702,0.07,0,0,202485702,0.07,PGX_AM_BS_SMZL10,{},-3.68,40.43,Point,ESP,Salamanca,Spain,"Salamanca, Spain",40.43,-3.68,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:40.924000,0,38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0be8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Splenic Marginal Zone Lymphoma,PMID:11337382,"Hernndez JM, Garca JL et al. (2001): Novel genomic imbalances in B-cell splenic...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvhcb4,P72Y,pgxind-kftx395i,pgxcs-kftvv661,258927348,0.09,51638689,0.018,207288659,0.072,PGX_AM_BS_SMZL11,{},-3.68,40.43,Point,ESP,Salamanca,Spain,"Salamanca, Spain",40.43,-3.68,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:40.925000,0,36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cd727983b2e00b0be9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Splenic Marginal Zone Lymphoma,PMID:11337382,"Hernndez JM, Garca JL et al. (2001): Novel genomic imbalances in B-cell splenic...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvhcb6,P69Y,pgxind-kftx395k,pgxcs-kftvv66j,242652627,0.084,0,0,242652627,0.084,PGX_AM_BS_SMZL12,{},-3.68,40.43,Point,ESP,Salamanca,Spain,"Salamanca, Spain",40.43,-3.68,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:40.926000,0,13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cd727983b2e00b0bee,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Splenic Marginal Zone Lymphoma,PMID:11337382,"Hernndez JM, Garca JL et al. (2001): Novel genomic imbalances in B-cell splenic...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvhcbd,P51Y,pgxind-kftx395u,pgxcs-kftvv68y,82796250,0.029,51621476,0.018,31174774,0.011,PGX_AM_BS_SMZL17,{},-3.68,40.43,Point,ESP,Salamanca,Spain,"Salamanca, Spain",40.43,-3.68,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:40.933000,0,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0bf0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Splenic Marginal Zone Lymphoma,PMID:11337382,"Hernndez JM, Garca JL et al. (2001): Novel genomic imbalances in B-cell splenic...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvhcbh,P70Y,pgxind-kftx395y,pgxcs-kftvv69w,0,0,0,0,0,0,PGX_AM_BS_SMZL19,{},-3.68,40.43,Point,ESP,Salamanca,Spain,"Salamanca, Spain",40.43,-3.68,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:40.936000,0,34,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cd727983b2e00b0bf1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Splenic Marginal Zone Lymphoma,PMID:11337382,"Hernndez JM, Garca JL et al. (2001): Novel genomic imbalances in B-cell splenic...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvhcbi,P68Y,pgxind-kftx3960,pgxcs-kftvv6ae,340685840,0.118,0,0,340685840,0.118,PGX_AM_BS_SMZL20,{},-3.68,40.43,Point,ESP,Salamanca,Spain,"Salamanca, Spain",40.43,-3.68,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:40.937000,0,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0bf2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Splenic Marginal Zone Lymphoma,PMID:11337382,"Hernndez JM, Garca JL et al. (2001): Novel genomic imbalances in B-cell splenic...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvhcbk,P72Y,pgxind-kftx3962,pgxcs-kftvv6av,547928575,0.191,108100108,0.038,439828467,0.153,PGX_AM_BS_SMZL21,{},-3.68,40.43,Point,ESP,Salamanca,Spain,"Salamanca, Spain",40.43,-3.68,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:40.939000,0,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0bf3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Splenic Marginal Zone Lymphoma,PMID:11337382,"Hernndez JM, Garca JL et al. (2001): Novel genomic imbalances in B-cell splenic...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvhcbl,P60Y,pgxind-kftx3964,pgxcs-kftvv6bc,0,0,0,0,0,0,PGX_AM_BS_SMZL22,{},-3.68,40.43,Point,ESP,Salamanca,Spain,"Salamanca, Spain",40.43,-3.68,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:40.940000,0,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cd727983b2e00b0bf4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Splenic Marginal Zone Lymphoma,PMID:11337382,"Hernndez JM, Garca JL et al. (2001): Novel genomic imbalances in B-cell splenic...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvhcbn,P39Y,pgxind-kftx3966,pgxcs-kftvv6bu,0,0,0,0,0,0,PGX_AM_BS_SMZL23,{},-3.68,40.43,Point,ESP,Salamanca,Spain,"Salamanca, Spain",40.43,-3.68,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:40.941000,0,28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0bf6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Splenic Marginal Zone Lymphoma,PMID:11337382,"Hernndez JM, Garca JL et al. (2001): Novel genomic imbalances in B-cell splenic...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvhcbq,P51Y,pgxind-kftx396a,pgxcs-kftvv6cs,259834457,0.09,45200045,0.016,214634412,0.075,PGX_AM_BS_SMZL25,{},-3.68,40.43,Point,ESP,Salamanca,Spain,"Salamanca, Spain",40.43,-3.68,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:40.944000,0,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cd727983b2e00b0bf7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Splenic Marginal Zone Lymphoma,PMID:11337382,"Hernndez JM, Garca JL et al. (2001): Novel genomic imbalances in B-cell splenic...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvhcbs,P55Y,pgxind-kftx396c,pgxcs-kftvv6da,369790647,0.129,0,0,369790647,0.129,PGX_AM_BS_SMZL26,{},-3.68,40.43,Point,ESP,Salamanca,Spain,"Salamanca, Spain",40.43,-3.68,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:40.946000,0,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0bf8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Splenic Marginal Zone Lymphoma,PMID:11337382,"Hernndez JM, Garca JL et al. (2001): Novel genomic imbalances in B-cell splenic...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvhcbt,P79Y,pgxind-kftx396e,pgxcs-kftvv6ds,146700147,0.051,0,0,146700147,0.051,PGX_AM_BS_SMZL27,{},-3.68,40.43,Point,ESP,Salamanca,Spain,"Salamanca, Spain",40.43,-3.68,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:40.947000,0,26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cd727983b2e00b0bfa,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Splenic Marginal Zone Lymphoma,PMID:11337382,"Hernndez JM, Garca JL et al. (2001): Novel genomic imbalances in B-cell splenic...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvhcbx,P52Y,pgxind-kftx396i,pgxcs-kftvv6er,0,0,0,0,0,0,PGX_AM_BS_SMZL29,{},-3.68,40.43,Point,ESP,Salamanca,Spain,"Salamanca, Spain",40.43,-3.68,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:40.950000,0,113,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cd727983b2e00b0be0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Splenic Marginal Zone Lymphoma,PMID:11337382,"Hernndez JM, Garca JL et al. (2001): Novel genomic imbalances in B-cell splenic...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvhcar,P72Y,pgxind-kftx3952,pgxcs-kftvv627,196654917,0.068,0,0,196654917,0.068,PGX_AM_BS_SMZL03,{},-3.68,40.43,Point,ESP,Salamanca,Spain,"Salamanca, Spain",40.43,-3.68,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:40.914000,1,72,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cd727983b2e00b0be1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Splenic Marginal Zone Lymphoma,PMID:11337382,"Hernndez JM, Garca JL et al. (2001): Novel genomic imbalances in B-cell splenic...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvhcat,P56Y,pgxind-kftx3954,pgxcs-kftvv62o,0,0,0,0,0,0,PGX_AM_BS_SMZL04,{},-3.68,40.43,Point,ESP,Salamanca,Spain,"Salamanca, Spain",40.43,-3.68,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:40.915000,1,77,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0be3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Splenic Marginal Zone Lymphoma,PMID:11337382,"Hernndez JM, Garca JL et al. (2001): Novel genomic imbalances in B-cell splenic...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvhcaw,P58Y,pgxind-kftx3958,pgxcs-kftvv63n,52138968,0.018,29938946,0.01,22200022,0.008,PGX_AM_BS_SMZL06,{},-3.68,40.43,Point,ESP,Salamanca,Spain,"Salamanca, Spain",40.43,-3.68,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:40.918000,1,17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0be5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Splenic Marginal Zone Lymphoma,PMID:11337382,"Hernndez JM, Garca JL et al. (2001): Novel genomic imbalances in B-cell splenic...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvhcaz,P63Y,pgxind-kftx395c,pgxcs-kftvv64m,60700060,0.021,38500038,0.013,22200022,0.008,PGX_AM_BS_SMZL08,{},-3.68,40.43,Point,ESP,Salamanca,Spain,"Salamanca, Spain",40.43,-3.68,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:40.921000,1,57,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0be6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Splenic Marginal Zone Lymphoma,PMID:11337382,"Hernndez JM, Garca JL et al. (2001): Novel genomic imbalances in B-cell splenic...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvhcb1,P66Y,pgxind-kftx395e,pgxcs-kftvv653,0,0,0,0,0,0,PGX_AM_BS_SMZL09,{},-3.68,40.43,Point,ESP,Salamanca,Spain,"Salamanca, Spain",40.43,-3.68,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:40.922000,1,29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cd727983b2e00b0bea,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Splenic Marginal Zone Lymphoma,PMID:11337382,"Hernndez JM, Garca JL et al. (2001): Novel genomic imbalances in B-cell splenic...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvhcb7,P74Y,pgxind-kftx395m,pgxcs-kftvv670,89373899,0.031,51621476,0.018,37752423,0.013,PGX_AM_BS_SMZL13,{},-3.68,40.43,Point,ESP,Salamanca,Spain,"Salamanca, Spain",40.43,-3.68,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:40.928000,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0beb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Splenic Marginal Zone Lymphoma,PMID:11337382,"Hernndez JM, Garca JL et al. (2001): Novel genomic imbalances in B-cell splenic...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvhcb9,P66Y,pgxind-kftx395o,pgxcs-kftvv67i,0,0,0,0,0,0,PGX_AM_BS_SMZL14,{},-3.68,40.43,Point,ESP,Salamanca,Spain,"Salamanca, Spain",40.43,-3.68,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:40.929000,1,22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cd727983b2e00b0bec,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Splenic Marginal Zone Lymphoma,PMID:11337382,"Hernndez JM, Garca JL et al. (2001): Novel genomic imbalances in B-cell splenic...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvhcba,P72Y,pgxind-kftx395q,pgxcs-kftvv67z,211527790,0.074,0,0,211527790,0.074,PGX_AM_BS_SMZL15,{},-3.68,40.43,Point,ESP,Salamanca,Spain,"Salamanca, Spain",40.43,-3.68,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:40.931000,1,36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0bed,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Splenic Marginal Zone Lymphoma,PMID:11337382,"Hernndez JM, Garca JL et al. (2001): Novel genomic imbalances in B-cell splenic...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvhcbc,P67Y,pgxind-kftx395s,pgxcs-kftvv68g,567829152,0.198,54300054,0.019,513529098,0.179,PGX_AM_BS_SMZL16,{},-3.68,40.43,Point,ESP,Salamanca,Spain,"Salamanca, Spain",40.43,-3.68,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:40.932000,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0bef,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Splenic Marginal Zone Lymphoma,PMID:11337382,"Hernndez JM, Garca JL et al. (2001): Novel genomic imbalances in B-cell splenic...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvhcbf,P69Y,pgxind-kftx395w,pgxcs-kftvv69f,113322086,0.039,0,0,113322086,0.039,PGX_AM_BS_SMZL18,{},-3.68,40.43,Point,ESP,Salamanca,Spain,"Salamanca, Spain",40.43,-3.68,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:40.935000,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cd727983b2e00b0bf5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Splenic Marginal Zone Lymphoma,PMID:11337382,"Hernndez JM, Garca JL et al. (2001): Novel genomic imbalances in B-cell splenic...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvhcbp,P45Y,pgxind-kftx3968,pgxcs-kftvv6cb,219400219,0.076,0,0,219400219,0.076,PGX_AM_BS_SMZL24,{},-3.68,40.43,Point,ESP,Salamanca,Spain,"Salamanca, Spain",40.43,-3.68,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:40.943000,1,36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cd727983b2e00b0bf9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Splenic Marginal Zone Lymphoma,PMID:11337382,"Hernndez JM, Garca JL et al. (2001): Novel genomic imbalances in B-cell splenic...",NCIT:C4663,Splenic Marginal Zone Lymphoma,icdom-96893,Splenic marginal zone B-cell lymphoma,icdot-C42.2,Spleen,pgxbs-kftvhcbv,P48Y,pgxind-kftx396g,pgxcs-kftvv6e9,55291487,0.019,0,0,55291487,0.019,PGX_AM_BS_SMZL28,{},-3.68,40.43,Point,ESP,Salamanca,Spain,"Salamanca, Spain",40.43,-3.68,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:40.949000,1,21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adced,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute monoblastic leukemia with differentiation [FAB M5b],PMID:17268525,"Tyybkinoja A, Elonen E et al. (2007): Oligonucleotide array-CGH reveals cryptic gene copy...",NCIT:C4861,Acute Monocytic Leukemia,icdom-98913,Acute monocytic leukemia,icdot-C42.1,Bone marrow,pgxbs-kftvgwx9,P48Y,pgxind-kftx2qcy,pgxcs-kftvqho9,0,0,0,0,0,0,PGX_AM_BS_AMLkarnorm-tyy-06,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:23.904000,0,27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adcee,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute monoblastic leukemia with differentiation [FAB M5b],PMID:17268525,"Tyybkinoja A, Elonen E et al. (2007): Oligonucleotide array-CGH reveals cryptic gene copy...",NCIT:C4861,Acute Monocytic Leukemia,icdom-98913,Acute monocytic leukemia,icdot-C42.1,Bone marrow,pgxbs-kftvgwxb,P47Y,pgxind-kftx2qd0,pgxcs-kftvqhor,0,0,0,0,0,0,PGX_AM_BS_AMLkarnorm-tyy-07,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:23.905000,0,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adcef,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute monoblastic leukemia with differentiation [FAB M5b],PMID:17268525,"Tyybkinoja A, Elonen E et al. (2007): Oligonucleotide array-CGH reveals cryptic gene copy...",NCIT:C4861,Acute Monocytic Leukemia,icdom-98913,Acute monocytic leukemia,icdot-C42.1,Bone marrow,pgxbs-kftvgwxc,P57Y,pgxind-kftx2qd1,pgxcs-kftvqhp8,0,0,0,0,0,0,PGX_AM_BS_AMLkarnorm-tyy-08,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:23.907000,0,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adcf2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute monoblastic leukemia with differentiation [FAB M5b],PMID:17268525,"Tyybkinoja A, Elonen E et al. (2007): Oligonucleotide array-CGH reveals cryptic gene copy...",NCIT:C4861,Acute Monocytic Leukemia,icdom-98913,Acute monocytic leukemia,icdot-C42.1,Bone marrow,pgxbs-kftvgwxh,P43Y,pgxind-kftx2qd7,pgxcs-kftvqhqn,0,0,0,0,0,0,PGX_AM_BS_AMLkarnorm-tyy-11,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:23.911000,0,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad5f0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute monoblastic leukemia [FAB M5],PMID:18190236,"Vranova V, Mentzlova D et al. (2008): Efficacy of high-resolution comparative genomic hybridization...",NCIT:C4861,Acute Monocytic Leukemia,icdom-98913,Acute monocytic leukemia,icdot-C42.1,Bone marrow,pgxbs-kftvguof,P1Y6M,pgxind-kftx2njz,pgxcs-kftvpsm9,0,0,0,0,0,0,PGX_AM_BS_ChAL-vra-28,{},16.61,49.2,Point,CZE,Brno,Czech Republic,"Brno, Czech Republic",49.2,16.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:21.410000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adcf5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute monoblastic leukemia with differentiation [FAB M5b],PMID:17268525,"Tyybkinoja A, Elonen E et al. (2007): Oligonucleotide array-CGH reveals cryptic gene copy...",NCIT:C4861,Acute Monocytic Leukemia,icdom-98913,Acute monocytic leukemia,icdot-C42.1,Bone marrow,pgxbs-kftvgwxm,P43Y,pgxind-kftx2qdd,pgxcs-kftvqhs3,0,0,0,0,0,0,PGX_AM_BS_AMLkarnorm-tyy-14,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:23.915000,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adcf6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Acute monoblastic leukemia with differentiation [FAB M5b],PMID:17268525,"Tyybkinoja A, Elonen E et al. (2007): Oligonucleotide array-CGH reveals cryptic gene copy...",NCIT:C4861,Acute Monocytic Leukemia,icdom-98913,Acute monocytic leukemia,icdot-C42.1,Bone marrow,pgxbs-kftvgwxn,P44Y,pgxind-kftx2qdf,pgxcs-kftvqhsk,0,0,0,0,0,0,PGX_AM_BS_AMLkarnorm-tyy-15,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002371,bone marrow,{},2020-09-10 17:44:23.916000,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac5d3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Anaplastic large cell lymphoma [cutaneous],PMID:19710685,"van Kester MS, Tensen CP et al. (2010): Cutaneous anaplastic large cell lymphoma and...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,Primary cutaneous CD30+ T-cell lymphoproliferative disorder,icdot-C44.9,"Skin, NOS",pgxbs-kftvgpif,P48Y,pgxind-kftx2h3i,pgxcs-kftvo6xq,467374278,0.163,467374278,0.163,0,0,PGX_AM_BS_PMID19710685-kes-ctnhl01,{},4.5,52.16,Point,NLD,Leiden,Netherlands,"Leiden, The Netherlands",52.16,4.5,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:15.719000,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac5d4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Anaplastic large cell lymphoma [cutaneous],PMID:19710685,"van Kester MS, Tensen CP et al. (2010): Cutaneous anaplastic large cell lymphoma and...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,Primary cutaneous CD30+ T-cell lymphoproliferative disorder,icdot-C44.9,"Skin, NOS",pgxbs-kftvgpih,P62Y,pgxind-kftx2h3k,pgxcs-kftvo6y7,85701918,0.03,47573271,0.017,38128647,0.013,PGX_AM_BS_PMID19710685-kes-ctnhl02,{},4.5,52.16,Point,NLD,Leiden,Netherlands,"Leiden, The Netherlands",52.16,4.5,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:15.720000,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac5d6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Anaplastic large cell lymphoma [cutaneous],PMID:19710685,"van Kester MS, Tensen CP et al. (2010): Cutaneous anaplastic large cell lymphoma and...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,Primary cutaneous CD30+ T-cell lymphoproliferative disorder,icdot-C44.9,"Skin, NOS",pgxbs-kftvgpik,P45Y,pgxind-kftx2h3o,pgxcs-kftvo6z9,507118128,0.176,55869399,0.019,451248729,0.157,PGX_AM_BS_PMID19710685-kes-ctnhl04,{},4.5,52.16,Point,NLD,Leiden,Netherlands,"Leiden, The Netherlands",52.16,4.5,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:15.723000,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac5d7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Anaplastic large cell lymphoma [cutaneous],PMID:19710685,"van Kester MS, Tensen CP et al. (2010): Cutaneous anaplastic large cell lymphoma and...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,Primary cutaneous CD30+ T-cell lymphoproliferative disorder,icdot-C44.9,"Skin, NOS",pgxbs-kftvgpim,P69Y,pgxind-kftx2h3q,pgxcs-kftvo6zq,81000536,0.028,81000536,0.028,0,0,PGX_AM_BS_PMID19710685-kes-ctnhl05,{},4.5,52.16,Point,NLD,Leiden,Netherlands,"Leiden, The Netherlands",52.16,4.5,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:15.724000,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac5d8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Anaplastic large cell lymphoma [cutaneous],PMID:19710685,"van Kester MS, Tensen CP et al. (2010): Cutaneous anaplastic large cell lymphoma and...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,Primary cutaneous CD30+ T-cell lymphoproliferative disorder,icdot-C44.9,"Skin, NOS",pgxbs-kftvgpin,P51Y,pgxind-kftx2h3s,pgxcs-kftvo707,228091211,0.079,68789395,0.024,159301816,0.055,PGX_AM_BS_PMID19710685-kes-ctnhl06,{},4.5,52.16,Point,NLD,Leiden,Netherlands,"Leiden, The Netherlands",52.16,4.5,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:15.726000,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac5d9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Anaplastic large cell lymphoma [cutaneous],PMID:19710685,"van Kester MS, Tensen CP et al. (2010): Cutaneous anaplastic large cell lymphoma and...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,Primary cutaneous CD30+ T-cell lymphoproliferative disorder,icdot-C44.9,"Skin, NOS",pgxbs-kftvgpip,P63Y,pgxind-kftx2h3u,pgxcs-kftvo70o,0,0,0,0,0,0,PGX_AM_BS_PMID19710685-kes-ctnhl07,{},4.5,52.16,Point,NLD,Leiden,Netherlands,"Leiden, The Netherlands",52.16,4.5,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:15.727000,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac5da,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Anaplastic large cell lymphoma [cutaneous],PMID:19710685,"van Kester MS, Tensen CP et al. (2010): Cutaneous anaplastic large cell lymphoma and...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,Primary cutaneous CD30+ T-cell lymphoproliferative disorder,icdot-C44.9,"Skin, NOS",pgxbs-kftvgpiq,P86Y,pgxind-kftx2h3w,pgxcs-kftvo715,367265540,0.128,52156172,0.018,315109368,0.11,PGX_AM_BS_PMID19710685-kes-ctnhl08,{},4.5,52.16,Point,NLD,Leiden,Netherlands,"Leiden, The Netherlands",52.16,4.5,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:15.728000,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac5dc,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Anaplastic large cell lymphoma [cutaneous],PMID:19710685,"van Kester MS, Tensen CP et al. (2010): Cutaneous anaplastic large cell lymphoma and...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,Primary cutaneous CD30+ T-cell lymphoproliferative disorder,icdot-C44.9,"Skin, NOS",pgxbs-kftvgpiu,P79Y,pgxind-kftx2h40,pgxcs-kftvo723,345779974,0.12,166582451,0.058,179197523,0.062,PGX_AM_BS_PMID19710685-kes-ctnhl10,{},4.5,52.16,Point,NLD,Leiden,Netherlands,"Leiden, The Netherlands",52.16,4.5,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:15.731000,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac5dd,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Anaplastic large cell lymphoma [cutaneous],PMID:19710685,"van Kester MS, Tensen CP et al. (2010): Cutaneous anaplastic large cell lymphoma and...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,Primary cutaneous CD30+ T-cell lymphoproliferative disorder,icdot-C44.9,"Skin, NOS",pgxbs-kftvgpiv,P44Y,pgxind-kftx2h43,pgxcs-kftvo72k,191513715,0.067,31152308,0.011,160361407,0.056,PGX_AM_BS_PMID19710685-kes-ctnhl11,{},4.5,52.16,Point,NLD,Leiden,Netherlands,"Leiden, The Netherlands",52.16,4.5,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:15.732000,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac5ec,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Anaplastic large cell lymphoma [cutaneous],PMID:19710685,"van Kester MS, Tensen CP et al. (2010): Cutaneous anaplastic large cell lymphoma and...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,Primary cutaneous CD30+ T-cell lymphoproliferative disorder,icdot-C44.9,"Skin, NOS",pgxbs-kftvgpjj,P74Y,pgxind-kftx2h4x,pgxcs-kftvo79o,712694383,0.248,477654524,0.166,235039859,0.082,PGX_AM_BS_PMID19710685-kes-ctnhl03,{},4.5,52.16,Point,NLD,Leiden,Netherlands,"Leiden, The Netherlands",52.16,4.5,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:15.753000,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac5f2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Anaplastic large cell lymphoma [cutaneous],PMID:19710685,"van Kester MS, Tensen CP et al. (2010): Cutaneous anaplastic large cell lymphoma and...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,Primary cutaneous CD30+ T-cell lymphoproliferative disorder,icdot-C44.9,"Skin, NOS",pgxbs-kftvgpjt,P70Y,pgxind-kftx2h59,pgxcs-kftvo7cp,312481664,0.109,288701320,0.1,23780344,0.008,PGX_AM_BS_PMID19710685-kes-ctnhl09,{},4.5,52.16,Point,NLD,Leiden,Netherlands,"Leiden, The Netherlands",52.16,4.5,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:15.762000,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af227,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, cutaneous type",PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,"Anaplastic large cell lymphoma, cutaneous type",icdot-C44.9,"Skin, NOS",pgxbs-kftvh41u,P32Y,pgxind-kftx2yug,pgxcs-kftvslp1,0,0,0,0,0,0,PGX_AM_BS_PTCL-ALCL-69,,9.95,49.79,Point,DEU,Wurzburg,Germany,"Wurzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.820000,0,48,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af229,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, cutaneous type",PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,"Anaplastic large cell lymphoma, cutaneous type",icdot-C44.9,"Skin, NOS",pgxbs-kftvh41y,P29Y,pgxind-kftx2yuk,pgxcs-kftvslpz,0,0,0,0,0,0,PGX_AM_BS_PTCL-ALCL-71,,9.95,49.79,Point,DEU,Wurzburg,Germany,"Wurzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.822000,0,24,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af22a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, cutaneous type",PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,"Anaplastic large cell lymphoma, cutaneous type",icdot-C44.9,"Skin, NOS",pgxbs-kftvh41z,P87Y,pgxind-kftx2yum,pgxcs-kftvslqg,105700105,0.037,45200045,0.016,60500060,0.021,PGX_AM_BS_PTCL-ALCL-72,,9.95,49.79,Point,DEU,Wurzburg,Germany,"Wurzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.824000,0,23,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af22c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, cutaneous type",PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,"Anaplastic large cell lymphoma, cutaneous type",icdot-C44.9,"Skin, NOS",pgxbs-kftvh422,P56Y,pgxind-kftx2yuq,pgxcs-kftvslre,0,0,0,0,0,0,PGX_AM_BS_PTCL-ALCL-74,,9.95,49.79,Point,DEU,Wurzburg,Germany,"Wurzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.826000,0,15,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af22e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, cutaneous type",PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,"Anaplastic large cell lymphoma, cutaneous type",icdot-C44.9,"Skin, NOS",pgxbs-kftvh426,P41Y,pgxind-kftx2yuu,pgxcs-kftvslsc,0,0,0,0,0,0,PGX_AM_BS_PTCL-ALCL-76,,9.95,49.79,Point,DEU,Wurzburg,Germany,"Wurzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.829000,0,7,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af230,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, cutaneous type",PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,"Anaplastic large cell lymphoma, cutaneous type",icdot-C44.9,"Skin, NOS",pgxbs-kftvh429,P57Y,pgxind-kftx2yuy,pgxcs-kftvslta,0,0,0,0,0,0,PGX_AM_BS_PTCL-ALCL-78,,9.95,49.79,Point,DEU,Wurzburg,Germany,"Wurzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.832000,0,8,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af231,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, cutaneous type",PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,"Anaplastic large cell lymphoma, cutaneous type",icdot-C44.9,"Skin, NOS",pgxbs-kftvh42b,P50Y,pgxind-kftx2yv0,pgxcs-kftvsltr,0,0,0,0,0,0,PGX_AM_BS_PTCL-ALCL-79,,9.95,49.79,Point,DEU,Wurzburg,Germany,"Wurzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.833000,0,5,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af24f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, cutaneous type",PMID:15086538,"Fischer TC, Gellrich S et al. (2004): Genomic aberrations and survival in cutaneous...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,"Anaplastic large cell lymphoma, cutaneous type",icdot-C44.9,"Skin, NOS",pgxbs-kftvh43n,P24Y,pgxind-kftx2ywp,pgxcs-kftvsm80,0,0,0,0,0,0,PGX_AM_BS_CTNHL-Fi-07,,13.37,52.52,Point,DEU,Berlin,Germany,"Berlin, Germany",52.52,13.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.875000,0,5,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af260,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma[pleomorphic, CD30 pos., stage IIIb]",PMID:15086538,"Fischer TC, Gellrich S et al. (2004): Genomic aberrations and survival in cutaneous...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,"Anaplastic large cell lymphoma, cutaneous type",icdot-C44.9,"Skin, NOS",pgxbs-kftvh44f,P78Y,pgxind-kftx2yxn,pgxcs-kftvsmg4,918374134,0.319,132522947,0.046,785851187,0.273,PGX_AM_BS_CTNHL-Fi-24,,13.37,52.52,Point,DEU,Berlin,Germany,"Berlin, Germany",52.52,13.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.899000,0,39,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af261,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma [pleomorphic, CD30 pos., stage IVa]",PMID:15086538,"Fischer TC, Gellrich S et al. (2004): Genomic aberrations and survival in cutaneous...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,"Anaplastic large cell lymphoma, cutaneous type",icdot-C44.9,"Skin, NOS",pgxbs-kftvh44h,P53Y,pgxind-kftx2yxp,pgxcs-kftvsmgl,1200982329,0.418,528643695,0.184,672338634,0.234,PGX_AM_BS_CTNHL-Fi-25,,13.37,52.52,Point,DEU,Berlin,Germany,"Berlin, Germany",52.52,13.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.901000,0,26,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af263,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, cutaneous type",PMID:15086538,"Fischer TC, Gellrich S et al. (2004): Genomic aberrations and survival in cutaneous...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,"Anaplastic large cell lymphoma, cutaneous type",icdot-C44.9,"Skin, NOS",pgxbs-kftvh44k,P71Y,pgxind-kftx2yxt,pgxcs-kftvsmhj,229974971,0.08,46500046,0.016,183474925,0.064,PGX_AM_BS_CTNHL-Fi-27,,13.37,52.52,Point,DEU,Berlin,Germany,"Berlin, Germany",52.52,13.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.904000,0,18,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af4cd,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, cutaneous type",PMID:14595754,"Prochazkova M, Chevret E et al. (2003): Chromosomal imbalances: a hallmark of tumour...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,"Anaplastic large cell lymphoma, cutaneous type",icdot-C44.9,"Skin, NOS",pgxbs-kftvh4wd,P68Y,pgxind-kftx2zwr,pgxcs-kftvsv5d,0,0,0,0,0,0,PGX_AM_BS_CTNHL-pr-01,{},-0.58,44.84,Point,FRA,Bordeaux,France,"Bordeaux, France",44.84,-0.58,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:32.755000,0,96,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c9727983b2e00af4ce,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, cutaneous type",PMID:14595754,"Prochazkova M, Chevret E et al. (2003): Chromosomal imbalances: a hallmark of tumour...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,"Anaplastic large cell lymphoma, cutaneous type",icdot-C44.9,"Skin, NOS",pgxbs-kftvh4wf,P28Y,pgxind-kftx2zwt,pgxcs-kftvsv5u,0,0,0,0,0,0,PGX_AM_BS_CTNHL-pr-02,{},-0.58,44.84,Point,FRA,Bordeaux,France,"Bordeaux, France",44.84,-0.58,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:32.756000,0,48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c9727983b2e00af4cf,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, cutaneous type",PMID:14595754,"Prochazkova M, Chevret E et al. (2003): Chromosomal imbalances: a hallmark of tumour...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,"Anaplastic large cell lymphoma, cutaneous type",icdot-C44.9,"Skin, NOS",pgxbs-kftvh4wh,P77Y,pgxind-kftx2zwv,pgxcs-kftvsv6b,0,0,0,0,0,0,PGX_AM_BS_CTNHL-pr-03,{},-0.58,44.84,Point,FRA,Bordeaux,France,"Bordeaux, France",44.84,-0.58,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:32.757000,0,36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c9727983b2e00af4d0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, cutaneous type",PMID:14595754,"Prochazkova M, Chevret E et al. (2003): Chromosomal imbalances: a hallmark of tumour...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,"Anaplastic large cell lymphoma, cutaneous type",icdot-C44.9,"Skin, NOS",pgxbs-kftvh4wi,P33Y,pgxind-kftx2zwx,pgxcs-kftvsv6v,0,0,0,0,0,0,PGX_AM_BS_CTNHL-pr-04,{},-0.58,44.84,Point,FRA,Bordeaux,France,"Bordeaux, France",44.84,-0.58,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:32.759000,0,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c9727983b2e00af4d1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, cutaneous type",PMID:14595754,"Prochazkova M, Chevret E et al. (2003): Chromosomal imbalances: a hallmark of tumour...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,"Anaplastic large cell lymphoma, cutaneous type",icdot-C44.9,"Skin, NOS",pgxbs-kftvh4wk,P57Y,pgxind-kftx2zwz,pgxcs-kftvsv7d,0,0,0,0,0,0,PGX_AM_BS_CTNHL-pr-05,{},-0.58,44.84,Point,FRA,Bordeaux,France,"Bordeaux, France",44.84,-0.58,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:32.760000,0,36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c9727983b2e00af4d3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, cutaneous type",PMID:14595754,"Prochazkova M, Chevret E et al. (2003): Chromosomal imbalances: a hallmark of tumour...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,"Anaplastic large cell lymphoma, cutaneous type",icdot-C44.9,"Skin, NOS",pgxbs-kftvh4wo,P39Y,pgxind-kftx2zx2,pgxcs-kftvsva8,752926046,0.262,614531190,0.214,138394856,0.048,PGX_AM_BS_CTNHL-pr-07,{},-0.58,44.84,Point,FRA,Bordeaux,France,"Bordeaux, France",44.84,-0.58,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:32.763000,0,36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c9727983b2e00af4d6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, cutaneous type",PMID:14595754,"Prochazkova M, Chevret E et al. (2003): Chromosomal imbalances: a hallmark of tumour...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,"Anaplastic large cell lymphoma, cutaneous type",icdot-C44.9,"Skin, NOS",pgxbs-kftvh4wt,P67Y,pgxind-kftx2zx8,pgxcs-kftvsvbq,171494889,0.06,84900084,0.03,86594805,0.03,PGX_AM_BS_CTNHL-pr-10,{},-0.58,44.84,Point,FRA,Bordeaux,France,"Bordeaux, France",44.84,-0.58,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:32.767000,0,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c9727983b2e00af4d7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, cutaneous type",PMID:14595754,"Prochazkova M, Chevret E et al. (2003): Chromosomal imbalances: a hallmark of tumour...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,"Anaplastic large cell lymphoma, cutaneous type",icdot-C44.9,"Skin, NOS",pgxbs-kftvh4wu,P79Y,pgxind-kftx2zxa,pgxcs-kftvsvc7,0,0,0,0,0,0,PGX_AM_BS_CTNHL-pr-11,{},-0.58,44.84,Point,FRA,Bordeaux,France,"Bordeaux, France",44.84,-0.58,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:32.768000,0,48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ca727983b2e00afb0b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, cutaneous type",PMID:12648233,"Gellrich S, Wilks A et al. (2003): T cell receptor-gamma gene analysis of...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,"Anaplastic large cell lymphoma, cutaneous type",icdot-C44.9,"Skin, NOS",pgxbs-kftvh6wa,P75Y,pgxind-kftx32e7,pgxcs-kftvthiq,0,0,0,0,0,0,PGX_AM_BS_CTNHL-ge-02,{},13.37,52.52,Point,DEU,Berlin,Germany,"Berlin, Germany",52.52,13.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:34.968000,0,23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00afb0c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, cutaneous type",PMID:12648233,"Gellrich S, Wilks A et al. (2003): T cell receptor-gamma gene analysis of...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,"Anaplastic large cell lymphoma, cutaneous type",icdot-C44.9,"Skin, NOS",pgxbs-kftvh6wc,P24Y,pgxind-kftx32e9,pgxcs-kftvthj8,0,0,0,0,0,0,PGX_AM_BS_CTNHL-ge-04,{},13.37,52.52,Point,DEU,Berlin,Germany,"Berlin, Germany",52.52,13.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:34.969000,0,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af22b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, cutaneous type",PMID:15111330,"Zettl A, Rdiger T et al. (2004): Genomic profiling of peripheral T-cell lymphoma,...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,"Anaplastic large cell lymphoma, cutaneous type",icdot-C44.9,"Skin, NOS",pgxbs-kftvh421,P54Y,pgxind-kftx2yuo,pgxcs-kftvslqx,0,0,0,0,0,0,PGX_AM_BS_PTCL-ALCL-73,{},9.95,49.79,Point,DEU,Wurzburg,Germany,"Wurzburg, Germany",49.79,9.95,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.825000,1,11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af25a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, cutaneous type",PMID:15086538,"Fischer TC, Gellrich S et al. (2004): Genomic aberrations and survival in cutaneous...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,"Anaplastic large cell lymphoma, cutaneous type",icdot-C44.9,"Skin, NOS",pgxbs-kftvh445,P39Y,pgxind-kftx2yxb,pgxcs-kftvsmd8,383264788,0.133,114143095,0.04,269121693,0.094,PGX_AM_BS_CTNHL-Fi-18,,13.37,52.52,Point,DEU,Berlin,Germany,"Berlin, Germany",52.52,13.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.891000,1,35,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af25c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, cutaneous type",PMID:15086538,"Fischer TC, Gellrich S et al. (2004): Genomic aberrations and survival in cutaneous...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,"Anaplastic large cell lymphoma, cutaneous type",icdot-C44.9,"Skin, NOS",pgxbs-kftvh448,P80Y,pgxind-kftx2yxf,pgxcs-kftvsme7,117670126,0.041,38300038,0.013,79370088,0.028,PGX_AM_BS_CTNHL-Fi-20,,13.37,52.52,Point,DEU,Berlin,Germany,"Berlin, Germany",52.52,13.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.894000,1,18,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af25d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, cutaneous type",PMID:15086538,"Fischer TC, Gellrich S et al. (2004): Genomic aberrations and survival in cutaneous...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,"Anaplastic large cell lymphoma, cutaneous type",icdot-C44.9,"Skin, NOS",pgxbs-kftvh44a,P62Y,pgxind-kftx2yxh,pgxcs-kftvsmeo,410642676,0.143,165879128,0.058,244763548,0.085,PGX_AM_BS_CTNHL-Fi-21,,13.37,52.52,Point,DEU,Berlin,Germany,"Berlin, Germany",52.52,13.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.895000,1,7,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af267,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, cutaneous type",PMID:15086538,"Fischer TC, Gellrich S et al. (2004): Genomic aberrations and survival in cutaneous...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,"Anaplastic large cell lymphoma, cutaneous type",icdot-C44.9,"Skin, NOS",pgxbs-kftvh44q,P67Y,pgxind-kftx2yy1,pgxcs-kftvsmjh,1497864524,0.521,785060500,0.273,712804024,0.248,PGX_AM_BS_CTNHL-Fi-32,,13.37,52.52,Point,DEU,Berlin,Germany,"Berlin, Germany",52.52,13.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.910000,1,32,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af4d9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, cutaneous type",PMID:14595754,"Prochazkova M, Chevret E et al. (2003): Chromosomal imbalances: a hallmark of tumour...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,"Anaplastic large cell lymphoma, cutaneous type",icdot-C44.9,"Skin, NOS",pgxbs-kftvh4wy,P72Y,pgxind-kftx2zxe,pgxcs-kftvsvd8,861546260,0.3,354420889,0.123,507125371,0.176,PGX_AM_BS_CTNHL-pr-13,{},-0.58,44.84,Point,FRA,Bordeaux,France,"Bordeaux, France",44.84,-0.58,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:32.771000,1,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ca727983b2e00afb0a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, cutaneous type",PMID:12648233,"Gellrich S, Wilks A et al. (2003): T cell receptor-gamma gene analysis of...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,"Anaplastic large cell lymphoma, cutaneous type",icdot-C44.9,"Skin, NOS",pgxbs-kftvh6w8,P36Y,pgxind-kftx32e5,pgxcs-kftvthi9,0,0,0,0,0,0,PGX_AM_BS_CTNHL-ge-01,{},13.37,52.52,Point,DEU,Berlin,Germany,"Berlin, Germany",52.52,13.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:34.966000,1,36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00afb0d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Anaplastic large cell lymphoma, cutaneous type",PMID:12648233,"Gellrich S, Wilks A et al. (2003): T cell receptor-gamma gene analysis of...",NCIT:C7195,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,icdom-97183,"Anaplastic large cell lymphoma, cutaneous type",icdot-C44.9,"Skin, NOS",pgxbs-kftvh6wd,P62Y,pgxind-kftx32eb,pgxcs-kftvthjp,206090216,0.072,99721524,0.035,106368692,0.037,PGX_AM_BS_CTNHL-pe-03,{},13.37,52.52,Point,DEU,Berlin,Germany,"Berlin, Germany",52.52,13.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:34.970000,1,19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af10e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Follicular lymphoma [cutaneous],PMID:15175042,"Hallermann C, Kaune KM et al. (2004): Chromosomal aberration patterns differ in subtypes...",NCIT:C7217,Primary Cutaneous Follicle Center Lymphoma,icdom-95973,Primary cutaneous follicle center lymphoma,icdot-C44.9,"Skin, NOS",pgxbs-kftvh3p4,P48Y,pgxind-kftx2yen,pgxcs-kftvshsn,54200054,0.019,0,0,54200054,0.019,PGX_AM_BS_C-BNHL-FCCL-01,{},9.92,51.54,Point,DEU,Goettingen,Germany,"Goettingen, Germany",51.54,9.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.432000,0,35,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af10f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Follicular lymphoma [cutaneous],PMID:15175042,"Hallermann C, Kaune KM et al. (2004): Chromosomal aberration patterns differ in subtypes...",NCIT:C7217,Primary Cutaneous Follicle Center Lymphoma,icdom-95973,Primary cutaneous follicle center lymphoma,icdot-C44.9,"Skin, NOS",pgxbs-kftvh3p6,P58Y,pgxind-kftx2yep,pgxcs-kftvsht5,844944109,0.294,35114591,0.012,809829518,0.282,PGX_AM_BS_C-BNHL-FCCL-02,{},9.92,51.54,Point,DEU,Goettingen,Germany,"Goettingen, Germany",51.54,9.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.434000,0,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af110,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Follicular lymphoma [cutaneous],PMID:15175042,"Hallermann C, Kaune KM et al. (2004): Chromosomal aberration patterns differ in subtypes...",NCIT:C7217,Primary Cutaneous Follicle Center Lymphoma,icdom-95973,Primary cutaneous follicle center lymphoma,icdot-C44.9,"Skin, NOS",pgxbs-kftvh3p7,P37Y,pgxind-kftx2yer,pgxcs-kftvshtm,0,0,0,0,0,0,PGX_AM_BS_C-BNHL-FCCL-03,{},9.92,51.54,Point,DEU,Goettingen,Germany,"Goettingen, Germany",51.54,9.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.435000,0,49,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af111,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Follicular lymphoma [cutaneous],PMID:15175042,"Hallermann C, Kaune KM et al. (2004): Chromosomal aberration patterns differ in subtypes...",NCIT:C7217,Primary Cutaneous Follicle Center Lymphoma,icdom-95973,Primary cutaneous follicle center lymphoma,icdot-C44.9,"Skin, NOS",pgxbs-kftvh3p9,P87Y,pgxind-kftx2yet,pgxcs-kftvshu3,0,0,0,0,0,0,PGX_AM_BS_C-BNHL-FCCL-04,{},9.92,51.54,Point,DEU,Goettingen,Germany,"Goettingen, Germany",51.54,9.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.437000,0,28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af112,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Follicular lymphoma [cutaneous],PMID:15175042,"Hallermann C, Kaune KM et al. (2004): Chromosomal aberration patterns differ in subtypes...",NCIT:C7217,Primary Cutaneous Follicle Center Lymphoma,icdom-95973,Primary cutaneous follicle center lymphoma,icdot-C44.9,"Skin, NOS",pgxbs-kftvh3pa,P74Y,pgxind-kftx2yev,pgxcs-kftvshuk,0,0,0,0,0,0,PGX_AM_BS_C-BNHL-FCCL-05,{},9.92,51.54,Point,DEU,Goettingen,Germany,"Goettingen, Germany",51.54,9.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.438000,0,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af113,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Follicular lymphoma [cutaneous],PMID:15175042,"Hallermann C, Kaune KM et al. (2004): Chromosomal aberration patterns differ in subtypes...",NCIT:C7217,Primary Cutaneous Follicle Center Lymphoma,icdom-95973,Primary cutaneous follicle center lymphoma,icdot-C44.9,"Skin, NOS",pgxbs-kftvh3pc,P61Y,pgxind-kftx2yey,pgxcs-kftvshv2,0,0,0,0,0,0,PGX_AM_BS_C-BNHL-FCCL-06,{},9.92,51.54,Point,DEU,Goettingen,Germany,"Goettingen, Germany",51.54,9.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.439000,0,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af114,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Follicular lymphoma [cutaneous],PMID:15175042,"Hallermann C, Kaune KM et al. (2004): Chromosomal aberration patterns differ in subtypes...",NCIT:C7217,Primary Cutaneous Follicle Center Lymphoma,icdom-95973,Primary cutaneous follicle center lymphoma,icdot-C44.9,"Skin, NOS",pgxbs-kftvh3pe,P58Y,pgxind-kftx2yf0,pgxcs-kftvshvj,0,0,0,0,0,0,PGX_AM_BS_C-BNHL-FCCL-07,{},9.92,51.54,Point,DEU,Goettingen,Germany,"Goettingen, Germany",51.54,9.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.440000,0,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af115,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Follicular lymphoma [cutaneous],PMID:15175042,"Hallermann C, Kaune KM et al. (2004): Chromosomal aberration patterns differ in subtypes...",NCIT:C7217,Primary Cutaneous Follicle Center Lymphoma,icdom-95973,Primary cutaneous follicle center lymphoma,icdot-C44.9,"Skin, NOS",pgxbs-kftvh3pf,P59Y,pgxind-kftx2yf2,pgxcs-kftvshw0,0,0,0,0,0,0,PGX_AM_BS_C-BNHL-FCCL-08,{},9.92,51.54,Point,DEU,Goettingen,Germany,"Goettingen, Germany",51.54,9.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.442000,0,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af116,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Follicular lymphoma [cutaneous],PMID:15175042,"Hallermann C, Kaune KM et al. (2004): Chromosomal aberration patterns differ in subtypes...",NCIT:C7217,Primary Cutaneous Follicle Center Lymphoma,icdom-95973,Primary cutaneous follicle center lymphoma,icdot-C44.9,"Skin, NOS",pgxbs-kftvh3ph,P64Y,pgxind-kftx2yf4,pgxcs-kftvshwi,0,0,0,0,0,0,PGX_AM_BS_C-BNHL-FCCL-09,{},9.92,51.54,Point,DEU,Goettingen,Germany,"Goettingen, Germany",51.54,9.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.443000,0,48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aafde,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma [IG-MYC neg., 3q2 break neg., t(14;18) neg.]",PMID:8652842,"Monni O, Joensuu H et al. (1996): DNA copy number changes in diffuse...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgiez,P50Y,pgxind-kftx28ef,pgxcs-kftvm2cd,0,0,0,0,0,0,PGX_AM_BS_DLBCL-mon-01,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:07.781000,0,60,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aafdf,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma [IG-MYC neg., 3q2 break neg., t(14;18) neg.]",PMID:8652842,"Monni O, Joensuu H et al. (1996): DNA copy number changes in diffuse...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgif0,P35Y,pgxind-kftx28eh,pgxcs-kftvm2cu,0,0,0,0,0,0,PGX_AM_BS_DLBCL-mon-02,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:07.782000,0,54,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aafe1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma,PMID:8652842,"Monni O, Joensuu H et al. (1996): DNA copy number changes in diffuse...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgif4,P47Y,pgxind-kftx28el,pgxcs-kftvm2ds,205106184,0.071,110306090,0.038,94800094,0.033,PGX_AM_BS_DLBCL-mon-04,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:07.785000,0,36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aafe2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma [IG-MYC maybe, 3q2 break neg., t(14;18) neg.]",PMID:8652842,"Monni O, Joensuu H et al. (1996): DNA copy number changes in diffuse...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgif5,P52Y,pgxind-kftx28em,pgxcs-kftvm2e8,1642283200,0.571,905084794,0.315,737198406,0.256,PGX_AM_BS_DLBCL-mon-05,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:07.787000,0,26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aafe3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma,PMID:8652842,"Monni O, Joensuu H et al. (1996): DNA copy number changes in diffuse...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgif7,P54Y,pgxind-kftx28eo,pgxcs-kftvm2ep,446102550,0.155,129800129,0.045,316302421,0.11,PGX_AM_BS_DLBCL-mon-06,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:07.788000,0,72,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aafe4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma [IG-MYC neg., 3q2 break pos., t(14;18) pos.]",PMID:8652842,"Monni O, Joensuu H et al. (1996): DNA copy number changes in diffuse...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgif9,P43Y,pgxind-kftx28eq,pgxcs-kftvm2f6,0,0,0,0,0,0,PGX_AM_BS_DLBCL-mon-07,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:07.790000,0,49,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aafe5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma [IG-MYC neg., 3q2 break neg., t(14;18) pos.]",PMID:8652842,"Monni O, Joensuu H et al. (1996): DNA copy number changes in diffuse...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgifa,P64Y,pgxind-kftx28es,pgxcs-kftvm2fn,0,0,0,0,0,0,PGX_AM_BS_DLBCL-mon-09,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:07.791000,0,36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aafe6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma [IG-MYC neg., 3q2 break neg., t(14;18) pos.]",PMID:8652842,"Monni O, Joensuu H et al. (1996): DNA copy number changes in diffuse...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgifc,P60Y,pgxind-kftx28eu,pgxcs-kftvm2g3,294551788,0.102,0,0,294551788,0.102,PGX_AM_BS_DLBCL-mon-10,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:07.792000,0,31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aafe7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma,PMID:8652842,"Monni O, Joensuu H et al. (1996): DNA copy number changes in diffuse...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgife,P59Y,pgxind-kftx28ew,pgxcs-kftvm2gl,0,0,0,0,0,0,PGX_AM_BS_DLBCL-mon-11,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:07.794000,0,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aafea,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma [IG-MYC neg., 3q2 break neg., t(14;18) neg.]",PMID:8652842,"Monni O, Joensuu H et al. (1996): DNA copy number changes in diffuse...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgifj,P51Y,pgxind-kftx28f2,pgxcs-kftvm2hy,452811618,0.157,170806150,0.059,282005468,0.098,PGX_AM_BS_DLBCL-mon-14,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:07.798000,0,59,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aaff1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma [IG-MYC neg., 3q2 break neg., t(14;18) neg.]",PMID:8652842,"Monni O, Joensuu H et al. (1996): DNA copy number changes in diffuse...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgifu,P59Y,pgxind-kftx28fg,pgxcs-kftvm2l8,775225642,0.27,310591039,0.108,464634603,0.162,PGX_AM_BS_DLBCL-mon-21,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:07.807000,0,125,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aaffa,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma,PMID:8652842,"Monni O, Joensuu H et al. (1996): DNA copy number changes in diffuse...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgig9,P71Y,pgxind-kftx28fy,pgxcs-kftvm2pe,464241622,0.161,220919955,0.077,243321667,0.085,PGX_AM_BS_DLBCL-mon-30,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:07.821000,0,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aaffb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma [IG-MYC neg., 3q2 break neg., t(14;18) pos.]",PMID:8652842,"Monni O, Joensuu H et al. (1996): DNA copy number changes in diffuse...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgigb,P39Y,pgxind-kftx28g0,pgxcs-kftvm2pu,185513940,0.065,0,0,185513940,0.065,PGX_AM_BS_DLBCL-mon-31,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:07.822000,0,72,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aaffc,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma,PMID:8652842,"Monni O, Joensuu H et al. (1996): DNA copy number changes in diffuse...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgigc,P37Y,pgxind-kftx28g1,pgxcs-kftvm2qb,230912752,0.08,127460263,0.044,103452489,0.036,PGX_AM_BS_DLBCL-mon-32,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:07.823000,0,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acefa,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsg6,P55Y,pgxind-kftx2krr,pgxcs-kftvp3p4,295412542,0.103,67678523,0.024,227734019,0.079,PGX_AM_BS_18765795_1004-mAdbID-77489,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:18.959000,0,80.6,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acefb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsg8,P54Y,pgxind-kftx2krt,pgxcs-kftvp3pl,99717851,0.035,57272467,0.02,42445384,0.015,PGX_AM_BS_18765795_1005-mAdbID-79582,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:18.960000,0,69.2,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acefd,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsgb,P67Y,pgxind-kftx2krx,pgxcs-kftvp3qk,998868996,0.347,697528257,0.243,301340739,0.105,PGX_AM_BS_18765795_1008-mAdbID-79581,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:18.963000,0,77.5,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acefe,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsgd,P59Y,pgxind-kftx2krz,pgxcs-kftvp3r1,685737154,0.239,297364326,0.103,388372828,0.135,PGX_AM_BS_18765795_1009-mAdbID-78202,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:18.964000,0,116.1,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf00,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsgg,P62Y,pgxind-kftx2ks3,pgxcs-kftvp3tk,1305683887,0.454,635790658,0.221,669893229,0.233,PGX_AM_BS_18765795_1021-mAdbID-78411,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:18.967000,0,175,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf0e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsh3,P79Y,pgxind-kftx2ksv,pgxcs-kftvp40b,127117859,0.044,47434760,0.016,79683099,0.028,PGX_AM_BS_18765795_1054-mAdbID-77583,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:18.987000,0,148,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf0f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsh5,P81Y,pgxind-kftx2ksy,pgxcs-kftvp40t,476313502,0.166,102049112,0.035,374264390,0.13,PGX_AM_BS_18765795_1055-mAdbID-75737,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:18.988000,0,93.7,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf12,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsha,P71Y,pgxind-kftx2kt4,pgxcs-kftvp428,232657008,0.081,130617374,0.045,102039634,0.035,PGX_AM_BS_18765795_1060-mAdbID-76800,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:18.992000,0,77.4,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf1a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgshn,,pgxind-kftx2ktk,pgxcs-kftvp462,383941485,0.134,211056888,0.073,172884597,0.06,PGX_AM_BS_18765795_2095-mAdbID-78309,{},-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.003000,0,11.5,,,,,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf1f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgshv,P42Y,pgxind-kftx2ktu,pgxcs-kftvp48g,422525885,0.147,346653119,0.121,75872766,0.026,PGX_AM_BS_18765795_528-mAdbID-76803,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.010000,0,19.6,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf22,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsi0,P76Y,pgxind-kftx2ku0,pgxcs-kftvp49v,388626228,0.135,130466107,0.045,258160121,0.09,PGX_AM_BS_18765795_434-mAdbID-76067,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.014000,0,126.3,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf23,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsi1,P35Y,pgxind-kftx2ku2,pgxcs-kftvp4ad,283206548,0.099,93209316,0.032,189997232,0.066,PGX_AM_BS_18765795_438-mAdbID-75916,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.016000,0,97.8,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf26,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsi6,P61Y,pgxind-kftx2ku8,pgxcs-kftvp4bs,47998637,0.017,15693577,0.005,32305060,0.011,PGX_AM_BS_18765795_449-mAdbID-76594,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.020000,0,109.9,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf28,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsia,P78Y,pgxind-kftx2kuc,pgxcs-kftvp4cq,239829186,0.083,67738906,0.024,172090280,0.06,PGX_AM_BS_18765795_459-mAdbID-75917,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.023000,0,115.8,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf29,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsib,P74Y,pgxind-kftx2kue,pgxcs-kftvp4d7,138989659,0.048,65359201,0.023,73630458,0.026,PGX_AM_BS_18765795_460-mAdbID-76805,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.024000,0,108.2,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf2b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsie,P42Y,pgxind-kftx2kui,pgxcs-kftvp4e6,394948726,0.137,247249272,0.086,147699454,0.051,PGX_AM_BS_18765795_470-mAdbID-76074,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.027000,0,134,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf2d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsii,P70Y,pgxind-kftx2kum,pgxcs-kftvp4f4,76713908,0.027,76265356,0.027,448552,0,PGX_AM_BS_18765795_479-mAdbID-76128,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.030000,0,86.8,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf2e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsik,P49Y,pgxind-kftx2kuo,pgxcs-kftvp4fl,15553335,0.005,14893612,0.005,659723,0,PGX_AM_BS_18765795_481-mAdbID-75320,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.031000,0,129,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf2f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsil,P68Y,pgxind-kftx2kuq,pgxcs-kftvp4g2,526982112,0.183,263612600,0.092,263369512,0.092,PGX_AM_BS_18765795_482-mAdbID-75288,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.032000,0,92.6,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf31,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsio,P60Y,pgxind-kftx2kuv,pgxcs-kftvp4h0,12004762,0.004,12004762,0.004,0,0,PGX_AM_BS_18765795_492-mAdbID-76068,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.035000,0,135.4,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf33,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsir,P49Y,pgxind-kftx2kuz,pgxcs-kftvp4hz,757932001,0.264,527851944,0.184,230080057,0.08,PGX_AM_BS_18765795_523-mAdbID-78410,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.038000,0,100.3,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf34,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsit,P60Y,pgxind-kftx2kv1,pgxcs-kftvp4ig,334409794,0.116,279308161,0.097,55101633,0.019,PGX_AM_BS_18765795_524-mAdbID-76742,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.039000,0,70.5,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf35,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsiv,P56Y,pgxind-kftx2kv3,pgxcs-kftvp4ix,1785784098,0.621,940588113,0.327,845195985,0.294,PGX_AM_BS_18765795_428-mAdbID-75500,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.041000,0,136.5,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf39,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsj1,P59Y,pgxind-kftx2kva,pgxcs-kftvp4ku,1128795481,0.393,755953013,0.263,372842468,0.13,PGX_AM_BS_18765795_541-mAdbID-75279,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.047000,0,49.3,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf3a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsj3,P71Y,pgxind-kftx2kvc,pgxcs-kftvp4lb,181865045,0.063,172262487,0.06,9602558,0.003,PGX_AM_BS_18765795_543-mAdbID-76130,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.048000,0,41.6,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf3f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsjb,P44Y,pgxind-kftx2kvk,pgxcs-kftvp4nq,784609074,0.273,197792373,0.069,586816701,0.204,PGX_AM_BS_18765795_550-mAdbID-76073,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.055000,0,261.3,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf42,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsjg,P56Y,pgxind-kftx2kvq,pgxcs-kftvp4p8,87802938,0.031,38325410,0.013,49477528,0.017,PGX_AM_BS_18765795_572-mAdbID-76911,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.060000,0,170.8,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf43,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsjh,P14Y,pgxind-kftx2kvs,pgxcs-kftvp4pp,169151771,0.059,81444375,0.028,87707396,0.031,PGX_AM_BS_18765795_577-mAdbID-79259,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.061000,0,19.8,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf44,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsjj,P46Y,pgxind-kftx2kvu,pgxcs-kftvp4q7,396425577,0.138,46204899,0.016,350220678,0.122,PGX_AM_BS_18765795_615-mAdbID-79255,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.062000,0,59.2,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf46,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsjn,P59Y,pgxind-kftx2kvy,pgxcs-kftvp4r5,281363628,0.098,278752348,0.097,2611280,0.001,PGX_AM_BS_18765795_617-mAdbID-77180,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.065000,0,70.5,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf47,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsjo,P47Y,pgxind-kftx2kw0,pgxcs-kftvp4rn,790018235,0.275,403662176,0.14,386356059,0.134,PGX_AM_BS_18765795_618-mAdbID-78972,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.066000,0,67.8,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf48,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsjq,P50Y,pgxind-kftx2kw2,pgxcs-kftvp4s4,454757929,0.158,254077544,0.088,200680385,0.07,PGX_AM_BS_18765795_619-mAdbID-76957,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.068000,0,105.1,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf49,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsjr,P45Y,pgxind-kftx2kw4,pgxcs-kftvp4sm,81078485,0.028,10930192,0.004,70148293,0.024,PGX_AM_BS_18765795_625-mAdbID-76914,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.069000,0,62.8,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf4c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsjw,P45Y,pgxind-kftx2kwa,pgxcs-kftvp4u2,424888980,0.148,128258404,0.045,296630576,0.103,PGX_AM_BS_18765795_633-mAdbID-75262,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.073000,0,24.2,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf53,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsk8,P72Y,pgxind-kftx2kwn,pgxcs-kftvp4xj,97347387,0.034,78604383,0.027,18743004,0.007,PGX_AM_BS_18765795_661-mAdbID-76220,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.084000,0,6.7,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf56,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgskd,P42Y,pgxind-kftx2kwt,pgxcs-kftvp4yz,254118525,0.088,180235440,0.063,73883085,0.026,PGX_AM_BS_18765795_668-mAdbID-74260,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.088000,0,77.2,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf57,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgskf,P64Y,pgxind-kftx2kwu,pgxcs-kftvp4zg,189604383,0.066,131853273,0.046,57751110,0.02,PGX_AM_BS_18765795_669-mAdbID-76219,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.089000,0,85.3,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf58,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgskg,P67Y,pgxind-kftx2kww,pgxcs-kftvp51i,37024541,0.013,30336230,0.011,6688311,0.002,PGX_AM_BS_18765795_671-mAdbID-76655,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.090000,0,40.2,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf59,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgski,P75Y,pgxind-kftx2kwx,pgxcs-kftvp520,590493335,0.205,96873311,0.034,493620024,0.172,PGX_AM_BS_18765795_672-mAdbID-76076,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.092000,0,81.3,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf5a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgskk,P72Y,pgxind-kftx2kwz,pgxcs-kftvp52h,120019301,0.042,44843541,0.016,75175760,0.026,PGX_AM_BS_18765795_674-mAdbID-79260,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.093000,0,86.6,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf5d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgskp,P69Y,pgxind-kftx2kx5,pgxcs-kftvp53x,206082783,0.072,86744940,0.03,119337843,0.042,PGX_AM_BS_18765795_681-mAdbID-76254,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.097000,0,116.4,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf63,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgskz,P26Y,pgxind-kftx2kxf,pgxcs-kftvp56s,246020957,0.086,214932377,0.075,31088580,0.011,PGX_AM_BS_18765795_692-mAdbID-78975,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.106000,0,126.3,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf64,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsl0,P46Y,pgxind-kftx2kxh,pgxcs-kftvp579,506977280,0.176,236027756,0.082,270949524,0.094,PGX_AM_BS_18765795_694-mAdbID-75281,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.107000,0,57.9,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf66,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsl3,P88Y,pgxind-kftx2kxl,pgxcs-kftvp588,422628085,0.147,293515336,0.102,129112749,0.045,PGX_AM_BS_18765795_698-mAdbID-77181,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.110000,0,46.5,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf68,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsl7,P52Y,pgxind-kftx2kxp,pgxcs-kftvp596,239467511,0.083,238838830,0.083,628681,0,PGX_AM_BS_18765795_701-mAdbID-76253,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.112000,0,46.8,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf6a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsla,P56Y,pgxind-kftx2kxt,pgxcs-kftvp5a5,561144531,0.195,214676939,0.075,346467592,0.121,PGX_AM_BS_18765795_704-mAdbID-79256,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.115000,0,116,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf6d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgslf,P47Y,pgxind-kftx2kxz,pgxcs-kftvp5bl,966169542,0.336,364002137,0.127,602167405,0.209,PGX_AM_BS_18765795_795-mAdbID-76131,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.120000,0,41.1,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf71,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsll,P60Y,pgxind-kftx2ky7,pgxcs-kftvp5dh,206043762,0.072,171434893,0.06,34608869,0.012,PGX_AM_BS_18765795_722-mAdbID-76251,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.125000,0,39.8,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf74,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgslq,P81Y,pgxind-kftx2kyd,pgxcs-kftvp5ex,823915880,0.287,538078098,0.187,285837782,0.099,PGX_AM_BS_18765795_726-mAdbID-75501,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.129000,0,91.4,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf76,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgslu,P56Y,pgxind-kftx2kyg,pgxcs-kftvp5fw,191257355,0.067,102611744,0.036,88645611,0.031,PGX_AM_BS_18765795_731-mAdbID-78100,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.132000,0,122.1,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf77,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgslv,P72Y,pgxind-kftx2kyi,pgxcs-kftvp5gd,387851524,0.135,242356260,0.084,145495264,0.051,PGX_AM_BS_18765795_742-mAdbID-78183,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.133000,0,49,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf78,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgslx,P39Y,pgxind-kftx2kyk,pgxcs-kftvp5gu,242330372,0.084,29483019,0.01,212847353,0.074,PGX_AM_BS_18765795_744-mAdbID-78101,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.135000,0,106.3,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf79,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsly,P66Y,pgxind-kftx2kym,pgxcs-kftvp5hc,847705190,0.295,424851888,0.148,422853302,0.147,PGX_AM_BS_18765795_747-mAdbID-76908,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.136000,0,184.9,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf7b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsm2,P43Y,pgxind-kftx2kyq,pgxcs-kftvp5ia,227665689,0.079,142264682,0.049,85401007,0.03,PGX_AM_BS_18765795_751-mAdbID-76912,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.139000,0,119.8,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf7d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsm5,P36Y,pgxind-kftx2kyu,pgxcs-kftvp5j9,633866227,0.22,414181108,0.144,219685119,0.076,PGX_AM_BS_18765795_756-mAdbID-75503,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.142000,0,86.5,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf7f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsm8,P45Y,pgxind-kftx2kyy,pgxcs-kftvp5k7,495083476,0.172,384472170,0.134,110611306,0.038,PGX_AM_BS_18765795_836-mAdbID-77487,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.145000,0,51.4,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf88,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsmn,P61Y,pgxind-kftx2kzg,pgxcs-kftvp5om,285585634,0.099,139573561,0.049,146012073,0.051,PGX_AM_BS_18765795_810-mAdbID-76069,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.157000,0,140.6,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf8d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsmv,P65Y,pgxind-kftx2kzq,pgxcs-kftvp5r0,174599965,0.061,45982564,0.016,128617401,0.045,PGX_AM_BS_18765795_821-mAdbID-77468,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.164000,0,113.6,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf90,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsn1,P32Y,pgxind-kftx2kzw,pgxcs-kftvp5sg,661995012,0.23,646250826,0.225,15744186,0.005,PGX_AM_BS_18765795_832-mAdbID-77486,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.168000,0,48.1,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf93,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsn6,P66Y,pgxind-kftx2l02,pgxcs-kftvp5tw,0,0,0,0,0,0,PGX_AM_BS_18765795_772-mAdbID-76910,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.172000,0,29.7,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf96,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsna,P52Y,pgxind-kftx2l08,pgxcs-kftvp5vb,201657817,0.07,146070856,0.051,55586961,0.019,PGX_AM_BS_18765795_840-mAdbID-77559,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.176000,0,40.8,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf97,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsnc,P62Y,pgxind-kftx2l0a,pgxcs-kftvp5vs,46332126,0.016,5221626,0.002,41110500,0.014,PGX_AM_BS_18765795_841-mAdbID-75277,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.178000,0,121.6,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf98,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsne,P80Y,pgxind-kftx2l0c,pgxcs-kftvp5w9,511469578,0.178,73912271,0.026,437557307,0.152,PGX_AM_BS_18765795_847-mAdbID-77182,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.179000,0,49.9,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf9a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsnh,P72Y,pgxind-kftx2l0g,pgxcs-kftvp5x8,8384186,0.003,8384186,0.003,0,0,PGX_AM_BS_18765795_855-mAdbID-77561,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.182000,0,20,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf9e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsnn,P56Y,pgxind-kftx2l0o,pgxcs-kftvp5z5,645822163,0.225,307560427,0.107,338261736,0.118,PGX_AM_BS_18765795_872-mAdbID-75436,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.187000,0,60,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acfa0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsnr,P50Y,pgxind-kftx2l0s,pgxcs-kftvp604,574575354,0.2,196189435,0.068,378385919,0.132,PGX_AM_BS_18765795_875-mAdbID-75497,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.190000,0,101.4,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acfa1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsns,P45Y,pgxind-kftx2l0u,pgxcs-kftvp60l,55841205,0.019,6032184,0.002,49809021,0.017,PGX_AM_BS_18765795_912-mAdbID-79315,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.192000,0,201.4,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acfa2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsnu,P50Y,pgxind-kftx2l0w,pgxcs-kftvp612,17160871,0.006,1485510,0.001,15675361,0.005,PGX_AM_BS_18765795_995-mAdbID-78207,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.193000,0,79.8,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ade1c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma, NOS",PMID:17170743,"Berglund M, Enblad G et al. (2007): Genomic imbalances during transformation from follicular...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxb2,P50Y,pgxind-kftx2qtu,pgxcs-kftvqlw4,0,0,0,0,0,0,PGX_AM_BS_TF-FCL-ber-03,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.322000,0,97,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ade23,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma, NOS",PMID:17170743,"Berglund M, Enblad G et al. (2007): Genomic imbalances during transformation from follicular...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxbd,P51Y,pgxind-kftx2qu8,pgxcs-kftvqlzh,267867142,0.093,115717269,0.04,152149873,0.053,PGX_AM_BS_TF-FCL-ber-10,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.331000,0,129,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afccc,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma, T-Cell/Histiocyte-Rich [stage IA]",PMID:12414532,"Franke S, Wlodarska I et al. (2002): Comparative genomic hybridization pattern distinguishes T-cell/histiocyte-rich...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh7gk,P53Y,pgxind-kftx333h,pgxcs-kftvtnut,83200082,0.029,0,0,83200082,0.029,PGX_AM_BS_THRBNHL-01,,4.7,50.88,Point,BEL,Leuven,Belgium,"Leuven, Belgium",50.88,4.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:35.588000,0,112,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afcce,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma, T-Cell/Histiocyte-Rich [stage IIB]",PMID:12414532,"Franke S, Wlodarska I et al. (2002): Comparative genomic hybridization pattern distinguishes T-cell/histiocyte-rich...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh7gn,P16Y,pgxind-kftx333l,pgxcs-kftvtnvr,227713982,0.079,177113931,0.062,50600051,0.018,PGX_AM_BS_THRBNHL-03,,4.7,50.88,Point,BEL,Leuven,Belgium,"Leuven, Belgium",50.88,4.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:35.591000,0,89,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00afcd2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma, T-Cell/Histiocyte-Rich [stage IIIA]",PMID:12414532,"Franke S, Wlodarska I et al. (2002): Comparative genomic hybridization pattern distinguishes T-cell/histiocyte-rich...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh7gu,P30Y,pgxind-kftx333t,pgxcs-kftvtnxn,182288679,0.063,78774821,0.027,103513858,0.036,PGX_AM_BS_THRBNHL-07,,4.7,50.88,Point,BEL,Leuven,Belgium,"Leuven, Belgium",50.88,4.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:35.596000,0,34,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afcd3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma, T-Cell/Histiocyte-Rich [stage IVA]",PMID:12414532,"Franke S, Wlodarska I et al. (2002): Comparative genomic hybridization pattern distinguishes T-cell/histiocyte-rich...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh7gv,P31Y,pgxind-kftx333v,pgxcs-kftvtny5,140600139,0.049,0,0,140600139,0.049,PGX_AM_BS_THRBNHL-08,,4.7,50.88,Point,BEL,Leuven,Belgium,"Leuven, Belgium",50.88,4.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:35.597000,0,30,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afcd5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma, T-Cell/Histiocyte-Rich [stage IVB]",PMID:12414532,"Franke S, Wlodarska I et al. (2002): Comparative genomic hybridization pattern distinguishes T-cell/histiocyte-rich...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh7gz,P31Y,pgxind-kftx333z,pgxcs-kftvtnz3,146836111,0.051,0,0,146836111,0.051,PGX_AM_BS_THRBNHL-10,,4.7,50.88,Point,BEL,Leuven,Belgium,"Leuven, Belgium",50.88,4.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:35.600000,0,17,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afcdb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma, T-Cell/Histiocyte-Rich [stage IVB]",PMID:12414532,"Franke S, Wlodarska I et al. (2002): Comparative genomic hybridization pattern distinguishes T-cell/histiocyte-rich...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh7h8,P55Y,pgxind-kftx334b,pgxcs-kftvto1z,205400203,0.071,0,0,205400203,0.071,PGX_AM_BS_THRBNHL-16,,4.7,50.88,Point,BEL,Leuven,Belgium,"Leuven, Belgium",50.88,4.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:35.608000,0,59,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aafe0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma [IG-MYC neg., 3q2 break neg., t(14;18) neg.]",PMID:8652842,"Monni O, Joensuu H et al. (1996): DNA copy number changes in diffuse...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgif2,P38Y,pgxind-kftx28ej,pgxcs-kftvm2db,323414077,0.112,63400064,0.022,260014013,0.09,PGX_AM_BS_DLBCL-mon-03,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:07.784000,1,51,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aafe8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma [IG-MYC neg., 3q2 break maybe, t(14;18) neg.]",PMID:8652842,"Monni O, Joensuu H et al. (1996): DNA copy number changes in diffuse...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgiff,P84Y,pgxind-kftx28ey,pgxcs-kftvm2h1,381262815,0.133,0,0,381262815,0.133,PGX_AM_BS_DLBCL-mon-12,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:07.795000,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aafe9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma [IG-MYC neg., 3q2 break neg., t(14;18) neg.]",PMID:8652842,"Monni O, Joensuu H et al. (1996): DNA copy number changes in diffuse...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgifh,P71Y,pgxind-kftx28f0,pgxcs-kftvm2hi,0,0,0,0,0,0,PGX_AM_BS_DLBCL-mon-13,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:07.796000,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aafec,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma [IG-MYC neg., 3q2 break neg., t(14;18) neg]",PMID:8652842,"Monni O, Joensuu H et al. (1996): DNA copy number changes in diffuse...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgifm,P64Y,pgxind-kftx28f6,pgxcs-kftvm2iv,708206121,0.246,0,0,708206121,0.246,PGX_AM_BS_DLBCL-mon-16,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:07.801000,1,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aaff0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma,PMID:8652842,"Monni O, Joensuu H et al. (1996): DNA copy number changes in diffuse...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgifs,P62Y,pgxind-kftx28fe,pgxcs-kftvm2kr,0,0,0,0,0,0,PGX_AM_BS_DLBCL-mon-20,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:07.806000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aaff2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse Large B-cell Lymphoma [extranodal, skin, 3q2 break neg., t[14;18] neg.]",PMID:8652842,"Monni O, Joensuu H et al. (1996): DNA copy number changes in diffuse...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgifw,P59Y,pgxind-kftx28fi,pgxcs-kftvm2lo,572721670,0.199,73200074,0.025,499521596,0.174,PGX_AM_BS_DLBCL-mon-22,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:07.809000,1,36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aaff6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma [IG-MYC neg., 3q2 break neg., t(14;18) neg.]",PMID:8652842,"Monni O, Joensuu H et al. (1996): DNA copy number changes in diffuse...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgig2,P77Y,pgxind-kftx28fq,pgxcs-kftvm2nj,968962240,0.337,171500171,0.06,797462069,0.277,PGX_AM_BS_DLBCL-mon-26,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:07.815000,1,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aaff7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma [IG-MYC neg., 3q2 break neg., t(14;18) neg.]",PMID:8652842,"Monni O, Joensuu H et al. (1996): DNA copy number changes in diffuse...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgig4,P37Y,pgxind-kftx28fs,pgxcs-kftvm2o0,0,0,0,0,0,0,PGX_AM_BS_DLBCL-mon-27,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:07.816000,1,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aaff8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma,PMID:8652842,"Monni O, Joensuu H et al. (1996): DNA copy number changes in diffuse...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgig5,P36Y,pgxind-kftx28fu,pgxcs-kftvm2og,458353127,0.159,193439109,0.067,264914018,0.092,PGX_AM_BS_DLBCL-mon-28,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:07.818000,1,49,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aaff9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma [IG-MYC neg., 3q2 break neg., t(14;18) pos.]",PMID:8652842,"Monni O, Joensuu H et al. (1996): DNA copy number changes in diffuse...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgig7,P54Y,pgxind-kftx28fw,pgxcs-kftvm2ox,1003189038,0.349,91700091,0.032,911488947,0.317,PGX_AM_BS_DLBCL-mon-29,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:07.819000,1,14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acef8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsg3,P70Y,pgxind-kftx2krn,pgxcs-kftvp3o6,1173412364,0.408,532483338,0.185,640929026,0.223,PGX_AM_BS_18765795_1000-mAdbID-77578,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:18.956000,1,8.2,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acef9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsg5,P83Y,pgxind-kftx2krp,pgxcs-kftvp3on,108356684,0.038,77161452,0.027,31195232,0.011,PGX_AM_BS_18765795_1001-mAdbID-79316,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:18.957000,1,3.9,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acefc,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsg9,P70Y,pgxind-kftx2krv,pgxcs-kftvp3q2,616882272,0.215,53188671,0.019,563693601,0.196,PGX_AM_BS_18765795_1007-mAdbID-77563,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:18.962000,1,27.1,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00aceff,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsge,P59Y,pgxind-kftx2ks1,pgxcs-kftvp3rj,89783101,0.031,45445115,0.016,44337986,0.015,PGX_AM_BS_18765795_1018-mAdbID-77490,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:18.966000,1,0.3,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf01,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsgi,P65Y,pgxind-kftx2ks5,pgxcs-kftvp3u2,1563208708,0.544,691745629,0.241,871463079,0.303,PGX_AM_BS_18765795_1023-mAdbID-77576,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:18.969000,1,66.8,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf02,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsgj,P55Y,pgxind-kftx2ks7,pgxcs-kftvp3uk,686825628,0.239,376824433,0.131,310001195,0.108,PGX_AM_BS_18765795_1026-mAdbID-79355,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:18.970000,1,83.2,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf03,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsgl,P57Y,pgxind-kftx2ks9,pgxcs-kftvp3v2,497285553,0.173,431410274,0.15,65875279,0.023,PGX_AM_BS_18765795_1027-mAdbID-79526,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:18.971000,1,3,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf04,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsgn,P77Y,pgxind-kftx2ksb,pgxcs-kftvp3vj,607223214,0.211,144593786,0.05,462629428,0.161,PGX_AM_BS_18765795_1031-mAdbID-75735,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:18.973000,1,79.6,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf05,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsgo,P63Y,pgxind-kftx2ksd,pgxcs-kftvp3w0,979422506,0.341,153868516,0.054,825553990,0.287,PGX_AM_BS_18765795_1034-mAdbID-75267,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:18.974000,1,27.7,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf06,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsgq,P54Y,pgxind-kftx2ksf,pgxcs-kftvp3wi,227955142,0.079,30038397,0.01,197916745,0.069,PGX_AM_BS_18765795_1037-mAdbID-78182,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:18.976000,1,2.7,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf07,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsgs,P41Y,pgxind-kftx2ksh,pgxcs-kftvp3wz,75092291,0.026,75092291,0.026,0,0,PGX_AM_BS_18765795_1038-mAdbID-75915,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:18.977000,1,8.5,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf08,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsgt,P49Y,pgxind-kftx2ksj,pgxcs-kftvp3xg,1065717608,0.371,575216282,0.2,490501326,0.171,PGX_AM_BS_18765795_1039-mAdbID-79524,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:18.979000,1,24.6,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf09,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsgv,P59Y,pgxind-kftx2ksl,pgxcs-kftvp3xx,7938718,0.003,2540893,0.001,5397825,0.002,PGX_AM_BS_18765795_1041-mAdbID-79521,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:18.980000,1,37.5,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf0a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsgx,P63Y,pgxind-kftx2ksn,pgxcs-kftvp3yf,287744428,0.1,86644263,0.03,201100165,0.07,PGX_AM_BS_18765795_1043-mAdbID-75736,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:18.981000,1,27.7,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf0b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsgy,P60Y,pgxind-kftx2ksp,pgxcs-kftvp3yw,147420359,0.051,71335652,0.025,76084707,0.026,PGX_AM_BS_18765795_1045-mAdbID-75524,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:18.983000,1,27.1,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf0c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsh0,P78Y,pgxind-kftx2ksr,pgxcs-kftvp3zc,0,0,0,0,0,0,PGX_AM_BS_18765795_1049-mAdbID-79523,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:18.984000,1,15.9,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf0d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsh1,P66Y,pgxind-kftx2kst,pgxcs-kftvp3zu,310000265,0.108,170000940,0.059,139999325,0.049,PGX_AM_BS_18765795_1051-mAdbID-78075,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:18.985000,1,1.4,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf10,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsh6,P77Y,pgxind-kftx2kt0,pgxcs-kftvp41a,380026604,0.132,232641845,0.081,147384759,0.051,PGX_AM_BS_18765795_1057-mAdbID-75493,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:18.989000,1,25.5,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf11,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsh8,P67Y,pgxind-kftx2kt2,pgxcs-kftvp41r,103111693,0.036,82336151,0.029,20775542,0.007,PGX_AM_BS_18765795_1059-mAdbID-79527,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:18.991000,1,24,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf13,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgshb,P74Y,pgxind-kftx2kt6,pgxcs-kftvp42q,1397119323,0.486,992205655,0.345,404913668,0.141,PGX_AM_BS_18765795_1061-mAdbID-75286,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:18.994000,1,12.4,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf14,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgshd,,pgxind-kftx2kt8,pgxcs-kftvp437,755094118,0.263,273132682,0.095,481961436,0.168,PGX_AM_BS_18765795_1946-mAdbID-78414,{},-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:18.995000,1,8.1,,,,,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf15,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgshe,,pgxind-kftx2kta,pgxcs-kftvp43p,253129473,0.088,135432323,0.047,117697150,0.041,PGX_AM_BS_18765795_1990-mAdbID-78314,{},-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:18.996000,1,0.7,,,,,,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf16,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgshg,,pgxind-kftx2ktc,pgxcs-kftvp446,149685156,0.052,138248930,0.048,11436226,0.004,PGX_AM_BS_18765795_1991-mAdbID-78312,{},-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:18.998000,1,12,,,,,,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf17,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgshi,,pgxind-kftx2kte,pgxcs-kftvp44n,485055418,0.169,181778742,0.063,303276676,0.105,PGX_AM_BS_18765795_1994-mAdbID-79531,{},-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:18.999000,1,14.4,,,,,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf18,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgshj,,pgxind-kftx2ktg,pgxcs-kftvp454,378203808,0.132,365095166,0.127,13108642,0.005,PGX_AM_BS_18765795_2001-mAdbID-78412,{},-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.001000,1,15.7,,,,,,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf19,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgshl,,pgxind-kftx2kti,pgxcs-kftvp45l,138873345,0.048,385547,0,138487798,0.048,PGX_AM_BS_18765795_2018-mAdbID-79533,{},-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.002000,1,1.9,,,,,,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf1b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsho,P45Y,pgxind-kftx2ktm,pgxcs-kftvp46j,826337154,0.287,372292881,0.129,454044273,0.158,PGX_AM_BS_18765795_413-mAdbID-75283,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.005000,1,7.2,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf1c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgshq,P85Y,pgxind-kftx2kto,pgxcs-kftvp470,225704363,0.079,107088431,0.037,118615932,0.041,PGX_AM_BS_18765795_415-mAdbID-76072,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.006000,1,64.5,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf1d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgshr,P58Y,pgxind-kftx2ktq,pgxcs-kftvp47i,84919598,0.03,84919598,0.03,0,0,PGX_AM_BS_18765795_421-mAdbID-76070,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.007000,1,14.8,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf1e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsht,P70Y,pgxind-kftx2kts,pgxcs-kftvp47z,505833176,0.176,452204009,0.157,53629167,0.019,PGX_AM_BS_18765795_424-mAdbID-76071,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.009000,1,127.4,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf20,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgshx,P64Y,pgxind-kftx2ktw,pgxcs-kftvp48x,830934332,0.289,351938875,0.122,478995457,0.167,PGX_AM_BS_18765795_432-mAdbID-78974,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.012000,1,4.5,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf21,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgshy,P32Y,pgxind-kftx2kty,pgxcs-kftvp49e,33943964,0.012,15471713,0.005,18472251,0.006,PGX_AM_BS_18765795_433-mAdbID-76075,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.013000,1,9.1,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf25,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsi5,P71Y,pgxind-kftx2ku6,pgxcs-kftvp4bb,660554998,0.23,365704508,0.127,294850490,0.103,PGX_AM_BS_18765795_446-mAdbID-75495,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.019000,1,33.8,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf27,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsi8,P52Y,pgxind-kftx2kua,pgxcs-kftvp4c9,377259936,0.131,119477329,0.042,257782607,0.09,PGX_AM_BS_18765795_458-mAdbID-76915,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.022000,1,14.1,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf2a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsid,P69Y,pgxind-kftx2kug,pgxcs-kftvp4dp,81415722,0.028,3963351,0.001,77452371,0.027,PGX_AM_BS_18765795_462-mAdbID-75434,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.026000,1,89.8,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf2c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsig,P35Y,pgxind-kftx2kuk,pgxcs-kftvp4en,227669967,0.079,116898525,0.041,110771442,0.039,PGX_AM_BS_18765795_477-mAdbID-75273,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.028000,1,20.4,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf30,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsin,P65Y,pgxind-kftx2kut,pgxcs-kftvp4gj,223800964,0.078,127304767,0.044,96496197,0.034,PGX_AM_BS_18765795_491-mAdbID-76802,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.034000,1,53.6,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf32,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsiq,P79Y,pgxind-kftx2kux,pgxcs-kftvp4hi,767003879,0.267,405313628,0.141,361690251,0.126,PGX_AM_BS_18765795_517-mAdbID-76127,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.037000,1,36.3,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf36,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsiw,P58Y,pgxind-kftx2kv5,pgxcs-kftvp4jf,233643726,0.081,39186785,0.014,194456941,0.068,PGX_AM_BS_18765795_529-mAdbID-76126,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.042000,1,12.7,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf37,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsiy,P62Y,pgxind-kftx2kv6,pgxcs-kftvp4jw,133606122,0.046,51810764,0.018,81795358,0.028,PGX_AM_BS_18765795_533-mAdbID-76129,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.044000,1,8.5,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf38,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsj0,P75Y,pgxind-kftx2kv8,pgxcs-kftvp4kd,201189147,0.07,42154789,0.015,159034358,0.055,PGX_AM_BS_18765795_538-mAdbID-75280,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.045000,1,4,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf3b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsj4,P73Y,pgxind-kftx2kve,pgxcs-kftvp4lt,166541518,0.058,162512873,0.057,4028645,0.001,PGX_AM_BS_18765795_544-mAdbID-75282,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.049000,1,15.7,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf3c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsj6,P73Y,pgxind-kftx2kvg,pgxcs-kftvp4ma,137099049,0.048,55659219,0.019,81439830,0.028,PGX_AM_BS_18765795_545-mAdbID-76132,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.051000,1,13.2,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf3d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsj8,P18Y,pgxind-kftx2kvh,pgxcs-kftvp4mr,106793219,0.037,105926757,0.037,866462,0,PGX_AM_BS_18765795_547-mAdbID-75274,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.052000,1,0.6,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf3e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsj9,P52Y,pgxind-kftx2kvi,pgxcs-kftvp4n9,804011868,0.28,138065420,0.048,665946448,0.232,PGX_AM_BS_18765795_549-mAdbID-76656,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.054000,1,32.1,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf40,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsjd,P75Y,pgxind-kftx2kvm,pgxcs-kftvp4o8,400264965,0.139,147382379,0.051,252882586,0.088,PGX_AM_BS_18765795_553-mAdbID-76741,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.057000,1,9.8,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf41,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsje,P47Y,pgxind-kftx2kvo,pgxcs-kftvp4or,294812527,0.103,9893470,0.003,284919057,0.099,PGX_AM_BS_18765795_565-mAdbID-76909,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.058000,1,109.3,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf45,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsjl,P72Y,pgxind-kftx2kvw,pgxcs-kftvp4qo,582670731,0.203,194388191,0.068,388282540,0.135,PGX_AM_BS_18765795_616-mAdbID-75502,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.064000,1,11.8,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf4a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsjt,P80Y,pgxind-kftx2kw6,pgxcs-kftvp4t3,6783377,0.002,6353250,0.002,430127,0,PGX_AM_BS_18765795_626-mAdbID-79261,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.070000,1,29.8,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf4b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsjv,P76Y,pgxind-kftx2kw8,pgxcs-kftvp4tl,22269865,0.008,18987464,0.007,3282401,0.001,PGX_AM_BS_18765795_627-mAdbID-76956,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.072000,1,15.2,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf4d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsjy,P76Y,pgxind-kftx2kwc,pgxcs-kftvp4uk,1757337277,0.611,1122190479,0.39,635146798,0.221,PGX_AM_BS_18765795_642-mAdbID-75270,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.075000,1,4,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf4e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsk0,P74Y,pgxind-kftx2kwe,pgxcs-kftvp4v2,345725947,0.12,206076176,0.072,139649771,0.049,PGX_AM_BS_18765795_644-mAdbID-75271,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.076000,1,3.7,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf4f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsk2,P41Y,pgxind-kftx2kwg,pgxcs-kftvp4vk,167951418,0.058,126136004,0.044,41815414,0.015,PGX_AM_BS_18765795_645-mAdbID-75285,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.078000,1,72.9,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf50,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsk3,P74Y,pgxind-kftx2kwh,pgxcs-kftvp4w1,714494471,0.249,234984019,0.082,479510452,0.167,PGX_AM_BS_18765795_646-mAdbID-75511,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.079000,1,31,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf51,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsk5,P72Y,pgxind-kftx2kwj,pgxcs-kftvp4wj,198713405,0.069,22747877,0.008,175965528,0.061,PGX_AM_BS_18765795_652-mAdbID-75138,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.081000,1,0.1,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf52,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsk6,P84Y,pgxind-kftx2kwl,pgxcs-kftvp4x1,412904647,0.144,125552268,0.044,287352379,0.1,PGX_AM_BS_18765795_660-mAdbID-75192,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.082000,1,2.4,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf54,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgska,P39Y,pgxind-kftx2kwp,pgxcs-kftvp4y0,574518274,0.2,98183093,0.034,476335181,0.166,PGX_AM_BS_18765795_663-mAdbID-75193,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.085000,1,7.4,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf55,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgskb,P58Y,pgxind-kftx2kwr,pgxcs-kftvp4yi,0,0,0,0,0,0,PGX_AM_BS_18765795_664-mAdbID-76913,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.086000,1,7.4,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf5b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgskl,P64Y,pgxind-kftx2kx1,pgxcs-kftvp52y,213946338,0.074,81932410,0.028,132013928,0.046,PGX_AM_BS_18765795_676-mAdbID-75194,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.095000,1,12,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf5c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgskn,P77Y,pgxind-kftx2kx3,pgxcs-kftvp53f,1019235017,0.355,812559693,0.283,206675324,0.072,PGX_AM_BS_18765795_678-mAdbID-75510,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.096000,1,0.7,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf5e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgskq,P79Y,pgxind-kftx2kx6,pgxcs-kftvp54e,2507192,0.001,1567538,0.001,939654,0,PGX_AM_BS_18765795_682-mAdbID-76654,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.099000,1,1.3,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf5f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsks,P56Y,pgxind-kftx2kx8,pgxcs-kftvp54v,507963776,0.177,49790942,0.017,458172834,0.159,PGX_AM_BS_18765795_684-mAdbID-76690,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.100000,1,23,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf60,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgskt,P62Y,pgxind-kftx2kxa,pgxcs-kftvp55c,1038346025,0.361,719741690,0.25,318604335,0.111,PGX_AM_BS_18765795_687-mAdbID-75195,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.101000,1,11.2,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf61,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgskv,P84Y,pgxind-kftx2kxb,pgxcs-kftvp55u,186037589,0.065,89058310,0.031,96979279,0.034,PGX_AM_BS_18765795_688-mAdbID-76907,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.103000,1,3.9,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf62,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgskx,P76Y,pgxind-kftx2kxd,pgxcs-kftvp56b,723476275,0.252,552767745,0.192,170708530,0.059,PGX_AM_BS_18765795_689-mAdbID-75196,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.104000,1,30.4,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf65,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsl2,P72Y,pgxind-kftx2kxj,pgxcs-kftvp57r,58786985,0.02,39527143,0.014,19259842,0.007,PGX_AM_BS_18765795_695-mAdbID-76252,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.108000,1,1.8,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf67,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsl5,P67Y,pgxind-kftx2kxn,pgxcs-kftvp58p,68458424,0.024,48861110,0.017,19597314,0.007,PGX_AM_BS_18765795_700-mAdbID-75491,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.111000,1,64.8,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf69,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsl8,P70Y,pgxind-kftx2kxr,pgxcs-kftvp59n,98725671,0.034,98725671,0.034,0,0,PGX_AM_BS_18765795_702-mAdbID-75490,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.114000,1,49.5,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf6b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgslb,P64Y,pgxind-kftx2kxv,pgxcs-kftvp5am,846812218,0.295,510396569,0.178,336415649,0.117,PGX_AM_BS_18765795_709-mAdbID-75276,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.117000,1,5.6,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf6c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsld,P60Y,pgxind-kftx2kxx,pgxcs-kftvp5b3,885543057,0.308,511910567,0.178,373632490,0.13,PGX_AM_BS_18765795_710-mAdbID-79263,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.118000,1,12.9,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf6e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgslg,P69Y,pgxind-kftx2ky1,pgxcs-kftvp5c2,362876600,0.126,144924089,0.05,217952511,0.076,PGX_AM_BS_18765795_712-mAdbID-79583,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.121000,1,39.1,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf6f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsli,P72Y,pgxind-kftx2ky3,pgxcs-kftvp5cj,51815300,0.018,26057276,0.009,25758024,0.009,PGX_AM_BS_18765795_714-mAdbID-75496,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.122000,1,29.4,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf70,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgslj,P78Y,pgxind-kftx2ky5,pgxcs-kftvp5d0,236847687,0.082,135997345,0.047,100850342,0.035,PGX_AM_BS_18765795_717-mAdbID-75265,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.124000,1,5,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf72,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsln,P55Y,pgxind-kftx2ky9,pgxcs-kftvp5dz,155192271,0.054,80466681,0.028,74725590,0.026,PGX_AM_BS_18765795_724-mAdbID-79262,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.126000,1,16.8,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf73,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgslo,P66Y,pgxind-kftx2kyb,pgxcs-kftvp5eg,869717973,0.303,596654598,0.208,273063375,0.095,PGX_AM_BS_18765795_725-mAdbID-75494,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.128000,1,11.5,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf75,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsls,P54Y,pgxind-kftx2kye,pgxcs-kftvp5fe,596836456,0.208,349684180,0.122,247152276,0.086,PGX_AM_BS_18765795_730-mAdbID-75509,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.131000,1,12.3,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf7a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsm0,P59Y,pgxind-kftx2kyo,pgxcs-kftvp5ht,322067291,0.112,261560565,0.091,60506726,0.021,PGX_AM_BS_18765795_748-mAdbID-76691,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.137000,1,12.1,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf7c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsm3,P80Y,pgxind-kftx2kys,pgxcs-kftvp5is,297444215,0.103,158431272,0.055,139012943,0.048,PGX_AM_BS_18765795_753-mAdbID-75291,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.140000,1,0.4,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf7e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsm6,P81Y,pgxind-kftx2kyw,pgxcs-kftvp5jr,55553633,0.019,31334249,0.011,24219384,0.008,PGX_AM_BS_18765795_771-mAdbID-75506,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.143000,1,81.6,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf80,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsma,P51Y,pgxind-kftx2kz0,pgxcs-kftvp5ks,908490627,0.316,355237824,0.124,553252803,0.192,PGX_AM_BS_18765795_779-mAdbID-75290,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.146000,1,4.2,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf82,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsmd,P81Y,pgxind-kftx2kz4,pgxcs-kftvp5lr,273175161,0.095,261233403,0.091,11941758,0.004,PGX_AM_BS_18765795_711-mAdbID-78099,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.149000,1,47.1,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf83,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsmf,P66Y,pgxind-kftx2kz6,pgxcs-kftvp5m8,299384037,0.104,105664893,0.037,193719144,0.067,PGX_AM_BS_18765795_800-mAdbID-75263,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.150000,1,3.9,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf84,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsmg,P34Y,pgxind-kftx2kz8,pgxcs-kftvp5mp,88874978,0.031,56760681,0.02,32114297,0.011,PGX_AM_BS_18765795_803-mAdbID-79317,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.152000,1,17.4,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf85,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsmi,P59Y,pgxind-kftx2kza,pgxcs-kftvp5n6,448970065,0.156,87187966,0.03,361782099,0.126,PGX_AM_BS_18765795_807-mAdbID-75261,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.153000,1,3.7,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf86,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsmk,P65Y,pgxind-kftx2kzc,pgxcs-kftvp5no,105336696,0.037,22768696,0.008,82568000,0.029,PGX_AM_BS_18765795_808-mAdbID-79314,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.154000,1,4.4,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf87,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsmm,P75Y,pgxind-kftx2kze,pgxcs-kftvp5o5,99074330,0.034,88087557,0.031,10986773,0.004,PGX_AM_BS_18765795_809-mAdbID-75508,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.156000,1,6.1,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf89,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsmp,P46Y,pgxind-kftx2kzi,pgxcs-kftvp5p3,328796858,0.114,189454238,0.066,139342620,0.048,PGX_AM_BS_18765795_816-mAdbID-78987,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.158000,1,22.3,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf8a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsmq,P75Y,pgxind-kftx2kzk,pgxcs-kftvp5pk,882550195,0.307,609108156,0.212,273442039,0.095,PGX_AM_BS_18765795_817-mAdbID-76801,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.160000,1,33.1,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf8b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsms,P75Y,pgxind-kftx2kzm,pgxcs-kftvp5q2,423689317,0.147,248557648,0.086,175131669,0.061,PGX_AM_BS_18765795_819-mAdbID-76164,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.161000,1,8.6,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf8c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsmu,P40Y,pgxind-kftx2kzo,pgxcs-kftvp5qj,62183616,0.022,35152460,0.012,27031156,0.009,PGX_AM_BS_18765795_820-mAdbID-75264,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.163000,1,19,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf8e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsmx,P83Y,pgxind-kftx2kzs,pgxcs-kftvp5rh,533522911,0.186,259966552,0.09,273556359,0.095,PGX_AM_BS_18765795_823-mAdbID-75432,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.165000,1,1.9,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf8f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsmz,P61Y,pgxind-kftx2kzu,pgxcs-kftvp5rz,150952327,0.053,9137191,0.003,141815136,0.049,PGX_AM_BS_18765795_831-mAdbID-77562,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.167000,1,132.2,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf91,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsn2,P77Y,pgxind-kftx2kzy,pgxcs-kftvp5sx,648744431,0.226,381637606,0.133,267106825,0.093,PGX_AM_BS_18765795_834-mAdbID-77004,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.169000,1,19.6,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf92,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsn4,P68Y,pgxind-kftx2l00,pgxcs-kftvp5te,1793658303,0.624,1001754252,0.348,791904051,0.275,PGX_AM_BS_18765795_835-mAdbID-75439,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.171000,1,14.6,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf94,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsn7,P62Y,pgxind-kftx2l04,pgxcs-kftvp5ud,332360781,0.116,76373864,0.027,255986917,0.089,PGX_AM_BS_18765795_838-mAdbID-77000,{},-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.173000,1,,,,,,,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf95,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsn9,P66Y,pgxind-kftx2l06,pgxcs-kftvp5uu,116921318,0.041,56325405,0.02,60595913,0.021,PGX_AM_BS_18765795_839-mAdbID-75278,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.175000,1,3.4,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf99,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsnf,P85Y,pgxind-kftx2l0e,pgxcs-kftvp5wq,36395002,0.013,0,0,36395002,0.013,PGX_AM_BS_18765795_854-mAdbID-78986,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.180000,1,18.1,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf9b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsnj,P79Y,pgxind-kftx2l0i,pgxcs-kftvp5xp,561830663,0.195,359453489,0.125,202377174,0.07,PGX_AM_BS_18765795_856-mAdbID-77002,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.183000,1,7.2,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acf9c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsnk,P81Y,pgxind-kftx2l0k,pgxcs-kftvp5y6,175419037,0.061,147859831,0.051,27559206,0.01,PGX_AM_BS_18765795_858-mAdbID-75522,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.185000,1,42.9,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf9d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsnm,P72Y,pgxind-kftx2l0m,pgxcs-kftvp5yn,352219216,0.123,62179584,0.022,290039632,0.101,PGX_AM_BS_18765795_860-mAdbID-77183,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.186000,1,36.3,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acf9f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsnp,P64Y,pgxind-kftx2l0q,pgxcs-kftvp5zm,646844262,0.225,415020668,0.144,231823594,0.081,PGX_AM_BS_18765795_874-mAdbID-78206,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.189000,1,1.4,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acfa3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgsnv,P72Y,pgxind-kftx2l0y,pgxcs-kftvp61j,455237492,0.158,126425050,0.044,328812442,0.114,PGX_AM_BS_18765795_996-mAdbID-75512,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:19.194000,1,2.5,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ade1d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma, NOS",PMID:17170743,"Berglund M, Enblad G et al. (2007): Genomic imbalances during transformation from follicular...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxb3,P62Y,pgxind-kftx2qtw,pgxcs-kftvqlwl,33200033,0.012,33200033,0.012,0,0,PGX_AM_BS_TF-FCL-ber-04,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.323000,1,18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ade1e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma, NOS",PMID:17170743,"Berglund M, Enblad G et al. (2007): Genomic imbalances during transformation from follicular...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxb5,P48Y,pgxind-kftx2qty,pgxcs-kftvqlx3,134500133,0.047,39000038,0.014,95500095,0.033,PGX_AM_BS_TF-FCL-ber-05,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.325000,1,130,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ade1f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma, NOS",PMID:17170743,"Berglund M, Enblad G et al. (2007): Genomic imbalances during transformation from follicular...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxb7,P50Y,pgxind-kftx2qu0,pgxcs-kftvqlxk,372514927,0.13,0,0,372514927,0.13,PGX_AM_BS_TF-FCL-ber-06,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.326000,1,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ade20,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma, NOS",PMID:17170743,"Berglund M, Enblad G et al. (2007): Genomic imbalances during transformation from follicular...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxb8,P51Y,pgxind-kftx2qu2,pgxcs-kftvqly1,244274053,0.085,85452470,0.03,158821583,0.055,PGX_AM_BS_TF-FCL-ber-07,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.327000,1,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ade21,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma, NOS",PMID:17170743,"Berglund M, Enblad G et al. (2007): Genomic imbalances during transformation from follicular...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxba,P49Y,pgxind-kftx2qu4,pgxcs-kftvqlyi,241217395,0.084,86400087,0.03,154817308,0.054,PGX_AM_BS_TF-FCL-ber-08,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.329000,1,25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ade24,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma, NOS",PMID:17170743,"Berglund M, Enblad G et al. (2007): Genomic imbalances during transformation from follicular...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxbf,P57Y,pgxind-kftx2qua,pgxcs-kftvqlzy,530466305,0.185,80517235,0.028,449949070,0.157,PGX_AM_BS_TF-FCL-ber-11,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.333000,1,57,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ade25,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma, NOS",PMID:17170743,"Berglund M, Enblad G et al. (2007): Genomic imbalances during transformation from follicular...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxbg,P58Y,pgxind-kftx2quc,pgxcs-kftvqm20,429469882,0.149,246019979,0.086,183449903,0.064,PGX_AM_BS_TF-FCL-ber-12,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.334000,1,98,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ade27,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma, NOS",PMID:17170743,"Berglund M, Enblad G et al. (2007): Genomic imbalances during transformation from follicular...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxbk,P61Y,pgxind-kftx2qug,pgxcs-kftvqm2z,797575544,0.277,474943813,0.165,322631731,0.112,PGX_AM_BS_TF-FCL-ber-13,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.337000,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ade29,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma, NOS",PMID:17170743,"Berglund M, Enblad G et al. (2007): Genomic imbalances during transformation from follicular...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvgxbn,P62Y,pgxind-kftx2quk,pgxcs-kftvqm3y,701480774,0.244,387745282,0.135,313735492,0.109,PGX_AM_BS_TF-FCL-ber-14,{},18.06,59.33,Point,SWE,Stockholm,Sweden,"Stockholm, Sweden",59.33,18.06,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:24.340000,1,84,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c8727983b2e00ae65a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [secondary cutaneous],PMID:16274455,"Gimnez S, Costa C et al. (2005): Comparative genomic hybridization analysis of cutaneous...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh09l,P75Y,pgxind-kftx2u3z,pgxcs-kftvrffo,701395529,0.244,64534835,0.022,636860694,0.222,PGX_AM_BS_PCBCL-gim-15,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:27.624000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c8727983b2e00ae65d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [secondary cutaneous],PMID:16274455,"Gimnez S, Costa C et al. (2005): Comparative genomic hybridization analysis of cutaneous...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh09q,P49Y,pgxind-kftx2u45,pgxcs-kftvrfh4,0,0,0,0,0,0,PGX_AM_BS_PCBCL-gim-18,{},2.16,41.39,Point,ESP,Barcelona,Spain,"Barcelona, Spain",41.39,2.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:27.628000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afccd,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma, T-Cell/Histiocyte-Rich [stage IVA]",PMID:12414532,"Franke S, Wlodarska I et al. (2002): Comparative genomic hybridization pattern distinguishes T-cell/histiocyte-rich...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh7gm,P46Y,pgxind-kftx333j,pgxcs-kftvtnva,1259721966,0.438,211500210,0.074,1048221756,0.365,PGX_AM_BS_THRBNHL-02,,4.7,50.88,Point,BEL,Leuven,Belgium,"Leuven, Belgium",50.88,4.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:35.589000,1,45,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00afccf,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma, T-Cell/Histiocyte-Rich [stage IVB]",PMID:12414532,"Franke S, Wlodarska I et al. (2002): Comparative genomic hybridization pattern distinguishes T-cell/histiocyte-rich...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh7gp,P59Y,pgxind-kftx333n,pgxcs-kftvtnw8,899601794,0.313,270596109,0.094,629005685,0.219,PGX_AM_BS_THRBNHL-04,,4.7,50.88,Point,BEL,Leuven,Belgium,"Leuven, Belgium",50.88,4.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:35.592000,1,1,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afcd1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma, T-Cell/Histiocyte-Rich [stage IIIA]",PMID:12414532,"Franke S, Wlodarska I et al. (2002): Comparative genomic hybridization pattern distinguishes T-cell/histiocyte-rich...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh7gs,P73Y,pgxind-kftx333r,pgxcs-kftvtnx7,65600065,0.023,0,0,65600065,0.023,PGX_AM_BS_THRBNHL-06,,4.7,50.88,Point,BEL,Leuven,Belgium,"Leuven, Belgium",50.88,4.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:35.595000,1,31,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00afcd4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma, T-Cell/Histiocyte-Rich [stage IIIB]",PMID:12414532,"Franke S, Wlodarska I et al. (2002): Comparative genomic hybridization pattern distinguishes T-cell/histiocyte-rich...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh7gx,P44Y,pgxind-kftx333x,pgxcs-kftvtnym,0,0,0,0,0,0,PGX_AM_BS_THRBNHL-09,,4.7,50.88,Point,BEL,Leuven,Belgium,"Leuven, Belgium",50.88,4.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:35.599000,1,4,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afcd6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma, T-Cell/Histiocyte-Rich [stage IVB]",PMID:12414532,"Franke S, Wlodarska I et al. (2002): Comparative genomic hybridization pattern distinguishes T-cell/histiocyte-rich...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh7h0,P35Y,pgxind-kftx3341,pgxcs-kftvtnzk,143013897,0.05,47600047,0.017,95413850,0.033,PGX_AM_BS_THRBNHL-11,,4.7,50.88,Point,BEL,Leuven,Belgium,"Leuven, Belgium",50.88,4.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:35.601000,1,12,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afcd7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma, T-Cell/Histiocyte-Rich [stage IIIB]",PMID:12414532,"Franke S, Wlodarska I et al. (2002): Comparative genomic hybridization pattern distinguishes T-cell/histiocyte-rich...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh7h2,P42Y,pgxind-kftx3343,pgxcs-kftvto01,31500032,0.011,11200011,0.004,20300021,0.007,PGX_AM_BS_THRBNHL-12,,4.7,50.88,Point,BEL,Leuven,Belgium,"Leuven, Belgium",50.88,4.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:35.603000,1,14,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afcd8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma, T-Cell/Histiocyte-Rich [stage IVB]",PMID:12414532,"Franke S, Wlodarska I et al. (2002): Comparative genomic hybridization pattern distinguishes T-cell/histiocyte-rich...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh7h4,P48Y,pgxind-kftx3345,pgxcs-kftvto0i,181661953,0.063,0,0,181661953,0.063,PGX_AM_BS_THRBNHL-13,,4.7,50.88,Point,BEL,Leuven,Belgium,"Leuven, Belgium",50.88,4.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:35.604000,1,7,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afcd9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma, T-Cell/Histiocyte-Rich [stage IVB]",PMID:12414532,"Franke S, Wlodarska I et al. (2002): Comparative genomic hybridization pattern distinguishes T-cell/histiocyte-rich...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh7h5,P41Y,pgxind-kftx3347,pgxcs-kftvto0z,334314088,0.116,0,0,334314088,0.116,PGX_AM_BS_THRBNHL-14,,4.7,50.88,Point,BEL,Leuven,Belgium,"Leuven, Belgium",50.88,4.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:35.606000,1,25,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afcda,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma, T-Cell/Histiocyte-Rich [stage IVB]",PMID:12414532,"Franke S, Wlodarska I et al. (2002): Comparative genomic hybridization pattern distinguishes T-cell/histiocyte-rich...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh7h7,P41Y,pgxind-kftx3349,pgxcs-kftvto1h,342028652,0.119,0,0,342028652,0.119,PGX_AM_BS_THRBNHL-15,,4.7,50.88,Point,BEL,Leuven,Belgium,"Leuven, Belgium",50.88,4.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:35.607000,1,10,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afcdc,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma, T-Cell/Histiocyte-Rich [stage IVB]",PMID:12414532,"Franke S, Wlodarska I et al. (2002): Comparative genomic hybridization pattern distinguishes T-cell/histiocyte-rich...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvh7ha,P46Y,pgxind-kftx334d,pgxcs-kftvto2g,0,0,0,0,0,0,PGX_AM_BS_THRBNHL-17,,4.7,50.88,Point,BEL,Leuven,Belgium,"Leuven, Belgium",50.88,4.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:44:35.610000,1,8,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d7ae,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSM286901,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvk9z7,P66Y,pgxind-kftx6c24,pgxcs-kftwq2ji,254660671,0.089,88713958,0.031,165946713,0.058,PGX_AM_BS_GSM286901,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.815000,1,4,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GPL6400,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,geo:gpl,geo:gse,,pubmed,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d7b1,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSM286893,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvk9zc,P72Y,pgxind-kftx6c2a,pgxcs-kftwq2h0,174327593,0.061,4355589,0.002,169972004,0.059,PGX_AM_BS_GSM286893,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.818000,1,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,geo:GPL6400,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,pubmed,geo:gse,,geo:gpl,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d7b2,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSM286894,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvk9ze,P84Y,pgxind-kftx6c2c,pgxcs-kftwq2hb,72030455,0.025,40995837,0.014,31034618,0.011,PGX_AM_BS_GSM286894,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.819000,1,2,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,geo:GSE11318,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GPL6400,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,geo:gse,geo:gpl,,pubmed,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d7b3,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSM286895,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvk9zf,P39Y,pgxind-kftx6c2e,pgxcs-kftwq2hn,134084564,0.047,74635529,0.026,59449035,0.021,PGX_AM_BS_GSM286895,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.820000,1,7,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,geo:GPL6400,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,pubmed,geo:gse,,geo:gpl,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d7b4,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSM286896,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvk9zh,P64Y,pgxind-kftx6c2g,pgxcs-kftwq2hy,223020608,0.078,88285865,0.031,134734743,0.047,PGX_AM_BS_GSM286896,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.821000,1,12,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GPL6400,,geo:GSE11318,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,pubmed,geo:gpl,,geo:gse,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d7b5,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSM286897,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvk9zj,P62Y,pgxind-kftx6c2j,pgxcs-kftwq2i9,240439019,0.084,24809251,0.009,215629768,0.075,PGX_AM_BS_GSM286897,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.822000,1,11,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GPL6400,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,geo:gpl,geo:gse,,pubmed,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d7b6,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvk9zk,P76Y,pgxind-kftx6c2l,pgxcs-kftwq2ik,69034665,0.024,48616979,0.017,20417686,0.007,PGX_AM_BS_GSM286898,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.823000,1,30,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,geo:GPL6400,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,geo:GSM286898,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),pubmed,geo:gpl,geo:gse,,geo:gsm,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d7b7,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSM286899,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvk9zm,P59Y,pgxind-kftx6c2n,pgxcs-kftwq2iw,198471634,0.069,53660530,0.019,144811104,0.05,PGX_AM_BS_GSM286899,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.824000,1,4,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,geo:GPL6400,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,pubmed,geo:gse,,geo:gpl,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d7b9,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GPL6400,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvk9zp,P40Y,pgxind-kftx6c2r,pgxcs-kftwq2ju,4342055,0.002,1126164,0,3215891,0.001,PGX_AM_BS_GSM286902,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.826000,1,19,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",geo:GSM286902,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gpl,geo:gse,pubmed,,geo:gsm,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d7ba,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvk9zr,P78Y,pgxind-kftx6c2t,pgxcs-kftwq2k5,220799940,0.077,131536125,0.046,89263815,0.031,PGX_AM_BS_GSM286903,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.827000,1,5,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GPL6400,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",geo:GSM286903,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gse,geo:gpl,pubmed,,geo:gsm,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d7bb,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSM286904,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvk9zt,P63Y,pgxind-kftx6c2v,pgxcs-kftwq2kg,343324183,0.119,124889404,0.043,218434779,0.076,PGX_AM_BS_GSM286904,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.828000,1,28,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GSE11318,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GPL6400,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,geo:gse,geo:gpl,,pubmed,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d7bc,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSM286905,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvk9zu,P76Y,pgxind-kftx6c2x,pgxcs-kftwq2ks,178361341,0.062,7796139,0.003,170565202,0.059,PGX_AM_BS_GSM286905,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.830000,1,4,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GPL6400,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,geo:gpl,geo:gse,,pubmed,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d7bd,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSM286906,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvk9zw,P74Y,pgxind-kftx6c2z,pgxcs-kftwq2l3,64430048,0.022,16828560,0.006,47601488,0.017,PGX_AM_BS_GSM286906,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.831000,1,4,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GPL6400,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,geo:gpl,geo:gse,,pubmed,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d7be,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GPL6400,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvk9zx,P35Y,pgxind-kftx6c31,pgxcs-kftwq2lf,193228600,0.067,101086044,0.035,92142556,0.032,PGX_AM_BS_GSM286907,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.832000,1,20,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",geo:GSM286907,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gpl,geo:gse,pubmed,,geo:gsm,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d7bf,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvk9zz,P18Y,pgxind-kftx6c33,pgxcs-kftwq2lq,5869734,0.002,3915682,0.001,1954052,0.001,PGX_AM_BS_GSM286908,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.833000,1,1,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GPL6400,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",geo:GSM286908,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gse,geo:gpl,pubmed,,geo:gsm,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d7c0,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GPL6400,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka01,P64Y,pgxind-kftx6c35,pgxcs-kftwq2m1,95168038,0.033,39005396,0.014,56162642,0.02,PGX_AM_BS_GSM286909,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.834000,1,6,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",geo:GSM286909,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gpl,geo:gse,pubmed,,geo:gsm,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d7c2,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka04,P66Y,pgxind-kftx6c39,pgxcs-kftwq2mo,94106161,0.033,55845428,0.019,38260733,0.013,PGX_AM_BS_GSM286911,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.836000,1,3,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GPL6400,,geo:GSM286911,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),pubmed,geo:gse,geo:gpl,,geo:gsm,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d7c3,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSM286913,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka05,P75Y,pgxind-kftx6c3b,pgxcs-kftwq2na,7546107,0.003,2556919,0.001,4989188,0.002,PGX_AM_BS_GSM286913,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.837000,1,4,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GPL6400,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,geo:gpl,geo:gse,,pubmed,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d7c5,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka09,P73Y,pgxind-kftx6c3f,pgxcs-kftwq2nx,41900434,0.015,32695058,0.011,9205376,0.003,PGX_AM_BS_GSM286915,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.839000,1,16,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GPL6400,,geo:GSM286915,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),pubmed,geo:gse,geo:gpl,,geo:gsm,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d7c6,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka0a,P45Y,pgxind-kftx6c3h,pgxcs-kftwq2o8,816585824,0.284,373552131,0.13,443033693,0.154,PGX_AM_BS_GSM286916,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.840000,1,7,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GPL6400,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,geo:GSM286916,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),pubmed,geo:gpl,geo:gse,,geo:gsm,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d7c7,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GPL6400,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka0c,P41Y,pgxind-kftx6c3j,pgxcs-kftwq2oj,150048783,0.052,107862538,0.038,42186245,0.015,PGX_AM_BS_GSM286917,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.841000,1,73,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",geo:GSM286917,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gpl,geo:gse,pubmed,,geo:gsm,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d7c8,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka0e,P74Y,pgxind-kftx6c3l,pgxcs-kftwq2ou,722985540,0.251,495948781,0.173,227036759,0.079,PGX_AM_BS_GSM286918,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.842000,1,12,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GPL6400,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",geo:GSM286918,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gse,geo:gpl,pubmed,,geo:gsm,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d7ca,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSM286920,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka0h,P51Y,pgxind-kftx6c3p,pgxcs-kftwq2ph,639742013,0.223,252923378,0.088,386818635,0.135,PGX_AM_BS_GSM286920,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.844000,1,4,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GPL6400,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,geo:gpl,geo:gse,,pubmed,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d7cb,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSM286921,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka0i,P80Y,pgxind-kftx6c3r,pgxcs-kftwq2pt,58697642,0.02,42026589,0.015,16671053,0.006,PGX_AM_BS_GSM286921,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.845000,1,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GSE11318,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GPL6400,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,geo:gse,geo:gpl,,pubmed,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d7cd,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka0m,P83Y,pgxind-kftx6c3v,pgxcs-kftwq2qf,521012603,0.181,245881338,0.086,275131265,0.096,PGX_AM_BS_GSM286923,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.847000,1,2,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GPL6400,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,geo:GSM286923,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),pubmed,geo:gpl,geo:gse,,geo:gsm,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d7ce,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GPL6400,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka0n,P69Y,pgxind-kftx6c3y,pgxcs-kftwq2qq,84574036,0.029,2285074,0.001,82288962,0.029,PGX_AM_BS_GSM286924,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.848000,1,90,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",geo:GSM286924,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gpl,geo:gse,pubmed,,geo:gsm,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d7d0,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GPL6400,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka0r,P68Y,pgxind-kftx6c42,pgxcs-kftwq2rd,738012600,0.257,494964506,0.172,243048094,0.085,PGX_AM_BS_GSM286926,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.851000,1,15,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",geo:GSM286926,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gpl,geo:gse,pubmed,,geo:gsm,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d7d1,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GPL6400,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka0s,P70Y,pgxind-kftx6c44,pgxcs-kftwq2ro,5820519,0.002,3901216,0.001,1919303,0.001,PGX_AM_BS_GSM286927,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.851000,1,50,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",geo:GSM286927,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gpl,geo:gse,pubmed,,geo:gsm,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d7d2,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSM286928,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka0u,P67Y,pgxind-kftx6c46,pgxcs-kftwq2s0,4398146,0.002,2740792,0.001,1657354,0.001,PGX_AM_BS_GSM286928,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.853000,1,65,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,geo:GPL6400,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,pubmed,geo:gse,,geo:gpl,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d7d3,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSM286929,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka0v,P77Y,pgxind-kftx6c48,pgxcs-kftwq2sb,303940050,0.106,159509229,0.055,144430821,0.05,PGX_AM_BS_GSM286929,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.854000,1,26,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GPL6400,,geo:GSE11318,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,pubmed,geo:gpl,,geo:gse,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d7d4,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka0x,P66Y,pgxind-kftx6c4a,pgxcs-kftwq2sm,293082919,0.102,102142074,0.036,190940845,0.066,PGX_AM_BS_GSM286930,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.855000,1,12,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,geo:GPL6400,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,geo:GSM286930,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),pubmed,geo:gpl,geo:gse,,geo:gsm,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d7d5,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka0z,P71Y,pgxind-kftx6c4c,pgxcs-kftwq2sx,69916652,0.024,14007392,0.005,55909260,0.019,PGX_AM_BS_GSM286931,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.856000,1,34,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GPL6400,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,geo:GSM286931,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),pubmed,geo:gpl,geo:gse,,geo:gsm,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d7d6,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka10,P72Y,pgxind-kftx6c4e,pgxcs-kftwq2t9,10235051,0.004,3894241,0.001,6340810,0.002,PGX_AM_BS_GSM286932,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.857000,1,29,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GPL6400,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",geo:GSM286932,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gse,geo:gpl,pubmed,,geo:gsm,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d7da,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka17,P72Y,pgxind-kftx6c4m,pgxcs-kftwq2ui,486083212,0.169,156703713,0.055,329379499,0.115,PGX_AM_BS_GSM286936,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.861000,1,12,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GPL6400,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",geo:GSM286936,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gse,geo:gpl,pubmed,,geo:gsm,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d7dc,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSM286938,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka1a,P81Y,pgxind-kftx6c4q,pgxcs-kftwq2v5,36068488,0.013,3054370,0.001,33014118,0.011,PGX_AM_BS_GSM286938,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.863000,1,82,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GPL6400,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,geo:gse,geo:gpl,,pubmed,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d7de,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSM286940,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka1d,P75Y,pgxind-kftx6c4u,pgxcs-kftwq2xj,82398648,0.029,81912016,0.028,486632,0,PGX_AM_BS_GSM286940,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.865000,1,6,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,geo:GPL6400,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,pubmed,geo:gse,,geo:gpl,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d7df,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSM286941,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka1f,P54Y,pgxind-kftx6c4w,pgxcs-kftwq2xv,246866291,0.086,86400630,0.03,160465661,0.056,PGX_AM_BS_GSM286941,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.866000,1,12,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,geo:GPL6400,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,pubmed,geo:gse,,geo:gpl,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d7e0,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka1h,P77Y,pgxind-kftx6c4y,pgxcs-kftwq2y7,200052281,0.07,115394981,0.04,84657300,0.029,PGX_AM_BS_GSM286942,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.867000,1,1,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GPL6400,,geo:GSM286942,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),pubmed,geo:gse,geo:gpl,,geo:gsm,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d7e1,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSM286943,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka1i,P74Y,pgxind-kftx6c50,pgxcs-kftwq2yi,597892062,0.208,154017749,0.054,443874313,0.154,PGX_AM_BS_GSM286943,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.868000,1,31,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GPL6400,,geo:GSE11318,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,pubmed,geo:gpl,,geo:gse,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d7e2,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSM286944,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka1k,P72Y,pgxind-kftx6c52,pgxcs-kftwq2yu,251132543,0.087,97342557,0.034,153789986,0.053,PGX_AM_BS_GSM286944,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.870000,1,3,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,geo:GPL6400,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,pubmed,geo:gse,,geo:gpl,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d7e3,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka1m,P81Y,pgxind-kftx6c54,pgxcs-kftwq2z5,6589851,0.002,3755291,0.001,2834560,0.001,PGX_AM_BS_GSM286945,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.871000,1,43,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GPL6400,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,geo:GSM286945,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),pubmed,geo:gpl,geo:gse,,geo:gsm,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d7e4,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka1n,P60Y,pgxind-kftx6c56,pgxcs-kftwq2zg,3240597,0.001,2563351,0.001,677246,0,PGX_AM_BS_GSM286946,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.872000,1,27,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GPL6400,,geo:GSM286946,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),pubmed,geo:gse,geo:gpl,,geo:gsm,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d7e5,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka1p,P77Y,pgxind-kftx6c58,pgxcs-kftwq2zs,348977455,0.121,113771092,0.04,235206363,0.082,PGX_AM_BS_GSM286947,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.873000,1,80,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GPL6400,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",geo:GSM286947,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gse,geo:gpl,pubmed,,geo:gsm,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d7e6,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GPL6400,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka1r,P63Y,pgxind-kftx6c5a,pgxcs-kftwq303,2291704,0.001,2279790,0.001,11914,0,PGX_AM_BS_GSM286948,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.874000,1,28,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GSE11318,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",geo:GSM286948,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gpl,geo:gse,pubmed,,geo:gsm,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d7e9,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka1w,P41Y,pgxind-kftx6c5h,pgxcs-kftwq311,7111308,0.002,6237130,0.002,874178,0,PGX_AM_BS_GSM286951,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.877000,1,9,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GPL6400,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,geo:GSM286951,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),pubmed,geo:gpl,geo:gse,,geo:gsm,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d7ef,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSM286957,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka25,P58Y,pgxind-kftx6c5t,pgxcs-kftwq32w,6287237,0.002,3457812,0.001,2829425,0.001,PGX_AM_BS_GSM286957,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.884000,1,15,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GPL6400,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,geo:gpl,geo:gse,,pubmed,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d7f0,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSM286958,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka27,P70Y,pgxind-kftx6c5v,pgxcs-kftwq337,507923757,0.177,452694046,0.157,55229711,0.019,PGX_AM_BS_GSM286958,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.885000,1,127,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GPL6400,,geo:GSE11318,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,pubmed,geo:gpl,,geo:gse,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d7f1,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka29,P85Y,pgxind-kftx6c5x,pgxcs-kftwq33j,126137925,0.044,35187755,0.012,90950170,0.032,PGX_AM_BS_GSM286959,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.886000,1,65,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GPL6400,,geo:GSM286959,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),pubmed,geo:gse,geo:gpl,,geo:gsm,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d7f4,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSM286962,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka2e,P32Y,pgxind-kftx6c63,pgxcs-kftwq34g,4489502,0.002,872625,0,3616877,0.001,PGX_AM_BS_GSM286962,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.889000,1,9,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GPL6400,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,,,,,,,geo:GSE11318,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,geo:gsm,geo:gpl,geo:gse,,pubmed,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d7f6,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka2h,P58Y,pgxind-kftx6c67,pgxcs-kftwq352,32817017,0.011,2872066,0.001,29944951,0.01,PGX_AM_BS_GSM286964,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.891000,1,13,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GPL6400,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,geo:GSM286964,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),pubmed,geo:gpl,geo:gse,,geo:gsm,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d7f7,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSM286965,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka2i,P79Y,pgxind-kftx6c69,pgxcs-kftwq35d,54668040,0.019,36445226,0.013,18222814,0.006,PGX_AM_BS_GSM286965,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.892000,1,36,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GPL6400,,geo:GSE11318,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,pubmed,geo:gpl,,geo:gse,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d7f9,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSM286967,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka2m,P62Y,pgxind-kftx6c6d,pgxcs-kftwq35z,697963,0,697963,0,0,0,PGX_AM_BS_GSM286967,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.894000,1,9,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GPL6400,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,,,,,,,geo:GSE11318,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,geo:gsm,geo:gpl,geo:gse,,pubmed,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d7fc,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSM286970,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka2r,P73Y,pgxind-kftx6c6j,pgxcs-kftwq36w,5364860,0.002,3688483,0.001,1676377,0.001,PGX_AM_BS_GSM286970,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.897000,1,13,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GSE11318,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,,,,,,,geo:GPL6400,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,geo:gsm,geo:gse,geo:gpl,,pubmed,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d7fd,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSM286971,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka2s,P75Y,pgxind-kftx6c6l,pgxcs-kftwq377,80726157,0.028,1050024,0,79676133,0.028,PGX_AM_BS_GSM286971,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.898000,1,9,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,geo:GPL6400,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,pubmed,geo:gse,,geo:gpl,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d804,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka34,P72Y,pgxind-kftx6c6z,pgxcs-kftwq39c,29882902,0.01,27427909,0.01,2454993,0.001,PGX_AM_BS_GSM286978,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.906000,1,2,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,geo:GPL6400,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",geo:GSM286978,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gse,geo:gpl,pubmed,,geo:gsm,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d81d,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],geo:GSM287003,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka49,P79Y,pgxind-kftx6c8e,pgxcs-kftwq3h3,7394936,0.003,4299771,0.001,3095165,0.001,PGX_AM_BS_GSM287003,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.932000,1,1,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,,,,,,,geo:GPL6400,,geo:GSE11318,,,,geo:gsm,pubmed,geo:gpl,,geo:gse,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d81f,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka4d,P52Y,pgxind-kftx6c8i,pgxcs-kftwq3hp,60132335,0.021,52162795,0.018,7969540,0.003,PGX_AM_BS_GSM287005,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.934000,1,32,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GPL6400,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",geo:GSM287005,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gse,geo:gpl,pubmed,,geo:gsm,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d821,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],geo:GPL6400,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka4g,P56Y,pgxind-kftx6c8m,pgxcs-kftwq3ic,315475450,0.11,32117843,0.011,283357607,0.099,PGX_AM_BS_GSM287007,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.936000,1,23,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",geo:GSM287007,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gpl,geo:gse,pubmed,,geo:gsm,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d822,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka4h,P59Y,pgxind-kftx6c8o,pgxcs-kftwq3in,75279441,0.026,26093787,0.009,49185654,0.017,PGX_AM_BS_GSM287008,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.937000,1,12,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GPL6400,,geo:GSM287008,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),pubmed,geo:gse,geo:gpl,,geo:gsm,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d824,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GPL6400,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka4l,P75Y,pgxind-kftx6c8s,pgxcs-kftwq3ja,54419381,0.019,32157458,0.011,22261923,0.008,PGX_AM_BS_GSM287010,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.940000,1,10,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GSE11318,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",geo:GSM287010,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gpl,geo:gse,pubmed,,geo:gsm,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d827,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka4q,P75Y,pgxind-kftx6c8z,pgxcs-kftwq3k8,258929233,0.09,44159876,0.015,214769357,0.075,PGX_AM_BS_GSM287013,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.943000,1,33,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GPL6400,,geo:GSM287013,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),pubmed,geo:gse,geo:gpl,,geo:gsm,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d828,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],geo:GSM287014,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka4r,P65Y,pgxind-kftx6c91,pgxcs-kftwq3kj,30639096,0.011,12315450,0.004,18323646,0.006,PGX_AM_BS_GSM287014,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.944000,1,54,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GPL6400,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,geo:gpl,geo:gse,,pubmed,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d82b,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka4w,P84Y,pgxind-kftx6c97,pgxcs-kftwq3lh,99841060,0.035,44857582,0.016,54983478,0.019,PGX_AM_BS_GSM287017,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.947000,1,4,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GSE11318,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GPL6400,,geo:GSM287017,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),pubmed,geo:gse,geo:gpl,,geo:gsm,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d82d,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSM287019,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka4z,P47Y,pgxind-kftx6c9b,pgxcs-kftwq3m4,291564461,0.101,10764121,0.004,280800340,0.098,PGX_AM_BS_GSM287019,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.949000,1,109,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,geo:GPL6400,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,geo:gpl,geo:gse,,pubmed,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d831,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka56,P58Y,pgxind-kftx6c9j,pgxcs-kftwq3nd,4977742,0.002,2496506,0.001,2481236,0.001,PGX_AM_BS_GSM287023,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.954000,1,7,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GPL6400,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,,,,,,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",geo:GSM287023,,,,geo:gse,geo:gpl,pubmed,,geo:gsm,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d833,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],geo:GSM287025,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka59,P52Y,pgxind-kftx6c9n,pgxcs-kftwq3nz,254639053,0.089,91672879,0.032,162966174,0.057,PGX_AM_BS_GSM287025,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.956000,1,14,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,geo:GPL6400,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,pubmed,geo:gse,,geo:gpl,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d834,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSM287026,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka5b,P76Y,pgxind-kftx6c9p,pgxcs-kftwq3ob,6415114,0.002,4407135,0.002,2007979,0.001,PGX_AM_BS_GSM287026,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.957000,1,15,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GPL6400,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,geo:gpl,geo:gse,,pubmed,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d836,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],geo:GSM287028,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka5e,P62Y,pgxind-kftx6c9t,pgxcs-kftwq3ox,106038861,0.037,2824894,0.001,103213967,0.036,PGX_AM_BS_GSM287028,{},-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.959000,1,,,,,,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,geo:GPL6400,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,pubmed,geo:gse,,geo:gpl,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d837,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],geo:GSM287029,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka5g,P79Y,pgxind-kftx6c9v,pgxcs-kftwq3p8,105674885,0.037,83955084,0.029,21719801,0.008,PGX_AM_BS_GSM287029,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.960000,1,7,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GSE11318,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GPL6400,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,geo:gse,geo:gpl,,pubmed,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d838,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],geo:GSM287030,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka5h,P77Y,pgxind-kftx6c9x,pgxcs-kftwq3pj,301245461,0.105,136895586,0.048,164349875,0.057,PGX_AM_BS_GSM287030,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.961000,1,20,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GPL6400,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,geo:gpl,geo:gse,,pubmed,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d83c,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSM287034,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka5o,P72Y,pgxind-kftx6ca6,pgxcs-kftwq3qt,354028535,0.123,62801493,0.022,291227042,0.101,PGX_AM_BS_GSM287034,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.965000,1,36,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,geo:GPL6400,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,pubmed,geo:gse,,geo:gpl,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d841,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],geo:GPL6400,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka5w,P59Y,pgxind-kftx6caf,pgxcs-kftwq3sg,3743363,0.001,3570542,0.001,172821,0,PGX_AM_BS_GSM287039,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.970000,1,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",geo:GSM287039,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gpl,geo:gse,pubmed,,geo:gsm,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d844,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],geo:GSM287042,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka61,P61Y,pgxind-kftx6cam,pgxcs-kftwq3te,65006112,0.023,2094769,0.001,62911343,0.022,PGX_AM_BS_GSM287042,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.973000,1,132,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,,,,,,,geo:GPL6400,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,geo:gsm,geo:gse,geo:gpl,,pubmed,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d845,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka63,P70Y,pgxind-kftx6cao,pgxcs-kftwq3tq,117047210,0.041,55197870,0.019,61849340,0.022,PGX_AM_BS_GSM287043,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.974000,1,27,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GPL6400,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,geo:GSM287043,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),pubmed,geo:gpl,geo:gse,,geo:gsm,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d846,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSM287044,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka65,P65Y,pgxind-kftx6caq,pgxcs-kftwq3u1,678990515,0.236,534861126,0.186,144129389,0.05,PGX_AM_BS_GSM287044,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.975000,1,67,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GPL6400,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,geo:gpl,geo:gse,,pubmed,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d847,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka66,P70Y,pgxind-kftx6cas,pgxcs-kftwq3ud,742200527,0.258,130399402,0.045,611801125,0.213,PGX_AM_BS_GSM287045,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.976000,1,8,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GPL6400,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,geo:GSM287045,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),pubmed,geo:gpl,geo:gse,,geo:gsm,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d849,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GPL6400,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka6a,P66Y,pgxind-kftx6caw,pgxcs-kftwq3uz,101155239,0.035,53079157,0.018,48076082,0.017,PGX_AM_BS_GSM287047,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.978000,1,1,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",geo:GSM287047,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gpl,geo:gse,pubmed,,geo:gsm,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d84a,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSM287048,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka6b,P81Y,pgxind-kftx6cay,pgxcs-kftwq3va,12957662,0.005,8079243,0.003,4878419,0.002,PGX_AM_BS_GSM287048,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.980000,1,47,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GPL6400,,geo:GSE11318,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,pubmed,geo:gpl,,geo:gse,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d84d,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GPL6400,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka6g,P54Y,pgxind-kftx6cb4,pgxcs-kftwq3w8,20064876,0.007,15257655,0.005,4807221,0.002,PGX_AM_BS_GSM287051,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.983000,1,3,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",geo:GSM287051,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gpl,geo:gse,pubmed,,geo:gsm,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d850,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka6l,P64Y,pgxind-kftx6cba,pgxcs-kftwq3x6,204003498,0.071,45784271,0.016,158219227,0.055,PGX_AM_BS_GSM287054,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.986000,1,1,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,geo:GSE11318,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GPL6400,,geo:GSM287054,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),pubmed,geo:gse,geo:gpl,,geo:gsm,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d853,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka6q,,pgxind-kftx6cbg,pgxcs-kftwq3y4,10331993,0.004,9644139,0.003,687854,0,PGX_AM_BS_GSM287057,{},-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.989000,1,12,,,,,,geo:GPL6400,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,,,,,,,geo:GSE11318,,geo:GSM287057,,,,pubmed,geo:gpl,geo:gse,,geo:gsm,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d854,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka6s,,pgxind-kftx6cbi,pgxcs-kftwq3yf,33591533,0.012,32192349,0.011,1399184,0,PGX_AM_BS_GSM287058,{},-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.990000,1,1,,,,,,geo:GPL6400,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,,,,,,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",geo:GSM287058,,,,geo:gse,geo:gpl,pubmed,,geo:gsm,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d857,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSM287061,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka6x,,pgxind-kftx6cbp,pgxcs-kftwq3zd,119063865,0.041,114091163,0.04,4972702,0.002,PGX_AM_BS_GSM287061,{},-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.993000,1,16,,,,,,geo:GSE11318,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GPL6400,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,geo:gse,geo:gpl,,pubmed,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d858,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka6y,,pgxind-kftx6cbr,pgxcs-kftwq3zp,118764639,0.041,118210881,0.041,553758,0,PGX_AM_BS_GSM287062,{},-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.994000,1,8,,,,,,geo:GPL6400,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",geo:GSM287062,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gse,geo:gpl,pubmed,,geo:gsm,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d85b,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSM287065,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka73,P64Y,pgxind-kftx6cbx,pgxcs-kftwq40n,241948211,0.084,177885492,0.062,64062719,0.022,PGX_AM_BS_GSM287065,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:36.997000,1,5,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GPL6400,,geo:GSE11318,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,pubmed,geo:gpl,,geo:gse,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d85e,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],geo:GSM287068,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka78,P85Y,pgxind-kftx6cc3,pgxcs-kftwq41m,4153612,0.001,2252970,0.001,1900642,0.001,PGX_AM_BS_GSM287068,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},10.09.20 17:46,1,18,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,,,,,,,geo:GPL6400,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,geo:gsm,geo:gse,geo:gpl,,pubmed,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d85f,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSM287069,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka7a,P46Y,pgxind-kftx6cc5,pgxcs-kftwq41x,227457814,0.079,172701329,0.06,54756485,0.019,PGX_AM_BS_GSM287069,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:37.001000,1,22,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GPL6400,,geo:GSE11318,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,pubmed,geo:gpl,,geo:gse,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d865,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka7k,P80Y,pgxind-kftx6cch,pgxcs-kftwq43t,835249,0,205984,0,629265,0,PGX_AM_BS_GSM287075,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:37.008000,1,30,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,,,,,,,geo:GPL6400,,geo:GSM287075,,,,pubmed,geo:gse,geo:gpl,,geo:gsm,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d866,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GPL6400,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka7l,P55Y,pgxind-kftx6ccj,pgxcs-kftwq444,35693447,0.012,9754293,0.003,25939154,0.009,PGX_AM_BS_GSM287076,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:37.009000,1,17,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,geo:GSE11318,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",geo:GSM287076,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gpl,geo:gse,pubmed,,geo:gsm,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d867,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSE11318,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka7n,P60Y,pgxind-kftx6ccl,pgxcs-kftwq44g,373621061,0.13,199980413,0.07,173640648,0.06,PGX_AM_BS_GSM287077,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:37.010000,1,13,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GPL6400,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",geo:GSM287077,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gse,geo:gpl,pubmed,,geo:gsm,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d868,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka7o,P65Y,pgxind-kftx6ccn,pgxcs-kftwq44r,52221884,0.018,1808495,0.001,50413389,0.018,PGX_AM_BS_GSM287078,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:37.011000,1,4,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GPL6400,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,geo:GSM287078,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),pubmed,geo:gpl,geo:gse,,geo:gsm,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d86a,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],geo:GSM287080,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka7s,P83Y,pgxind-kftx6ccr,pgxcs-kftwq45d,15681192,0.005,7081194,0.002,8599998,0.003,PGX_AM_BS_GSM287080,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:37.013000,1,4,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,geo:GPL6400,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,geo:gpl,geo:gse,,pubmed,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d86b,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSM287081,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka7t,P34Y,pgxind-kftx6cct,pgxcs-kftwq45p,9528274,0.003,4670305,0.002,4857969,0.002,PGX_AM_BS_GSM287081,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:37.014000,1,17,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,,,,,,,geo:GPL6400,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,geo:gsm,geo:gse,geo:gpl,,pubmed,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d86c,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka7v,P55Y,pgxind-kftx6ccv,pgxcs-kftwq460,48732361,0.017,48732361,0.017,0,0,PGX_AM_BS_GSM287082,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:37.015000,1,83,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GPL6400,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,,,,,,,geo:GSE11318,,geo:GSM287082,,,,pubmed,geo:gpl,geo:gse,,geo:gsm,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d86d,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [Unclassified],geo:GSM287083,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka7w,P59Y,pgxind-kftx6ccx,pgxcs-kftwq46b,2947918,0.001,2612513,0.001,335405,0,PGX_AM_BS_GSM287083,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:37.016000,1,38,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GPL6400,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GSE11318,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,geo:gpl,geo:gse,,pubmed,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d86e,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka7y,P78Y,pgxind-kftx6ccz,pgxcs-kftwq46m,1586430,0.001,1526805,0.001,59625,0,PGX_AM_BS_GSM287084,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:37.017000,1,16,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GSE11318,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GPL6400,,geo:GSM287084,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),pubmed,geo:gse,geo:gpl,,geo:gsm,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d86f,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],geo:GSM287085,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka80,P49Y,pgxind-kftx6cd1,pgxcs-kftwq46x,513428950,0.179,271355277,0.094,242073673,0.084,PGX_AM_BS_GSM287085,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:37.018000,1,25,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GPL6400,,geo:GSE11318,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,pubmed,geo:gpl,,geo:gse,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d870,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSM287086,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka81,P57Y,pgxind-kftx6cd3,pgxcs-kftwq478,14709564,0.005,3251728,0.001,11457836,0.004,PGX_AM_BS_GSM287086,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:37.019000,1,3,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,geo:GPL6400,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,,,,,,,geo:GSE11318,,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,geo:gsm,geo:gpl,geo:gse,,pubmed,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d871,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSM287087,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka83,P67Y,pgxind-kftx6cd5,pgxcs-kftwq47k,49115444,0.017,48599272,0.017,516172,0,PGX_AM_BS_GSM287087,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:37.020000,1,24,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,,,,,,,geo:GPL6400,,geo:GSE11318,,,,geo:gsm,pubmed,geo:gpl,,geo:gse,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d873,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka86,,pgxind-kftx6cd9,pgxcs-kftwq486,321375410,0.112,114828746,0.04,206546664,0.072,PGX_AM_BS_GSM287089,{},-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:37.022000,1,14,,,,,,geo:GSE11318,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GPL6400,,geo:GSM287089,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),pubmed,geo:gse,geo:gpl,,geo:gsm,arraymap import,,,,,,,,,,,,,,,F
5dc1853e09d374f6dd84d874,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [germinal center B-cell-like],PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka88,,pgxind-kftx6cdb,pgxcs-kftwq48i,9836854,0.003,3613581,0.001,6223273,0.002,PGX_AM_BS_GSM287090,{},-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:37.023000,1,2,,,,,,geo:GPL6400,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,,,,,,,geo:GSE11318,,geo:GSM287090,,,,pubmed,geo:gpl,geo:gse,,geo:gsm,arraymap import,,,,,,,,,,,,,,,M
5dc1853e09d374f6dd84d877,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,diffuse large B-cell lymphoma [activated B-cell-like],geo:GSM287093,,NCIT:C80280,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C77.9,"Lymph nodes, NOS",pgxbs-kftvka8d,P69Y,pgxind-kftx6cdi,pgxcs-kftwq49g,164206675,0.057,52264973,0.018,111941702,0.039,PGX_AM_BS_GSM287093,,-77.1,38.98,Point,USA,Bethesda,United States of America,"Bethesda, United States",38.98,-77.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000029,lymph node,{},2020-09-10 17:46:37.026000,1,39,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,PMID:18765795,"Lenz G, Wright GW et al. (2008): Molecular subtypes of diffuse large B-cell...",,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,geo:GPL6400,,geo:GSE11318,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),geo:gsm,pubmed,geo:gpl,,geo:gse,arraymap import,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aab1f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [gastrointestinal],PMID:9596681,"Barth TF, Dhner H et al. (1998): Characteristic pattern of chromosomal gains and...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C17.9,Small intestine,pgxbs-kftva6aa,P53Y,pgxind-kftx26j5,pgxcs-kftvllrs,0,0,0,0,0,0,PGX_AM_BS_GI-NHL01,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002108,small intestine,{},2020-09-10 17:44:06.085000,0,69,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aab20,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [gastrointestinal],PMID:9596681,"Barth TF, Dhner H et al. (1998): Characteristic pattern of chromosomal gains and...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C16.9,stomach,pgxbs-kftva6ac,P54Y,pgxind-kftx26j7,pgxcs-kftvllsa,0,0,0,0,0,0,PGX_AM_BS_GI-NHL02,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000945,stomach,{},2020-09-10 17:44:06.086000,0,71,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aab23,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [gastrointestinal],PMID:9596681,"Barth TF, Dhner H et al. (1998): Characteristic pattern of chromosomal gains and...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C16.9,stomach,pgxbs-kftva6ah,P83Y,pgxind-kftx26jd,pgxcs-kftvlltq,84693614,0.029,0,0,84693614,0.029,PGX_AM_BS_GI-NHL05,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000945,stomach,{},2020-09-10 17:44:06.090000,0,15,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aab26,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [gastrointestinal],PMID:9596681,"Barth TF, Dhner H et al. (1998): Characteristic pattern of chromosomal gains and...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C16.9,stomach,pgxbs-kftva6am,P62Y,pgxind-kftx26jj,pgxcs-kftvllv5,0,0,0,0,0,0,PGX_AM_BS_GI-NHL08,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000945,stomach,{},2020-09-10 17:44:06.094000,0,62,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aab28,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [gastrointestinal],PMID:9596681,"Barth TF, Dhner H et al. (1998): Characteristic pattern of chromosomal gains and...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C16.9,stomach,pgxbs-kftva6ap,P62Y,pgxind-kftx26jn,pgxcs-kftvllw4,110047213,0.038,0,0,110047213,0.038,PGX_AM_BS_GI-NHL10,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000945,stomach,{},2020-09-10 17:44:06.097000,0,46,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aab29,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [gastrointestinal],PMID:9596681,"Barth TF, Dhner H et al. (1998): Characteristic pattern of chromosomal gains and...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C16.9,stomach,pgxbs-kftva6aq,P41Y,pgxind-kftx26jp,pgxcs-kftvllwl,122800124,0.043,85600086,0.03,37200038,0.013,PGX_AM_BS_GI-NHL11,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000945,stomach,{},2020-09-10 17:44:06.098000,0,1,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aab2b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [gastrointestinal],PMID:9596681,"Barth TF, Dhner H et al. (1998): Characteristic pattern of chromosomal gains and...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C16.9,stomach,pgxbs-kftva6au,P46Y,pgxind-kftx26jt,pgxcs-kftvllxk,74600075,0.026,54300054,0.019,20300021,0.007,PGX_AM_BS_GI-NHL13,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000945,stomach,{},2020-09-10 17:44:06.101000,0,39,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aab2f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [gastrointestinal],PMID:9596681,"Barth TF, Dhner H et al. (1998): Characteristic pattern of chromosomal gains and...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C16.9,stomach,pgxbs-kftva6b0,P43Y,pgxind-kftx26k1,pgxcs-kftvllzi,0,0,0,0,0,0,PGX_AM_BS_GI-NHL17,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000945,stomach,{},2020-09-10 17:44:06.106000,0,86,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aab31,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [gastrointestinal],PMID:9596681,"Barth TF, Dhner H et al. (1998): Characteristic pattern of chromosomal gains and...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C16.9,stomach,pgxbs-kftva6b4,P63Y,pgxind-kftx26k5,pgxcs-kftvlm0g,0,0,0,0,0,0,PGX_AM_BS_GI-NHL19,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000945,stomach,{},2020-09-10 17:44:06.109000,0,48,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aab32,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [gastrointestinal],PMID:9596681,"Barth TF, Dhner H et al. (1998): Characteristic pattern of chromosomal gains and...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C16.9,stomach,pgxbs-kftva6b5,P80Y,pgxind-kftx26k7,pgxcs-kftvlm0y,0,0,0,0,0,0,PGX_AM_BS_GI-NHL20,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000945,stomach,{},2020-09-10 17:44:06.111000,0,40,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aab33,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [gastrointestinal],PMID:9596681,"Barth TF, Dhner H et al. (1998): Characteristic pattern of chromosomal gains and...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C16.9,stomach,pgxbs-kftva6b7,P71Y,pgxind-kftx26k9,pgxcs-kftvlm1f,0,0,0,0,0,0,PGX_AM_BS_GI-NHL21,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000945,stomach,{},2020-09-10 17:44:06.112000,0,29,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aab35,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [gastrointestinal],PMID:9596681,"Barth TF, Dhner H et al. (1998): Characteristic pattern of chromosomal gains and...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C16.9,stomach,pgxbs-kftva6ba,P80Y,pgxind-kftx26kd,pgxcs-kftvlm2e,0,0,0,0,0,0,PGX_AM_BS_GI-NHL23,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000945,stomach,{},2020-09-10 17:44:06.115000,0,36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aab36,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [gastrointestinal],PMID:9596681,"Barth TF, Dhner H et al. (1998): Characteristic pattern of chromosomal gains and...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C17.9,Small intestine,pgxbs-kftva6bc,P89Y,pgxind-kftx26kf,pgxcs-kftvlm2w,0,0,0,0,0,0,PGX_AM_BS_GI-NHL24,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002108,small intestine,{},2020-09-10 17:44:06.117000,0,91,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aab38,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [gastrointestinal],PMID:9596681,"Barth TF, Dhner H et al. (1998): Characteristic pattern of chromosomal gains and...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C16.9,stomach,pgxbs-kftva6bf,P41Y,pgxind-kftx26kk,pgxcs-kftvlm3u,0,0,0,0,0,0,PGX_AM_BS_GI-NHL26,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000945,stomach,{},2020-09-10 17:44:06.120000,0,72,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aab39,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [gastrointestinal],PMID:9596681,"Barth TF, Dhner H et al. (1998): Characteristic pattern of chromosomal gains and...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C16.9,stomach,pgxbs-kftva6bh,P77Y,pgxind-kftx26km,pgxcs-kftvlm4c,0,0,0,0,0,0,PGX_AM_BS_GI-NHL27,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000945,stomach,{},2020-09-10 17:44:06.121000,0,47,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aab3a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [gastrointestinal],PMID:9596681,"Barth TF, Dhner H et al. (1998): Characteristic pattern of chromosomal gains and...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C16.9,stomach,pgxbs-kftva6bi,P74Y,pgxind-kftx26ko,pgxcs-kftvlm4s,178376968,0.062,30500031,0.011,147876937,0.051,PGX_AM_BS_GI-NHL28,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000945,stomach,{},2020-09-10 17:44:06.122000,0,68,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aab3c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [gastrointestinal],PMID:9596681,"Barth TF, Dhner H et al. (1998): Characteristic pattern of chromosomal gains and...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C16.9,stomach,pgxbs-kftva6bm,P74Y,pgxind-kftx26ks,pgxcs-kftvlm5r,0,0,0,0,0,0,PGX_AM_BS_GI-NHL30,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000945,stomach,{},2020-09-10 17:44:06.125000,0,72,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af117,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [cutaneous],PMID:15175042,"Hallermann C, Kaune KM et al. (2004): Chromosomal aberration patterns differ in subtypes...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C44.9,"Skin, NOS",pgxbs-kftvh3pi,P65Y,pgxind-kftx2yf6,pgxcs-kftvshwz,249488363,0.087,0,0,249488363,0.087,PGX_AM_BS_C-BNHL-LBCL-01,{},9.92,51.54,Point,DEU,Goettingen,Germany,"Goettingen, Germany",51.54,9.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.445000,0,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af119,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [cutaneous],PMID:15175042,"Hallermann C, Kaune KM et al. (2004): Chromosomal aberration patterns differ in subtypes...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C44.9,"Skin, NOS",pgxbs-kftvh3pm,P74Y,pgxind-kftx2yfa,pgxcs-kftvshxw,154892051,0.054,94874837,0.033,60017214,0.021,PGX_AM_BS_C-BNHL-LBCL-03a,{},9.92,51.54,Point,DEU,Goettingen,Germany,"Goettingen, Germany",51.54,9.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.448000,0,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af11a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [cutaneous],PMID:15175042,"Hallermann C, Kaune KM et al. (2004): Chromosomal aberration patterns differ in subtypes...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C44.9,"Skin, NOS",pgxbs-kftvh3pn,P74Y,pgxind-kftx2yfc,pgxcs-kftvshyd,154892051,0.054,94874837,0.033,60017214,0.021,PGX_AM_BS_C-BNHL-LBCL-03b,{},9.92,51.54,Point,DEU,Goettingen,Germany,"Goettingen, Germany",51.54,9.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.449000,0,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af120,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [cutaneous],PMID:15175042,"Hallermann C, Kaune KM et al. (2004): Chromosomal aberration patterns differ in subtypes...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C44.9,"Skin, NOS",pgxbs-kftvh3px,P77Y,pgxind-kftx2yfo,pgxcs-kftvsi17,920074420,0.32,0,0,920074420,0.32,PGX_AM_BS_C-BNHL-LBCL-07,{},9.92,51.54,Point,DEU,Goettingen,Germany,"Goettingen, Germany",51.54,9.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.457000,0,18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af122,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [cutaneous],PMID:15175042,"Hallermann C, Kaune KM et al. (2004): Chromosomal aberration patterns differ in subtypes...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C44.9,"Skin, NOS",pgxbs-kftvh3q0,P47Y,pgxind-kftx2yfs,pgxcs-kftvsi26,0,0,0,0,0,0,PGX_AM_BS_C-BNHL-LBCL-09,{},9.92,51.54,Point,DEU,Goettingen,Germany,"Goettingen, Germany",51.54,9.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.460000,0,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af123,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [cutaneous],PMID:15175042,"Hallermann C, Kaune KM et al. (2004): Chromosomal aberration patterns differ in subtypes...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C44.9,"Skin, NOS",pgxbs-kftvh3q1,P70Y,pgxind-kftx2yfu,pgxcs-kftvsi2n,205155996,0.071,0,0,205155996,0.071,PGX_AM_BS_C-BNHL-LBCL-10,{},9.92,51.54,Point,DEU,Goettingen,Germany,"Goettingen, Germany",51.54,9.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.461000,0,14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af124,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [cutaneous],PMID:15175042,"Hallermann C, Kaune KM et al. (2004): Chromosomal aberration patterns differ in subtypes...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C44.9,"Skin, NOS",pgxbs-kftvh3q3,P53Y,pgxind-kftx2yfw,pgxcs-kftvsi34,666766810,0.232,0,0,666766810,0.232,PGX_AM_BS_C-BNHL-LBCL-11,{},9.92,51.54,Point,DEU,Goettingen,Germany,"Goettingen, Germany",51.54,9.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.463000,0,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af125,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [cutaneous],PMID:15175042,"Hallermann C, Kaune KM et al. (2004): Chromosomal aberration patterns differ in subtypes...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C44.9,"Skin, NOS",pgxbs-kftvh3q5,P84Y,pgxind-kftx2yfy,pgxcs-kftvsi3l,438319132,0.152,95706076,0.033,342613056,0.119,PGX_AM_BS_C-BNHL-LBCL-12a,{},9.92,51.54,Point,DEU,Goettingen,Germany,"Goettingen, Germany",51.54,9.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.464000,0,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af126,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [cutaneous],PMID:15175042,"Hallermann C, Kaune KM et al. (2004): Chromosomal aberration patterns differ in subtypes...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C44.9,"Skin, NOS",pgxbs-kftvh3q6,P84Y,pgxind-kftx2yg0,pgxcs-kftvsi42,438319132,0.152,95706076,0.033,342613056,0.119,PGX_AM_BS_C-BNHL-LBCL-12b,{},9.92,51.54,Point,DEU,Goettingen,Germany,"Goettingen, Germany",51.54,9.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.465000,0,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af127,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [cutaneous],PMID:15175042,"Hallermann C, Kaune KM et al. (2004): Chromosomal aberration patterns differ in subtypes...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C44.9,"Skin, NOS",pgxbs-kftvh3q8,P90Y,pgxind-kftx2yg3,pgxcs-kftvsi4j,582322235,0.203,173749893,0.06,408572342,0.142,PGX_AM_BS_C-BNHL-LBCL-13,{},9.92,51.54,Point,DEU,Goettingen,Germany,"Goettingen, Germany",51.54,9.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.467000,0,29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aab21,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [gastrointestinal],PMID:9596681,"Barth TF, Dhner H et al. (1998): Characteristic pattern of chromosomal gains and...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C16.9,stomach,pgxbs-kftva6ad,P75Y,pgxind-kftx26j9,pgxcs-kftvllsr,0,0,0,0,0,0,PGX_AM_BS_GI-NHL03,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000945,stomach,{},2020-09-10 17:44:06.087000,1,4,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aab24,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [gastrointestinal],PMID:9596681,"Barth TF, Dhner H et al. (1998): Characteristic pattern of chromosomal gains and...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C17.9,Small intestine,pgxbs-kftva6ai,P89Y,pgxind-kftx26jf,pgxcs-kftvllu7,262452645,0.091,59500059,0.021,202952586,0.071,PGX_AM_BS_GI-NHL06,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002108,small intestine,{},2020-09-10 17:44:06.091000,1,0.5,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aab25,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [gastrointestinal],PMID:9596681,"Barth TF, Dhner H et al. (1998): Characteristic pattern of chromosomal gains and...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C16.9,stomach,pgxbs-kftva6ak,P78Y,pgxind-kftx26jh,pgxcs-kftvlluo,0,0,0,0,0,0,PGX_AM_BS_GI-NHL07,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000945,stomach,{},2020-09-10 17:44:06.093000,1,7,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aab27,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [gastrointestinal],PMID:9596681,"Barth TF, Dhner H et al. (1998): Characteristic pattern of chromosomal gains and...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C16.9,stomach,pgxbs-kftva6an,P46Y,pgxind-kftx26jl,pgxcs-kftvllvn,0,0,0,0,0,0,PGX_AM_BS_GI-NHL09,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000945,stomach,{},2020-09-10 17:44:06.096000,1,12,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aab2a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [gastrointestinal],PMID:9596681,"Barth TF, Dhner H et al. (1998): Characteristic pattern of chromosomal gains and...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C16.9,stomach,pgxbs-kftva6as,P63Y,pgxind-kftx26jr,pgxcs-kftvllx2,196766087,0.068,15300015,0.005,181466072,0.063,PGX_AM_BS_GI-NHL12,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000945,stomach,{},2020-09-10 17:44:06.100000,1,3,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aab2c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [gastrointestinal],PMID:9596681,"Barth TF, Dhner H et al. (1998): Characteristic pattern of chromosomal gains and...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C16.9,stomach,pgxbs-kftva6av,P68Y,pgxind-kftx26jv,pgxcs-kftvlly1,247549783,0.086,155300156,0.054,92249627,0.032,PGX_AM_BS_GI-NHL14,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000945,stomach,{},2020-09-10 17:44:06.102000,1,0.5,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aab2d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [gastrointestinal],PMID:9596681,"Barth TF, Dhner H et al. (1998): Characteristic pattern of chromosomal gains and...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C16.9,stomach,pgxbs-kftva6ax,P79Y,pgxind-kftx26jx,pgxcs-kftvllyj,0,0,0,0,0,0,PGX_AM_BS_GI-NHL15,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000945,stomach,{},2020-09-10 17:44:06.104000,1,3,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aab2e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [gastrointestinal],PMID:9596681,"Barth TF, Dhner H et al. (1998): Characteristic pattern of chromosomal gains and...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C17.9,Small intestine,pgxbs-kftva6az,P74Y,pgxind-kftx26jz,pgxcs-kftvllz0,258538895,0.09,219500219,0.076,39038676,0.014,PGX_AM_BS_GI-NHL16,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002108,small intestine,{},2020-09-10 17:44:06.105000,1,23,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aab30,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [gastrointestinal],PMID:9596681,"Barth TF, Dhner H et al. (1998): Characteristic pattern of chromosomal gains and...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C18.9,"large intestine, excl. rectum and rectosigmoid junction",pgxbs-kftva6b2,P74Y,pgxind-kftx26k3,pgxcs-kftvllzz,0,0,0,0,0,0,PGX_AM_BS_GI-NHL18,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001155,colon,{},2020-09-10 17:44:06.108000,1,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aab34,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [gastrointestinal],PMID:9596681,"Barth TF, Dhner H et al. (1998): Characteristic pattern of chromosomal gains and...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C18.9,"large intestine, excl. rectum and rectosigmoid junction",pgxbs-kftva6b8,P74Y,pgxind-kftx26kb,pgxcs-kftvlm1x,42000042,0.015,21700021,0.008,20300021,0.007,PGX_AM_BS_GI-NHL22,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001155,colon,{},2020-09-10 17:44:06.114000,1,13,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aab37,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [gastrointestinal],PMID:9596681,"Barth TF, Dhner H et al. (1998): Characteristic pattern of chromosomal gains and...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C16.9,stomach,pgxbs-kftva6bd,P77Y,pgxind-kftx26kh,pgxcs-kftvlm3d,0,0,0,0,0,0,PGX_AM_BS_GI-NHL25,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000945,stomach,{},2020-09-10 17:44:06.118000,1,4,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aab3b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [gastrointestinal],PMID:9596681,"Barth TF, Dhner H et al. (1998): Characteristic pattern of chromosomal gains and...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C16.9,stomach,pgxbs-kftva6bk,P81Y,pgxind-kftx26kq,pgxcs-kftvlm5a,166649702,0.058,34300035,0.012,132349667,0.046,PGX_AM_BS_GI-NHL29,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000945,stomach,{},2020-09-10 17:44:06.124000,1,3,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aafeb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse large B-cell lymphoma [spleen, IG-MYC maybe, 3q2 break neg., t(14;18) neg.]",PMID:8652842,"Monni O, Joensuu H et al. (1996): DNA copy number changes in diffuse...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C42.2,Spleen,pgxbs-kftvgifk,P25Y,pgxind-kftx28f4,pgxcs-kftvm2if,0,0,0,0,0,0,PGX_AM_BS_DLBCL-mon-15,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002106,spleen,{},2020-09-10 17:44:07.799000,1,29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aafed,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse Large B-cell Lymphoma [extranodal, small bowel]",PMID:8652842,"Monni O, Joensuu H et al. (1996): DNA copy number changes in diffuse...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C17.9,small intestine,pgxbs-kftvgifn,P69Y,pgxind-kftx28f8,pgxcs-kftvm2jc,92300092,0.032,32600033,0.011,59700059,0.021,PGX_AM_BS_DLBCL-mon-17,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002108,small intestine,{},2020-09-10 17:44:07.802000,1,11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aafee,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse Large B-cell Lymphoma [extranodal, mesentery]",PMID:8652842,"Monni O, Joensuu H et al. (1996): DNA copy number changes in diffuse...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C48.9,retroperitoneum and peritoneum,pgxbs-kftvgifp,P47Y,pgxind-kftx28fa,pgxcs-kftvm2jt,156858024,0.055,85600086,0.03,71257938,0.025,PGX_AM_BS_DLBCL-mon-18,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0003693,retroperitoneal space,{},2020-09-10 17:44:07.803000,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aafef,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse Large B-cell Lymphoma [extranodal, mesentery, 3q2 break neg., t(14;18) neg.]",PMID:8652842,"Monni O, Joensuu H et al. (1996): DNA copy number changes in diffuse...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C48.9,retroperitoneum and peritoneum,pgxbs-kftvgifr,P70Y,pgxind-kftx28fc,pgxcs-kftvm2ka,265219999,0.092,110306090,0.038,154913909,0.054,PGX_AM_BS_DLBCL-mon-19,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0003693,retroperitoneal space,{},2020-09-10 17:44:07.805000,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aaff3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse Large B-cell Lymphoma [extranodal, breast, IG-MYC neg., 3q2 break neg., t(14;18) neg.]",PMID:8652842,"Monni O, Joensuu H et al. (1996): DNA copy number changes in diffuse...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C50.9,"Breast, NOS",pgxbs-kftvgifx,P59Y,pgxind-kftx28fk,pgxcs-kftvm2m5,761552114,0.265,270020004,0.094,491532110,0.171,PGX_AM_BS_DLBCL-mon-23,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000310,breast,{},2020-09-10 17:44:07.810000,1,29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aaff4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse Large B-cell Lymphoma [extranodal, stomach]",PMID:8652842,"Monni O, Joensuu H et al. (1996): DNA copy number changes in diffuse...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C16.9,stomach,pgxbs-kftvgifz,P81Y,pgxind-kftx28fm,pgxcs-kftvm2mm,277863752,0.097,154913909,0.054,122949843,0.043,PGX_AM_BS_DLBCL-mon-24,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000945,stomach,{},2020-09-10 17:44:07.812000,1,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aaff5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Diffuse Large B-cell Lymphoma [extranodal, abdominal wall, IG-MYC maybe, 3q2 break neg., t(14;18) pos.]",PMID:8652842,"Monni O, Joensuu H et al. (1996): DNA copy number changes in diffuse...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgig1,P39Y,pgxind-kftx28fo,pgxcs-kftvm2n2,472825148,0.164,117627372,0.041,355197776,0.124,PGX_AM_BS_DLBCL-mon-25,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:07.813000,1,17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af118,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [cutaneous],PMID:15175042,"Hallermann C, Kaune KM et al. (2004): Chromosomal aberration patterns differ in subtypes...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C44.9,"Skin, NOS",pgxbs-kftvh3pk,P89Y,pgxind-kftx2yf8,pgxcs-kftvshxf,116000115,0.04,56900056,0.02,59100059,0.021,PGX_AM_BS_C-BNHL-LBCL-02,{},9.92,51.54,Point,DEU,Goettingen,Germany,"Goettingen, Germany",51.54,9.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.446000,1,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af11b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [cutaneous],PMID:15175042,"Hallermann C, Kaune KM et al. (2004): Chromosomal aberration patterns differ in subtypes...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C44.9,"Skin, NOS",pgxbs-kftvh3pp,P82Y,pgxind-kftx2yfe,pgxcs-kftvshyv,180006160,0.063,110306090,0.038,69700070,0.024,PGX_AM_BS_C-BNHL-LBCL-04a,{},9.92,51.54,Point,DEU,Goettingen,Germany,"Goettingen, Germany",51.54,9.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.450000,1,38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af11c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [cutaneous],PMID:15175042,"Hallermann C, Kaune KM et al. (2004): Chromosomal aberration patterns differ in subtypes...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C44.9,"Skin, NOS",pgxbs-kftvh3pq,P82Y,pgxind-kftx2yfg,pgxcs-kftvshzc,331563700,0.115,172742117,0.06,158821583,0.055,PGX_AM_BS_C-BNHL-LBCL-04b,{},9.92,51.54,Point,DEU,Goettingen,Germany,"Goettingen, Germany",51.54,9.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.452000,1,38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af11d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [cutaneous],PMID:15175042,"Hallermann C, Kaune KM et al. (2004): Chromosomal aberration patterns differ in subtypes...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C44.9,"Skin, NOS",pgxbs-kftvh3ps,P73Y,pgxind-kftx2yfi,pgxcs-kftvshzt,0,0,0,0,0,0,PGX_AM_BS_C-BNHL-LBCL-05,{},9.92,51.54,Point,DEU,Goettingen,Germany,"Goettingen, Germany",51.54,9.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.453000,1,18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af11e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [cutaneous],PMID:15175042,"Hallermann C, Kaune KM et al. (2004): Chromosomal aberration patterns differ in subtypes...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C44.9,"Skin, NOS",pgxbs-kftvh3pu,P69Y,pgxind-kftx2yfk,pgxcs-kftvsi0a,0,0,0,0,0,0,PGX_AM_BS_C-BNHL-LBCL-06a,{},9.92,51.54,Point,DEU,Goettingen,Germany,"Goettingen, Germany",51.54,9.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.454000,1,35,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af11f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [cutaneous],PMID:15175042,"Hallermann C, Kaune KM et al. (2004): Chromosomal aberration patterns differ in subtypes...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C44.9,"Skin, NOS",pgxbs-kftvh3pv,P69Y,pgxind-kftx2yfm,pgxcs-kftvsi0r,188674931,0.066,109900110,0.038,78774821,0.027,PGX_AM_BS_C-BNHL-LBCL-06b,{},9.92,51.54,Point,DEU,Goettingen,Germany,"Goettingen, Germany",51.54,9.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.456000,1,35,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af121,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Diffuse large B-cell lymphoma [cutaneous],PMID:15175042,"Hallermann C, Kaune KM et al. (2004): Chromosomal aberration patterns differ in subtypes...",NCIT:C8851,Diffuse Large B-Cell Lymphoma,icdom-96803,"Malignant lymphoma, large B-cell, diffuse, NOS",icdot-C44.9,"Skin, NOS",pgxbs-kftvh3py,P75Y,pgxind-kftx2yfq,pgxcs-kftvsi1o,274914852,0.096,47400048,0.016,227514804,0.079,PGX_AM_BS_C-BNHL-LBCL-08,{},9.92,51.54,Point,DEU,Goettingen,Germany,"Goettingen, Germany",51.54,9.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000014,zone of skin,{},2020-09-10 17:44:31.459000,1,73,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
